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Abstract 
Previous economic analysis of brucellosis control in Mongolia provided a basis for 
further research. It was observed that there was a long tradition of brucellosis control 
in Mongolia but little knowledge on its effect on the spread of disease. This thesis 
addressed this gap and analysed the relationship between stated surveillance policy, 
the brucellosis prevalence in animals, and the brucellosis incidence in humans. The 
aim was to contribute to better understanding of the brucellosis surveillance policies 
applied in Mongolia and their effectiveness, and to draw conclusions and recom- 
mendations for control of brucellosis. 
Four aims were formulated providing steps for investigating the research question. 
The first two aims focused on (i) the establishment of the epidemiological patterns 
of brucellosis in Mongolia over the time period 1966 to 2002, and on (ii) the provi- 
sion of a historical overview of the different strategies applied to the control of 
brucellosis in Mongolia over the same time period. The third aim was to assess the 
interactions between the spread of brucellosis and the surveillance strategies, and 
finally the forth aim was to issue recommendations about future surveillance policies 
for brucellosis. 
It was found that the published figures reflected the Brucellosis abortus incidence in 
the population that could be serologically tested. However, the population at risk 
(herders) with the main burden of disease, and suffering from Brucellosis melitensis, 
was underdiagnosed and not treated properly, additionally, the immunisation cam- 
paigns in small ruminants did not reach the critical vaccination level for eradication. 
Therefore, the diagnosis and treatment of Brucellosis melitensis in humans has to be 
assured at Soum (district) level. The current immunisation campaign has to be moni- 
tored and evaluated, and the knowledge of brucellosis in humans has to be recog- 
nised by policy makers, physicians and general population. 
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search. Access to a wide range of skills and insights to various disciplines is needed 
to face the challenge of understanding and adapting scientific knowledge to achieve 
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troducing managed care in Switzerland, I took over the managing lead of one of the 
first Health Maintenance Organisation (HMO) in Switzerland. Joining the Swiss 
Tropical Institute (STI) as senior officer in the directorate, I was managing various 
projects in Developing Countries. I followed up the DrPH programme part-time, 
working whilst as manager of the EQUAM Foundation (ZMch / Switzerland), pro- 
moting a quality label for quality management in primary health care. 
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I was the coordinator of a research study on the impact of brucellosis on households, 
a survey with special consideration of its direct and indirect costs and on coping 
strategies. This allowed me to conduct the research work in one of the most fascinat- 
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Chapter 1 
Introduction 
The interest in the topic of the thesis arose from previous work on brucellosis control 
in Mongolia. Brucellosis control occurred for many years but remained unevaluated. 
The aim of the thesis was to analyse the possible interactions between the surveil- 
lance strategies applied to control brucellosis - and its spread - to formulate recom- 
mendations about future surveillance policies. 
1. Brucellosis 
Man and animals have long since lived with brucellosis. Hippocrates (450 bc) de- 
scribed brucellosis in humans (Parnas J et al, 1966) and examinations of the skele- 
tons of victims of the eruption of Mount Vesuvius (79 AD) reveal a high prevalence 
of brucellosis as bone lesions - typical of brucellosis - were found in 17.4% of the 
adults (Capasso L, 1999), presumably due to the consumption of milk from sheep 
and goats. During the 18'h* century this disease was commonly known in the Medi- 
terranean region as "Malta fever", "Mediterranean fever", "Gibraltar fever", "Crete 
fever", 'Neapolitan fever", "Cyprus fever", etc. The etiology of brucellosis was not 
known at that time. In the 20'h' century, brucellosis became recognised as a clinical 
entity. It was called "undulant feve: e'. 
Brucellosis is a zoonosis caused by the bacteria from the Brucella group. Brucella 
species create chronic diseases persisting for life. In animals, the organisms is local- 
ised in the reproductive organs and cause abortion and sterility; these organisms are 
shed through the urine, milk or placental fluid. This facilitates infection not only to 
other animals but also to humans. Brucella spp. can survive for long periods outside 
the animal body and can enter the human body through food (un-pasteurised infected 
milk) or respiration, cutaneous contact, conjunctival contact. Transmission of 
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Brucella organisms from human to human is extremely rare. Human brucellosis is a 
febrile illness with varied clinical manifestations and may simulate other diseases. In 
the absence of specific treatment, human brucellosis may persist and progress to a 
chronically incapacitating disease with severe complications. 
Despite the biotechnological improvements achieved during the last half century, 
brucellosis, has remained one of the most important bacterial zoonosis worldwide 
(Young E, 1995) (Cutler SJ et al, 2005) (Cutler S et al, 2003). Brucellosis was clas- 
sified as a list B disease by OIE (Office International des Epizooties; Organisation 
mondiale de la sant6 animale), as being of importance from a socio-economic and / 
or public health points of view (see appendix 1.1 for list B). Only 17 countries were 
considered to be free of brucellosis (1994), and this status could only be maintained 
with a considerable surveillance investment (see appendix 1.2for countries listed). 
When present, this disease is a huge burden in developing countries, perpetuating 
poverty through the loss of productivity and livestock, and causes severe and debili- 
tating disease in humans. Although controlled or even eradicated by rigorous sur- 
veillance policies in most developed countries, re-introduction of brucellosis remains 
a constant threat. WHOTAO/O. I. E. joint consultation on emerging zoonotic dis- 
eases (WHO et al, 2004) considers brucellosis as one of the key zoonosis of concern, 
leading Dr. William Amanful to state: '7his is the second most important zoonosis in 
the world after rabies" (Cutler S et al, 2003). 
It is estimated that about half a million new human infections cases occur worldwide 
per year (Cutler SJ et al, 2005) (Roberts A et al, 2001) (Araj G F, 1999) (Cutler S et 
al, 2003). This may not reflect the actual number, because brucellosis is not consid- 
ered a notifiable disease in many parts of the world; there is no disease-reporting 
system in many countries, and relevant statistics are lacking or not comparable. Hu- 
man brucellosis is considered to be under-diagnosed and under-reported (Madkour 
M., 2001). In developing countries, diagnosis is difficult, and reporting systems are 
1 Animal Health Officer (Bacterial and Zoonotic Diseases) at FAO/Rome 
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less reliable than in industrialised countries. But even in developed countries - where 
the disease is being controlled -a reporting rate of only 20% is estimated in France 
(Foulon G et al, 1981), and even less in Spain (8%) (Aller B, 1975), or the USA 
(3,5%) (911se R 1,1980). More recent estimations report the ratio of reported to un- 
reported cases of 1: 26 (Araj G F, 1999), without giving more specific background 
information. 
Despite the eradication in a few countries, brucellosis in humans and animals is in- 
creasing worldwide. Brucellosis was serious and longstanding in livestock and hu- 
mans in the former USSR-Countries, such as Russia (Caucasus region) (Flynn M P, 
1983) (Liamkin GI et al, 1995) and its central Asian states Kyrgyzstan (UN Office 
for the Coordination of Humanitarian Affairs, 2003) (Kyrgyzstan Development 
Gateway Social sector annual data, 2001), Tajikistan (Jackson R et al, 2003) and 
Kazakhstan. Despite the fact that these countries, with former centrally planned 
economies, had made considerable efforts to control brucellosis for many years, re- 
lated data and published articles are very few (Dobrean Vet al, 2002). The weaken- 
ing of the veterinary system and the transition from large government controlled 
farms to small-scale private farming has lead to the re-emergence of brucellosis. The 
unequal distribution of the spread of brucellosis may reflect deteriorating control 
over the past 10 years, uncontrolled movements of livestock, and influences of envi- 
ronmental factors on local animal management practices (Jackson R et al, 2003). 
This situation fits the current situation in Mongolia, the focus of the thesis. 
2. Mongolia 
Mongolia has unique demographic and environmental characteristics which impact 
health significantly (Government of Mongolia et al, 1999). Few inhabitants (2.475 
million) (National Statistical Ojftce of Mongolia, 2003) who live in a large geo- 
graphical territory of 1.566 million km2 (National Statistical Office of Mongolia, 
2003). Ensuring adequate health services throughout a sparsely populated terrain 
(only 1.58 inhabitant per km2) is a challenge. Providing access to health services for 
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rural populations who are semi-nomadic pastoralists is particularly difficult due to 
the long distances and poor road infrastructure compounded by the severe climatic 
conditions. 
Mongolia had close political and economical relations with the Soviet Union from 
1921 (Mongolian communist revolution) up to the collapse of the Soviet bloc 1989. 
The Soviet Union used to provide about a third of the Mongolian GDP (WHO, 
2005a). This contributed to the gradual transformation of a society based on a no- 
madic lifestyle to a more industrialised and urban society. 
The loss of former assistance, and trade from the Soviet Union, has led to severe 
economic difficulties. The GDP per capita dropped by about 20% between 1990 and 
1993 (World Bank, 1997b). During the transition from a centrally planned economy 
to a market oriented economy Mongolia has seen dramatic changes in all aspects of 
the social, political and economic life. Since 1994, the GDP per capita has grown, 
with fluctuations, from per capita ppp-dollar 1290. -- in 1995 to 1710. -- in 20022 
(UN Common Database / World Bank, 2006). However, there was a growing dispar- 
ity between rural / urban and rich / poor. The fraction of GDP produced in the capi- 
tal Ulaanbaatar (UB) had grown to 54.9% in 2001 (46.6% in 1999) (National Statis- 
tical Office ofMongolia, 2003). There is a high level of internal migration from rural 
to urban areas, leading to ad hoc urbanisation around urban centres particularly 
Ulaanbaatar. About a third of the population are poor (United Nations economic and 
social council, 2002), the fraction of poor in rural areas is increasing. 
Traditionally, the survival of a major section of the population and of the country as 
a whole depended largely on breeding animals. "The main livelihood source and the 
wealth is livestock in Mongolia" (National Statistical Office of Mongolia, 2003). 
However, due to three consecutive harsh winters (2000 to 2002) the number of live- 
stock has declined from 33.5 million in 1999 to 23.9 million in 2002, and the agri- 
culture sector has experienced a sharp reduction; its contribution to GDP has de- 
clined from 38% in 1995 to 20.1% in 2002 (National Statistical Office ofMongolia, 
2 Ranking as 120'h country in 2002 after Laos and before Bangladesh (as 130 country in 1995) 
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2003). As livestock production contributed to 78.9% of the total agriculture produc- 
tion, its contribution to GDP still reached 16% in 2002, and provided 5.5% of the 
national exports (National Statistical Office of Mongolia, 2003). The production is 
mainly nomadic and extensive. 
The Soviet-style health system covered the entire nation, with universal access to 
hospital-based medical services provided free of charge. There was a strong prefer- 
ence for in-patient rather than ambulant care. The system was supported by commu- 
nity-based health workers (Bag Feldshers), Sourn (district) health centres and Aimag 
(provincial) hospitals. The first Health Sector Development Programme (HSDP) 
(1997-2002) aimed at shifting the hospital based services towards a more responsive 
primary health care-orientated system based on family group practice (WHO, 2005a) 
(O'Rourke M et al, 2001). This has been implemented in urban areas. The second 
HSDP (2003-2008) focused on reforms to the first level of referral for rural health 
services, the Sourn hospitals (Hill PS et al, 2006). The total health spending ac- 
counted to 6.2% of GDP (1998), representing per capita total health expenditure of 
USD 24, or expressed in ppp (purchasing power parity) of USD 88 (WHO, 2005a). 
3. Brucellosis in Mongolia 
Mongolia has a long history of brucellosis control, starting in the early 1960s with 
wide-scale epidemiological studies led by the WHO, and intervention programmes 
in animals assisted by COMECON States. After various control activities over dec- 
ades, surveys conducted in the 1980s and 1990s among humans at risk, such as 
herders and workers in slaughterhouses, still confirmed high contamination rates: 
between 15% and 25% of the tested persons were sero-positive, and about 10% of 
the tested persons had active brucellosis (clinical signs). Brucellosis continues to be 
listed among the four major chronic infections, together with hepatitis B and C, tu- 
berculosis and sexually transmitted diseases (STDs) (Ebright JR et al. 2003). 
Brucellosis is thus one of the major veterinary and public health problems. Important 
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in this context is the big population proportion being at risk: about 23 %3 of the 
population live in rural areas and lead a nomadic or semi nomadic way of life 
(Ebright JR et al, 2003). 
4. Previous work leading to the research question 
Being a centrally planned country most livestock was the property of the State and 
kept in co-operative herds. This assured prescribed preventive measures taken by the 
herders. Along the transition in the early 1990s, introducing a market oriented econ- 
omy, most livestock have been returned to private ownership and the state funding 
for animal health activities has been reduced and veterinary services privatised. To 
regain control of the increasing spread of brucellosis, the Mongolian Government 
adopted in 2000, on the recommendation of WHO, a whole-herd vaccination strat- 
egy, seen as the only feasible option and most appropriate approach. 
Prior to the implementation of the whole herd immunisation, the economic implica- 
tions and the effectiveness of this whole-herd vaccination programme was estimated 
by the author who on behalf of WHO and FAO conducted and coordinated a benefit- 
cost analysis and a cost-effectiveness analysis in 2000, with the technical support of 
experts from the RVC, WHO, FAO, STL and in collaboration with Mongolian coun- 
terparts from the MoH and MoA (Roth F. et al, 2001). 
The study concluded that mass vaccinations of livestock against brucellosis in Mon- 
golia would be cost-effective and would result in net economic benefits, if the inter- 
ventions costs were shared between the different beneficiaries on the basis of an 
intersectoral economic assessment. 
In general, there are various factors on different levels which make control, eradica- 
tion or prevention of brucellosis difficult. One set of hampering factors have eco- 
3 Other source mention 28% (Foggin, Peter M et al, 199 7) 
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nomic, political and psychological origins: there were few studies, evaluating the 
costs of various methods to prevent, control, and eradicate this disease. An important 
impact of animal brucellosis is human disease and its associated costs. So it is both 
logical and necessary that both animal and human health authorities promote brucel- 
losis control programmes and allocate their costs through an intersectoral approach. 
Only cost benefit analysis considering the overall costs and benefits for both the 
animal and human sectors can demonstrate their real benefits. Brucellosis often be- 
comes chronic and fails to generate enthusiasm among livestock owners and others 
for longstanding control and eradication efforts. 
The results of the study were therefore useful for policy-makers in determi ig 
strategies, and publication became an important issue. The topic has been split into 
two parts to better reach scientists. The first is oriented to health economics and 
health policy, whereas the second tackles dynamic modelling of transmission from 
animal to animal, and from animal to human. The paper estimating the economic 
benefit, cost-effectiveness and the distribution of benefit has been published in the 
WHO Bulletin (Roth F. et al, 2003). The other paper reporting the dynamic model of 
livestock to human transmission, which was developed as an underlying framework 
to estimate the profitability, has been published in the Preventive Veterinary Medi- 
cine (Zinsstag J. et al, 2005a). Both papers are enclosed in the pocket at the end of 
this thesis. 
The involvement with policy and the analysis of the economic implications stimu- 
lated interest in previous policy to control brucellosis in Mongolia. It also provided a 
basis from which finther research could be conducted. 
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5. Research question 
The author observed that there was a long tradition of brucellosis control in Mongo- 
lia, but that unfortunately there was little knowledge of the effects these surveillance 
policies had had. Therefore, this thesis now proposes to explore these effects and 
provide a better guide to future control efforts in Mongolia. This crucial investiga- 
tion has been greatly facilitated by the author's previous work on brucellosis control 
in Mongolia which established a data collection network in Mongolia, and important 
relationships with scientists, public authorities, policy makers, and health officers. 
The central research question is to determine whether there was any relationship 
between the stated surveillance policy and the brucellosis prevalence in animals and 
humans between 1966 and 2002. To accomplish this aim the empirical evidence of 
epidemiological patterns in animals and humans had to be provided, as well as over- 
view of the different surveillance strategies. 
The observation period begins in the mid 1960s, the start of comprehensive surveil- 
lance activities and data collection. The elements of the applied surveillance policies 
have to be analysed to assess their possible effectiveness. The dataset on the epide- 
miological patterns allow quantitative analyses of the effects of surveillance policy 
on the spread of brucellosis. The findings allow addressing recommendations for 
brucellosis control policies in Mongolia. 
6. Overview of the thesis 
The characteristics of brucellosis are discussed in chapter 2., which provides an 
overview of the symptoms, transmission paths and techniques of diagnosis. The 
worldwide spread of brucellosis is analysed and the Mongolian situation put in this 
context. Basic elements of surveillance are elaborated and put in current context of 
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brucellosis surveillance, providing the critical elements for a qualitative policy 
analysis. 
The research question is presented in chapter 3, and an overview given on the meth- 
odology applied for addressing it. This includes the definition of the type of informa- 
tion required, listing of the data sources, and describing the methodology for data 
collection during the field work in Mongolia, conducted in autumn 2003. The quality 
assurance of the collected data was an important aspect, as the data collection had to 
cope with the language barTier and constraints of conducting research in a large 
sparsely populated developing country. Its methodology is therefore described sepa- 
rately. Finally the methodologies leading to qualitative and quantitative analyses are 
presented. 
The history and evolvement of brucellosis in Mongolia is elaborated in chapter 4, 
creating a comprehensive picture. The etiological aspects determining the sources, 
factors and routes of transmission gave important baseline infon-nation for assessing 
the surveillance policy. 
The history of the different surveillance policies applied to the control of brucellosis 
in Mongolia is analysed in chapter 5. The policy papers provided detailed insight on 
the various elements defining the policies, and allowing ftu-ther analyses carried out 
in chapter 6. Data collection on testing and vaccination allowed an assessment of the 
policy implementation with quantitative data. 
Chapter 6 brings the spread of brucellosis (chapter 4) and the control policy (chapter 
5) together by analysing possible interactions. Qualitative analysis of the surveil- 
lance policies opened the view on policy gaps and on finther possibilities for quanti- 
tative analysis. The vaccination scheme was analysed with mathematical modelling, 
the animal human transmission with multiple regression. Both analysis, the qualita- 
tive and quantitative, allowed drawing conclusion on the applied policies and its 
effectiveness in controlling brucellosis. 
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The last chapter 7 summarises the main findings and discusses the limitation and 
contribution of the thesis. Recommendations for policy makers are formulated. 
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Chapter 2 
Brucellosis 
1. Characteristics of Brucellosis 
History 
In 1886, the British scientist David Bruce (who was later knighted) discovered on 
Malta micrococci probably causing the fever affecting British troops stationed in 
Malta. Microscopic examination of tissue from the spleen of soldiers dying after 
developing "Malta fever" (Parnas J et al, 1966) had revealed them, and he called 
the organism Micrococcus melitensis after the Isle of Malta. In 1918, the bacteria 
would be named Brucella to honour this discovery. The infection's reservoir in 
goats, however, was found only in 1905 by Sir Themistokles Zammit (Parnas J et 
al, 1966). 
The Danish veterinarian Bernhard L. F. Bang discovered in 1897 that the cause of 
cattle mass abortions in Denmark was located in infections caused by a bacteria he 
named "Bacillus abortus bovis". Mass abortions in pigs also caused by bacterial 
infections were described in the USA in 1914 by Trauni (Madkour M, 2001). Fi- 
nally, in 1918, Alice Evans noticed the similarities between micrococcus melitensis 
causing "Malta Fever" in humans and the Bacillus abortus causing mass abortions in 
cattle, pigs, sheep and goats. Micrococcus melitensis was found to be a bacillus. The 
division of the pathology into human and animal, as well as insufficient collabora- 
tion between physicians and veterinarians all combined to delay the linkage between 
human and animal research. 
In the late 30s, it was finally recognised that the fight against brucellosis in humans 
should begin with animals. After WW II, a WHO-Expert Committee on Brucellosis 
was created through the initiative of Martin Kaplan, head of the epidemiological 
department at WHO. The Office International des Epizooties; Organisation mondiale 
27 
de la santd animale (O. I. E. ) became the coordination centre for collecting data on the 
Brucellosis reservoir worldwide. 
The bacteria Brucella 
Brucellosis is a zoonosis caused by the bacteria from the Brucella group. Geneti- 
cally, it can be regarded as variants of a single species, with differentiation into six 
main species: B. abortus, B. suis, B. melitensis, B. neatomae, B. ovis and B. canis. 
This is of practical importance, as the epidemiology and the severity of the diseases 
in humans is influenced by the Brucella type and its source (Corbel M. et al, 2000): 
B. abortus is normally associated with cattle, B. melitensis with sheep and goats, B. 
suis with swine, B. ovis causes infections specific for sheep and has not been impli- 
cated in human diseases, A canis is usually associated with diseases in dogs but oc- 
casionally causes human brucellosis, and B. neatomae has been isolated on few oc- 
casions and has never been implicated in human diseases. The most common 
Brucella species to affect humans is B. melitensis, the most pathogenic species pro- 
ducing the most intense symptoms, the greatest tissue damage, and the most frequent 
incidence of localisation in body organs, systems and tissue. 
Brucellosis in animals 
Clinical features 
The course of brucellosis in animals is sub-acute or chronic. The initial phase fol- 
lowing infection is often unapparent, and the clinical signs are not pathognomic. In 
most host animals, abortions in the latter part of pregnancy, premature births and 
retained placenta are characteristic but not specific signs. The interference with fer- 
tility is usually temporary as most infected animals will abort only once, or have no 
abortion. The infection localises itself in the reproduction system and typically pro- 
duces placentitis in females and epididymitis and orchitis in males. 
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Diagnosis 
Infections acquired in utero or when sexually immature may be negative to serologi- 
cal testing until the animal aborts (Madkour M., 2001). Thus, the identification of 
one or more infected animals is enough evidence for the presence of brucellosis in 
the herd. Other serologically negative animals may present a risk as they might in- 
cubate the disease. 
In view of the fact that clinical signs of brucellosis are not pathognomic, or may be 
absent, laboratory procedures are necessary. There are two categories of diagnostic 
tests, one demonstrating the presence of the organisms using some culture methods, 
and the other detecting an immune response to its antigens in serum. The later is, in 
practice, more feasible, but provides only a provisional diagnosis. For definite proof 
of the infection, the isolation method of Brucella is required. This may also be useful 
to monitor the progress of a vaccination programme. Unfortunately, the facilities 
needed are not always available, and the defuiite identification can only be made 
using techniques available at Brucella Reference Centres (Corbel M et al, 2000). 
Treatment 
Economic losses occur in reproductive efficiency, in livestock commerce, and in 
animal replacement costs. But in most cases, treatment is not an option due to costs 
of therapy, antibiotic residues in milk, and high failure rates (Madkour M., 2001). 
Transmission between animals 
The organisms are shed out through the urine, milk or placenta fluid, thus potentially 
spreading at alarming rates. As pasture areas or accommodations may be contami- 
nated, the bacteria are most frequently ingested, but they can be inhaled, spread by 
conjunctival inoculation and skin contamination as well. Sexual transmission plays a 
particularly important role in transmission of B. meUtensis and B. suis. The transmis- 
sion of diseases is facilitated by factors such as commingling of herds of different 
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owners, close contact caused by high flock density, and by purchasing unscreened 
animals. Brucella species are host specific to some extent, however cross-species 
infections occur: dogs can be infected with B. abortus, B. melitensis or B. suis, by 
ingesting ruminant foetal or placental material, and can then excrete bacteria and 
present a serious hazard to humans and domestic livestock (Corbel M. et al, 2000). 
Cattle can be infected with B. melitensis or even B. suis through close contact with 
small ruminants or swine herds (Poester FP et al, 2002) (Ist International Confer- 
ence on Emerging Zoonoses, 1997). 
Brucellosis in humans 
Transmission to humans 
Brucella spp. can survive for long periods in dust, soil, slush, water, dung, aborted 
foetuses, meat or dairy products, and enter the human body through several ways 
varying according to the endemic situation (Madkour M., 2001). In endemic areas it 
is usually transmitted to humans through food. 
Other modes of infection are respiration, cutaneous contact, the conjunctival contact 
or auto-inoculation. Transmission of Brucella organisms through inhalation com- 
monly occurs among shepherds, animal handlers, farm workers, slaughterhouse 
workers and butchers, veterinarians and laboratory workers. Other risks among 
slaughterhouse workers are transmission through skin abrasion or accidental skin 
penetration. Veterinarians risk infection through accidental splash of live Brucella 
vaccines into the eyes or the accidental self-injection of live Brucella vaccines. 
Transmission of Brucella organisms from human to human is extremely rare. 
Clinical features 
Human brucellosis is an acute or sub-acute febrile illness marked by an intermittent 
or remittent fever ("undulant fever). The most frequent clinical symptoms beside 
fever are chill or shaking, malaise, generalised aches and pains, joint and low back 
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pain, headaches, anorexia, tiredness, general weakness and mental depression 
(Madkour M., 2001). During systemic spread, the Brucella organisms disseminate 
widely from regional lymphoid tissue and may localise in lymph nodes, spleen, liver 
or bone marrow. Thus, human brucellosis is a disease with varied clinical manifesta- 
tions and may simulate other diseases. In the absence of specific treatment human 
brucellosis may persist and progress to a chronically incapacitating disease with se- 
vere complications. 
Incubation period 
In about half of the cases brucellosis is acute, with an incubation period of two to 
three weeks. In the other half, the onset is insidious, developing over a period of 
weeks to months from the infection. The incubation period may vary according to 
the virulence of the organisms, the route of entry and the infecting dose (Madkour 
M., 2001). 
Diagnosis 
The diagnosis of human brucellosis is based on the history of exposure to a known 
or probable source of Brucella, the history of features of the disease at its onset, and 
significantly raised or rising Brucella antibody titres with or without positive cul- 
tures from blood or other fluids or tissues (Madkour M., 2001). Due to the extraordi- 
nary variety of manifestations of this disease, the diagnosis cannot be made solely on 
clinical grounds. The Rose Bengal Test (RBT) can be used as the most sensitive 
rapid screening test, but the results must be confirmed by bacteriological and other 
serological tests (Corbel M. et al, 2000). However, the presence of antibodies does 
not always mean an active case of brucellosis. In endemic areas, sub-clinical infec- 
tion with Brucella organisms may lead to the presence of a high titre of Brucella 
agglutinins in an otherwise asymptomatic individual. In endemic areas, a titre of 
1: 640 is significant, while in non-endemic areas a titre of 1: 160 is significant 
(Madkour M., 2001). Therefore, there are no agreed unified agglutination titre levels 
which can be considered significant and indicative of active brucellosis. 
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Treatment 
The essential element in the treatment of all forms of brucellosis is the administra- 
tion of effective antibiotics, and treatment should be implemented at an early stage. 
Treatment regimes usually consist of combination of at least two agents; however, 
the optimum antibiotic therapy is still disputed (Ist International Conference on 
Emerging Zoonoses, 1997). The full treatment lasts 7 to 12 weeks. A shorter dura- 
tion of treatment is associated with higher relapse rates. Additionally, severely ill 
patients should be treated in a hospital. In those patients with complications, addi- 
tional treatment is necessary including, in some cases, surgical intervention. 
2. Worldwide spread of Brucellosis 
There is no worldwide, coordinated and comprehensive reporting on the spread of 
brucellosis and therefore there are no statistics available or published. This thesis's 
overview on the burden of brucellosis in the different parts of the world has been 
assembled by reviewing the literature and choosing the most robust available data. 
Some of this data were overviews supplied by the O. I. E. and FAO, and surveys and 
conference notes on the spread of brucellosis provided by literature search through 
the internet. This results in the maps shown in thefigure 2.1. of worldwide brucello- 
sis distribution. The template map has been downloaded from internee. 
The database for the spread of B. melitensis and B. abortus were culled from a 1994 
report on the First International Conference on Emerging Zoonoses (Ist Interna- 
tional Conference an Emerging Zoonoses, 1997). The incidence is shown in broad 
categories: (i) not present or eradicated, (ii) low sporadic incidence, (iii) high inci- 
dence and (iv) no data. 
4 http: //www. rbgkew. org. uk/gis/tdwg/index. hunl 
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The maps concerning animals show that B. abortus is more spread out worldwide 
than B. melitensis, - the latter remaining the principal cause of human brucellosis. 
The third map aggregates the burden of B. abortus and B. melitensis. 
This analysis considered only B. abortus in cattle and B. melitensis in sheep and 
goats, as this was relevant for the further search of the brucellosis epidemiology in 
Mongolia. However, the following species affected by brucellosis worldwide are: 
cattle, sheep, goats, pigs, and with a lower importance: bison, camels, dogs, horses, 
reindeer, yaks and marine mammals (Corbel M. et al, 2000). 
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Figure 2.1.: Worldwide spread of Brucellosis 
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Data that were more than ten years old have been included because there is little data 
on the topic. 
The map d) offigure 2. L shows the average worldwide human brucellosis distribu- 
tion for 1996 to 2004, and is based on human cases reported by O. I. E (Ojf1ce Inter- 
national des Epizooties, 2005). Even though human brucellosis is reported in the 
literature for Brazil (Poester FP et al, 2002), India (Renukaradhya GJ et al, 2002) 
and China (Dequi S et al, 2002), no such data is reported to O. I. E on behalf of these 
big countries. Problematic endemic regions do stand out: Central Asia, parts of Af- 
rica, the Near East and the Arabian Peninsula, the Mediterranean region, and Latin 
America. 
In Europe, several control and eradication programmes have been implemented re- 
sulting in a diverse epidemiological situation among different regions. Nevertheless, 
North European Countries such as the LJK (Cutler SJ et al, 2005) are free from 
brucellosis (see also appendix 1.2. ), while the situation concerning B. melitensis 
(Taleski V et al, 2002) is less favourable in Southern European Countries. Thus, the 
challenge remains and is currently made more difficult by several factors, such as 
(Godfroid J et al, 2002): (i) infected cattle with Yersinia enterocolitica 0: 9 (Y09) 
which induce false positive serological reactions in brucellosis tests; (ii) there is a 
Brucella spp. reservoir in wildlife, mainly in hares and wild boars, infected by B. 
suis biovar 2, though this particular biovar is not an important pathogen for humans, 
it remains a threat to eradication programmes; (iii) B. melitensis infections in cattle 
are increasing worldwide, but basic information regarding this strain is lacking (epi- 
demiology, diagnostics and vaccination), making control and eradication difficult 
too. 
In North America, B. abortus and B. suis had accounted for brucellosis in most ani- 
mals, but immunisation of herds combined with surveillance and culling of infected 
animals has been successful and the region has been essentially free of brucellosis 
for several years now (Ragan V E, 2002). Still, B. abortus continues to be present in 
wild animals such as bison and elk in the Rocky Mountains, which poses a threat of 
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infection to cattle, or reindeer in Alaska, accounting for occasional human cases 
(Rust R S, 2004). 
Historically, B. abortus was endemic in cattle herds in New Zealand and Australia, 
but a successful animal vaccination and surveillance campaign resulted in eradica- 
tion. in both countries by 1989 (Miller M et al, 2005) (Crump JA et al, 2001). B. 
melitensis is absent in animals in most parts of these countries, though a few human 
cases occur. 
In Latin America, brucellosis is mainly reported in the context of cattle fanning, 
where beef production contributes to a significant part of the GDP (Baumgarten D, 
2002). As the economic impact of brucellosis is considerable, important investments 
have been made towards efforts to control this disease, as reported from Chile 
(Rivera SA et al, 2002), Argentina (Samartino L E, 2002), Paraguay (Baumgarten 
D, 2002), Brazil (Poester FP et al, 2002), Venezuela (Francisco J et al, 2002), Cen- 
tral American States (Moreno E et al, 2002) and Mexico (Luna-Martinez EJ et al, 
2002). Brucellosis in sheep and goats is considered a disease of minor importance, 
with the exception of Mexico and the Andes States (Peru) (WHO et al, 2005). Hu- 
man infection is considered to be underestimated as the reporting and diagnostic 
services for human brucellosis are inadequate (Poester FP et al, 2002). An underre- 
porting rate is published for Mexico, where the real notification rate of human cases 
is estimated at 3 0% (Luna-Martinez E Jet al, 2002). 
In sub-Saharan Affica, brucellosis remains mainly a neglected disease with little 
attention to control and prevention (Smits HL et al, 2004), except in the southern 
African region, were successful control policy has been reported in Botswana, Zim- 
babwe and South Africa (McDerrnott J et al, 2002). In fact, brucellosis is prevalent 
in most sub-Saharan livestock production systems, common in cattle and perceived 
to a lesser level in small ruminants. This is not only the consequence of lack of 
awareness by both veterinarians and health care staff but also to the absence of ac- 
cessible laboratory diagnostic facilities. The difficulty in diagnosing brucellosis in 
humans without laboratory testing is due to the similarity with clinical presentations 
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of other infections occurring in sub-Saharan Africa such as malaria. The situation in 
the animal sector is similar as the cause of abortions is confounded with other com- 
mon animal diseases present in Africa (Zinsstag J et al, 2004). 
In countries of the Near East region and the Arabian Peninsula, brucellosis infection 
has had a long history (WHO, 2005b), due to the traditional consumption of raw 
milk and milk products (Awed R, 1998). The disease is considered a major risk for 
humans; 40,000 new human cases are reported every year and the true infection rate 
is probably higher. Brucellosis often remains unrecognised and is treated in the same 
fashion as other diseases, labelled "fever of unknown causes". Most human infec- 
tions are due to B. melitensis, which can be transmitted by almost all domestic ani- 
mals. There is a rising awareness concerning the importance of controlling brucello- 
sis in animals; most countries have already attempted to control it, some with good 
results, while others do little (Refai M, 2002). 
There is a low sporadic incidence of brucellosis over the Asian continent (Bandara 
AB et al, 2002). Areas of highest incidence in the region are Sri Lanka (Bandara A 
B et al, 2002) and the Indian subcontinent (Renukaradhya GJ et al, 2002). Re- 
markably neither of these countries has ever controlled brucellosis. It is not present 
in the animals of Malaysia (Sabah), the Philippines and Japan (Ist International 
Conference on Emerging Zoonoses, 1997). In former USSR-Countries and Central 
Asia brucellosis is a serious and longstanding problem in livestock and humans. 
China has a longstanding experience with brucellosis control, especially in provinces 
where stock raising is important, with the dominant strain being B. melitensis. Also 
Inner Mongolia has suffered from severe epidemics before the 1980s and has suf- 
fered again since the 1990s. (Dequi S et al, 2002). China has established control 
programmes since the 1950s, with comprehensive measures based on studies of the 
infection sources and transmission modes. Methods employed were quarantine, 
separation and elimination of infected animals and also immunisation campaigns, 
starting in the late 1950s (Dequi S et al, 2002). Nevertheless, brucellosis remains a 
serious public health issue. 
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3. Mongolia's situation in an international context 
The main risk of infection is different in the non-endemic areas, where the source of 
infection is mostly work-related (veterinarians, abattoir workers and laboratory per- 
sonnel), from the risk of infection in the endemic areas, where the infection is 
mainly related to hygienic methods and community eating habits (consumption of 
raw food such as contaminated raw milk or un-pasteurised cheese) (Araj G F, 1999). 
To analyse the animal to human transmission we need to quantify the relation be- 
tween disease reservoir in the animals and new infections in humans. The most 
comprehensive data available in an international context concerns the Near East re- 
gion, which is one of the most contaminated regions of the world. The review article 
of M. Refai (Refai M, 2002) tries to assess brucellosis in man and animals in the 
region, while mindful of the lack of information. In fact, besides using publications, 
M. Refai depended on data he accumulated during FAO/WHO consultancy missions 
through seminars, workshops and country reports. In the following analysis, the hu- 
man incidence is put in relation to the prevalence of B. melitensis in SR, as this 
strain is the predominant cause of brucellosis in humans5 (Refai M, 2002) (Awed R, 
1998ý 
The data extracted out of this review for our purpose are plotted in the figure 2.2.. 
The negative binomial regression analysis showed a significant correlation (LRT = 
12.58, P-value = 0.0004) between the prevalence in animals and the incidence in 
human for these countries of the Near East Region. Despite all limitations, such as 
poor data quality, different study designs, different observation years etc., we can 
statistically establish what is known: the disease incidence in humans closely paral- 
lels animal prevalence, although the likelihood of disease in human is fin-ther greatly 
influenced by the degree of contact with animals and their excreta, or the ingestion 
of animal products (Rust R S, 2004). Thus, by adding the corresponding data of 
5 B. melitensis infecting cattle can not be considered as there are no data available distinguishing the 
infection in cattle between B abortw and A melitensis. 
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Mongolia infigure 2.2., we see that Mongolia takes an "outlier position" because of 
its lowest brucellosis prevalence in animals combined with very high incidence in 
humans (even compared with Near East countries, representing one of the most con- 
taminated region of the world! ). This is important to consider for choosing and ap- 
plying surveillance policies, such as testing methods (specificity of the tests) and 
prevention measures. Compared to other countries, there seems to be an extremely 
close animal-human contact in Mongolia, which could be due to its nomadic live- 
stock rising, where both transmission routes (the work related and the alimentary) 
have to be considered at the same time. 
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Figure 2.2: Brucellosis prevalence in small ruminants and incidence in 
humans: situation in the Near East (1984-1999) and Mongolia (1999) 
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4. Brucellosis control 
The first section of this chapter described the characteristics of brucellosis and 
showed that most human brucellosis originates from an infected animal. Human to 
human infection is rare. Prevention includes health education and pasteurisation of 
milk. However, education campaigns alone have never succeeded in fully eliminat- 
ing these risks to humans (Robinson A, 2003a). Attempts at vaccinating people at 
risk have resulted in effective protection, but also provoked severe reactions when 
given to sensitised individuals, or when administered incorrectly (Schurig GG et al, 
2002). As a result, vaccination of humans is no longer routinely usedý; the ultimate 
prevention of human infection remains the elimination of the brucellosis in animals. 
This section describes the measures to control, eradicate and prevent brucellosis in 
animals. It provides the basis for understanding and analysing Mongolia's brucello- 
sis control policy, described in chapter 5. Currently, methods used to prevent infec- 
tions are test and slaughter (T&S) of seropositive animals, vaccination, hygiene 
measures, and management. Various factors influence the choice of methods used 
such as husbandry system, climate, nomadic livestock breeding, prevalence of 
brucellosis among various animal species, and control programme resources avail- 
able. As clinical signs are not evident, testing is crucial to estimate the prevalence of 
brucellosis. Therefore, the details of methods will be preceded by an overview of 
brucellosis tests. 
6 "Renewed interest in Brucella as a potential biological warfare agent has ... drawn attention to the 
need for effective vaccines for humans. ... The cost implication and limited commercial possibilities for vaccines against human brucellosis mean that development is likely to be restricted to national 
defence agencies. " (Schupig GG et al, 2002) 
Brucella species are considered by the CDC (Centersfor Disease Control and Prevention, 2000a) to 
be Category B biological warfare agents, which are the second highest priority agents. The biological 
warfare route of infection is most likely aerosol. Category B agents are moderately easy to dissemi- 
nate, cause moderate morbidity and low mortality, and require specific enhancement of diagnostic 
capacity and enhanced disease surveillance. Additionally, brucellosis is listed among critical biologi- 
cal agents as having disease characteristics with particular potential for biologic terrorism (Centers 
for Disease Control and Prevention, 2004). To ensure a prompt response to a biological terrorist 
event, early detection is essential. However, this is difficult in a population with a low prevalence of 
disease, as to rule out false-positive laboratory findings, diagnostic laboratory testing has to be inte- 
grated with lengthy epidemiologic investigation (Centersfor Disease Control and Prevention, 
2000b). 
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Testing 
Brucellosis can be diagnosed only by isolating and identifying the causative organ- 
ism, Brucella spp. But this is not possible in the field as techniques for this are only 
available at Brucella Reference Centres (Corbel M. et al, 2000). Therefore, the most 
practical diagnosis of brucellosis involves an indirect test using antibody specific 
tests in serum or milk. Serological. diagnosis can be unclear, as vaccines may be 
serologically indistinguishable from virulent strains, and cross-reaction with other 
agents may occur. This leads to diagnostic dilemmas. With the development of an 
assay, vaccination antibodies could be distinguished from antibodies resulting from 
field infection. But the acceptance of these serological tests has been slow (Nielsen 
K, 2002). The same tests are applicable to animal and human serology. 
A number of tests have been developed for brucellosis (seefigure 2.3). A test with 
higher sensitivity misses fewer false negatives. A test with higher specificity will 
result in fewer false positives. This has to be considered according to the circum- 
stances applied and the stage achieved in the process of controlling and eradication 
of the disease. At the beginning of a control programme, when broad screening is 
carried out to get an overview of the spread of disease, sensitivity of a test is most 
important. When eradication is progressing, then the specificity of a test becomes 
crucial to obtain a precise view on the residual elements of disease and identify the 
individual carrier of pathogens. After eradication it is important to monitor changes 
in the situation and investigate particular problem herds or areas; for this a test with 
good sensitivity should be used again. Table 2.3. lists the sensitivity and specificity 
values for various serological tests and shows that no individual test is perfect. 
Predicted value positive indicates the probability a case is infected given a positive 
test result (right positive). Analogously, predicted value negative indicates the prob- 
ability a case is not infected given a negative test result (right negative). Increasing 
the specificity of a screening test (by changing the criterion of positivity) increases 
its predictive value positive. The predictive value positive of a screening test can 
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Figure 2.3.: Diagnosis of brucellosis by serology 
Senwivity. . 9wificity. aml perfounance index of the wMogical tests for brucellosis 
Tcst Sensitivity' spocificity, PcrforTnance Rcfcrences 
indcx* 
SAT 29.1-100 99.2-100 1-79.1-200 Van Acrt ct al, 1984. Lord ct al, 1989 
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Card 743-99.0 7.4-100 106.4-1875 Stemshorn et A. 1985, Huber and Nicalcat 
1986, 
I. Awd et al., 1989 
B PAT 75.4-99.9 90.6-100 1743-199.7 Steffishorn et al.. 1985, Uzal et al, 1996, 
Samartino ct al.. 1999 
RtV 503400 21.9-400 108.7-200 Huber and NicticttL 1986; Lord ct at. 1989; 
Dajer et al.. 1999 
2KIE 56.2-1.00 99.8-100 1561-200 Lord ct al., 1989; Sternshorn et al- 1985. 
Saluvi ct all 1995 
cFIr 23.0-97.1 30.6-100 123. G-197.5 Huberand NicolettL 1996, Van Acrt et at. 1984; 
Saravi ct al, 1995 
PCHA 92. G-99.1 48.6-69.9 140,6-168.0 Nicoletti and Tanya, 1993. Nielsen et al., 1998 
MUSA 923-100 90.6-100 190.9-200 DL)hoo et al., 198(k. Rojas and Ak)nso, 1994 
CELISA 973-100 99.7-99.8 1973-199.8 Saniartino ct al., 1999; Nielsen and Galt 2001 
FP. A 99.0-993 96.9-100 195.9-1993 DaJcr ct al., 1999, Nielsen and Gal, 2001 
' Sensitivity and specificity values are prewntod as percentranges of the worst and best results. The literature 
cites for each test with very low results used sensitivity and specificity calculations relative to other sezological 
tests while the higher values were obtained using sera from cattle from which A abortux was cultured or 
expcrimemally infected animals. The performance index is the sum of the % sensitivity and specificityý 
(Nielsen K, 2002) 
also be increased by increasing the prevalence in the screened population (targeting 
to groups with high risk) (Hennekens CH et al, 1987). Therefore, a combination of 
tests has to be applied, according to considerations such as budget restrictions, tech- 
nical possibilities, and need for sensitivity or specificity. Tests can be administered 
either in parallel or in series, whereas parallel testing increases generally the sensi- 
tivity, and serial testing increases the specificity (Hennekens CH et al, 198 7). There- 
fore, an appropriate testing procedure for brucellosis is serial testing. The test first 
applied should have a high sensitivity, detecting all positive samples and leaving 
only true negatives. The first test should ideally be inexpensive and easy to adminis- 
ter, and may be weak in specificity. From the first run, only positive samples are 
kept for the second run, which should have a high specificity and exclude false posi- 
tives. This procedure can reduce costs since as the second more specific test may be 
more complex and costly (Honhold N., 1994b). 
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In most brucellosis control situations, the entity of interest should be the infected 
flock or herd rather than the infected individual animal (Food and Agriculture Or- 
ganisation of the United Nations Rome, Italy, 1992). Whatever testing is applied it is 
impossible to detect all infected animals at a particular time; hence, the entire flock 
should be regarded as infected even if only one animal proves to be positive. Each 
infected flock poses a risk for public health (Garin-Bastuji B., 1999): Human cases 
may often be a useful indicator of the presence of the disease in animal populations 
or may sometimes be the only source of information for surveillance (Corbel M. et 
al, 2000). 
The following tests are suitable for herd surveillance: (i) the Milk Ring Test (MRT): 
a relatively insensitive agglutination test, appropriate only for locating infected dairy 
cattle herds (World Health Organization et al, 1986); (ii) The Allergic Skin Test 
(AST), a more promising method for detecting infected herds of sheep and goats. It 
involves only minimum handling of the animals, and an individual animal identifica- 
tion is not required. 
The following tests are widely applied for diagnosing individual animals: (i) The 
Rose Bengal Test (RBT), a standardised spot agglutination test, simple to perform 
and inexpensive. However, there are conflicting opinions on the efficiency of this 
test in detecting infected animals (World Health Organization et al, 1986). As most 
agglutination tests, RBT is susceptible to false positive reactions (or oversensitive) 
due to cross-reactions 7 and vaccine titres in Brucella-vaccinated animals (Nielsen K, 
2002). To confirm reactors it is therefore necessary to apply another test. (ii) The 
Serum Agglutination test (SAT), a simple test, but many studies have reported a 
poor sensitivity as well as specificity (World Health Organization et al, 1986). (iii) 
The Complement Fixation Test (CFT), recognised as the most reliable and effective 
test for diagnosing brucellosis in individual cattle, sheep and goats (World Health 
Organization et al, 1986). As it is associated with a high work load, and the proce- 
dure is technically complex, its worth lies in the use for confirming positive reactors 
7 with Y. enterocolitica 09-infected animals and animals with other Gram-negative bacteria 
(Erdenebaatar Jet al, 2004) 
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found in preliminary screening tests. (iv) New generations of tests with Enzyme- 
Linked Immuno-Sorbent Assay (ELISA) based on the characterisation of diagnostic 
antigen (DNA), knowledge of the host immune responses, and use of specific anti- 
body reagents (Food and Agriculture Organisation of the United Nations Rome, 
Italy, 1992). These tests aim to overcome most of the drawbacks associated with 
conventional techniques of serological tests; they improve both sensitivity and speci- 
ficity, implement a high level of international standardisation, and discriminate re- 
sponses due to immunisation or exposure to cross-reacting organism from field in- 
fection. 
In Mongolia, tests used must be simple, quick and cheap. Although sensitivity might 
be lower, experiences in developing countries have shown that simple screening 
tests (such as card agglutination test with buffered antigen) meet most diagnostic 
needs (Kolar J., 2001). A firther test helpful for brucellosis surveillance in nomadic 
conditions is the allergic skin test (Kolar J, 2001). For specification or verification 
of doubtful results, serological quantitative tests such as SAT or CFT are helpful 
(Kolar J, 2001). Also, recent studies in Mongolia demonstrated good results when 
combining RBT for screening and ELISA tests with sarcosine extracts for confirma- 
tion (Erdenebaatar J et al, 2004). ELISA could discriminate positive results in such 
cases. Further, ELISA with sacrosine extracts proved to be more convenient for 
practical applications than CFT, and a more useful confirmatory test in the Mongo- 
lian context. 
Test and Slaughter 
The following steps are usually applied in T&S programmes, where animals are 
tested for evidence of antibodies to brucellosis and positives are separated from 
other animals (Madkour M., 2001): (1) identification of the susceptible animals, for 
example with ear tags; (2) perforniing serum tests, (3) removal of seropositive ani- 
mals for isolation or slaughtering; (4) retesting remaining animals, until herd tests 
are negative for at least 6 months; (5) purchasing new animals from brucellosis-free 
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populations only; (6) keeping herds under surveillance. T&S is based upon the fact 
that infected animals can be contagious throughout their life-time while not showing 
pathognomic signs. If possible, infected animals should be removed from the popu- 
lation prior to parturition, when transmission occurs. T&S has been successful in 
situations where farms and herds are small, and where there is little movement of 
livestock. 
T&S is often ineffective in large populations as animals, tested positive with sero- 
logical tests, may have spread Brucella by the time they are identified. One problem 
is that up to 20% of infected cattle do not show blood antibodies, until after they 
abort. It is during abortion that transmission risks are highest, when billions of or- 
ganisms are spread (Honhold N., 1994b). Only few countries have been able to 
eliminate brucellosis in sheep and goats through T&S. In nomadic settings, the limi- 
tations of T&S are most revealed by the great size and movement of the herds, the 
poor logistics of test administration, the lack of sufficient funds for programme ad- 
ministration and for financial compensation to owners. The separation of the in- 
fected animals has to be enforced by government regulations, and slaughtering 
within a certain period after testing (2 weeks) has to be compulsory. The prerequisite 
of this is an accurate identification tool, and the use of a compensation scheme is 
essential to ensure the owners' co-operation. 
Vaccination 
T&S is not realistic in the majority of places where B. melitensis is endemic (Band 
M, 2002). Therefore, until the disease prevalence is significantly reduced, whole 
herd immunisation should precede T&S activities. Experts advise a shifting away 
from immunisation to a T&S policy only after the individual prevalence rate is no 
greater than 2-3% and the herd prevalence is 5-10% (Food and Agriculture Organi- 
sation of the United Nations Rome, Italy, 1992). 
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Vaccine protection from infection is not absolute and to achieve high vaccination 
coverage, animal owners have to give their consent and a vaccine campaign has to 
be backed up with sufficient regulatory authority and resources. Furthermore, the 
correct administration of vaccines is crucial to develop rapidly a herd's resistance. 
The vaccines have been initially developed on an empirical basis, and their admini- 
stration was based on trial experience and was subject to continuous evolution (see 
chapter 5). The current research on brucellosis vaccine attempts to stimulate a pro- 
tective immune response by introducing genes encoding protein antigens (DNA vac- 
cines) (Schurig GG et al, 2002). But these recent attempts have been hindered by an 
incomplete knowledge of the protective antigens of Brucella (Schurig GG et al, 
2002)8. 
The most successful vaccines used so far for the immunisation of farm animals were 
S19 and Rev. l. Both used live smooth attenuated derivates of Brucella spp., S19 of 
B. abortus and Rev. 1 of B. melitensis. S19 had been developed by Buck in late 
1930'h and protects cattle against A abortus but not against B. melitensis (Kolar J, 
1992). Depending on animal age, dose, and route of vaccine administration, antibod- 
ies appear and persist in serum, and prevent the differentiation of vaccinated from 
infected cattle. This makes the use of this vaccine incompatible with simultaneous 
T&S, application (Schurig GG et al, 2002). In 1996, APHIS licensed the B. abortus 
Strain RB51 Vaccine, a live attenuated rough strain, which does not stimulate the 
production of antibodies on standard diagnostic tests (Lin DX et al, 2000). Primarily 
responsible for the immunisation is the production of a cell-mediated response. This 
vaccine has been implemented in the USA, Mexico and Chile, and replaced S19 
(Schurig GG et al, 2002). 
Rev. 1 vaccine can be used also in cattle, where B. melitensis is prevalent in SR, and 
where it may be the cause of infection in cattle. The protection against B. abortus is 
8 Brucella is found inside the cells rather than in the circulation. So, as the Brucella is therefore pro- 
tected from antibodies, it is not the antibodies that protect the animals from infection by Brucella 
bacteria, but cell mediated immunity (Honhold N., 1994b). 
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comparable to protection provided by S19 (Kolar J, 1992), or even better (Schurig 
GG et al, 2002). However, because of fear of the risk of Rev. I excretion in milk, 
epidemiologists resist the use of Rev. 1, preferring instead S19 to fight B. abortus 
(Banai M, 2002). To obtain protection against B. melitensis infection, Rev. I vaccina- 
tion of cattle has been used in Mongolia (see chapter 5). The extension of this proce- 
dure to endemic areas is suggested (Banai M, 2002). 
The Rev. 1 vaccine is used for immunisation of SR against B. melitensis. "Rev. 1 vac- 
cine is a live, attenuated B. melitensis strain derived from a virulent B. melitensis 
isolate which became dependent on streptomycin for its growth, but lost this charac- 
teristic, although remaining streptomycin resistant, upon further subculture" (Elberg 
S. et al, 1956) (Schurig GG et al, 2002). The Rev. 1 strain has been isolated by Prof. 
S. Elbere, and has been intensively studied since 1955 in several countries world- 
wide, and was proven to protect SR in endemic areas. Like the S 19 vaccine, the vac- 
cine Rev. 1 also induces positive serology, preventing the differentiation between 
vaccinated and infected animals. However, this interference could be reduced by 
shifting from subcutaneous administration to the ocular method (conjunctival ad- 
ministration) (Banai M, 2002). 
This leads to an important topic of this thesis: in the late 1960s and 1970s local pro- 
duction of the Rev. 1 vaccines had been established for local use. The vaccine be- 
came the basis of several national control programmes, such as in Italy, Iran, Israel, 
USSR, Turkey, South Africa, Peru and Mongolia (Elberg S., 1981). Later on, in late 
1970s and 1980s, Rev. 1 vaccination of SR became an important pillar in the control 
programmes in France, Greece, Spain and Kuwait as well (Elberg S., 1996). The 
control programmes, and the use of Rev. 1, varied between these countries, but no 
conclusion regarding the success or failure of these immunisation campaigns could 
be reached, as the results were not obvious (Banai M, 2002). Chapter 5 looks into 
the 1970s Mongolian large-scale immunisation programme, which is considered to 
be one of the most successful (Elberg S., 1996). It eventually became one of the 
world's largest immunisation campaigns using Rev. 1 in SR, vaccinating about 33 
Sanford S. Elberg, School of Public Health, University of California, Berkley, USA 
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million of them. Only one other vaccination programme was larger: in the Central 
Asian Republics of the USSR several hundred million SR were vaccinated with 
Rev. I (Elberg S., 1996). 
Management practices 
Hygiene methods or management practices can be applied to reduce exposure of 
susceptible animals and reduce exposure to their discharges and tissues. As diagnos- 
tic tests in individuals are not sufficiently reliable to assure the absence of disease, 
animal replacements have to be purchased from herds that are certified Brucella- 
free. Commingling with herds of unknown status should be prevented and animals 
should be isolated at parturition to prevent possible transmission of infection. All 
these measures aim to reduce exposure, but may be difficult to put into action in 
nomadic conditions. 
5. Key thoughts on Brucellosis 
Despite powerful approaches provided by technical improvements during the last 
decade, the understanding of the Brucella pathogenesis still remains in its infancy 
and the scientific community is far from understanding the molecular mechanisms of 
Brucella and how this bacteria causes brucellosis (Letesson JJ et al, 2002). Devel- 
opments in radiological and laboratory diagnostic methods have contributed to ad- 
vances in information about the effect of the disease on every organ of the human 
body. Therapy, however, has not kept pace with these advances. In treating patients 
with brucellosis, relapses and therapeutic failure still constitute the major problems 
(Agalar C et al, 1999) (Ariza Jet al, 1995). 
Factors contributing to the rising spread of brucellosis in animals are related to the 
recent expansion of the animal industry (Madkour M, 2001). Three new develop- 
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ments in the epidemiology of brucellosis challenge control policies (Maurin M, 
2005): (i) the reservoir of brucellosis in wildlife is expanding, possibly impacting on 
domestic animals; (ii) cattle are infected by B. melitensis but vaccines are not yet 
well-established for this constellation; and (iii) a disease reservoir has been recog- 
nized in marine mammals, and their potential virulence to humans remains un- 
known. 
Brucellosis can impact more deeply on poorer communities (Perry BD et al, 2002). 
As surveillance of brucellosis needs huge financial investments, it is not uncommon 
to encounter large - scale efforts to control the disease where large-scale cattle and 
sheep husbandry have an important economic role. This is the case in Latin Ameri- 
can countries, the USA, New Zealand and Australia. These countries have succeeded 
in controlling or even eradicating B. abortus. However, the most difficult to control 
is B. melitensis (Nicoletti P, 2002), which is at the same time the most virulent spe- 
cies for humans. Commonly, regions infected are pastoral communities, in which 
sheep and goats play an important role and where husbandry practices create diffi- 
culties for the control of brucellosis. However, pastoralist systems account for only a 
small part (5%) of the rural poor, where the great majority of poor associated with 
livestock are found in mixed crop-livestock systems (Perry BD et al, 2002), com- 
mon in developing countries endemic with brucellosis. The disease presents a con- 
stant threat to both reproductive performance amongst animals and human health. 
The development and application of suitable control strategies for these smallholder 
dairy systems would mean an important step in poverty alleviation through im- 
proved animal health. 
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Chapter 3 
Methodology 
1. Research question 
The central research question addressed in this thesis is: "Is there any relationship 
between stated surveillance policy and the brucellosis prevalence in animals and the 
brucellosis incidence in humans? " Four aims provide investigative steps to address 
this question: 
1. To establish epidemiological patterns of brucellosis in animals and humans in 
Mongolia from 1966 to 2002; 
2. To provide an historical overview of the different strategies applied to the control 
of brucellosis in Mongolia; 
3. To analyse the possible interactions between the strategies applied to control 
brucellosis and its spread; 
4. To make recommendations about surveillance policies for brucellosis. 
2. Type of information required and how it was ob- 
tained 
Type of information required 
The following information was needed for the analysis: 
(i) Infonnation on the characteristics of bruccllosis, its epidemiological aspects and 
methods of surveillance. 
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(ii) To estimate the spread of brucellosis in Mongolia (aim 1), consistent and reliable 
data by year and by AimagIO was required on the human incidence and animal 
prevalence. 
(iii) Information on the methods for control, eradication and prevention was re- 
quired. (aim 2). The surveillance policy was defted for the whole nation, but 
implemented during different years at the Aimag level. So surveillance policy 
was needed on Aimag level. To understand the surveillance policies in their his- 
torical context, information on the political and economic situation was col- 
lected. To underpin this qualitative information quantitative data on production, 
vaccine use, and animal testing were collected. 
(iv) Information on the etiology of brucellosis was needed to understand and assess 
possible interactions between the strategies applied to control brucellosis and the 
spread of disease (aim 3). 
(v) Information on the worldwide spread of brucellosis in animals and humans, and 
the current efforts for control, eradication and prevention was needed, to inform 
surveillance policy. 
How the required information was obtained 
Information and data as described above were collected first in London, Prague, and 
Geneva. The field work in Mongolia searching paper and electronic records and in- 
terviewing key persons completed gaps of information and data required. 
Paper and electronic records 
This included electronic searches of databases for journals and catalogues of librar- 
ies, searching the internet and searches in the intranet of WHO headquarters. Non- 
electronic searches were conducted in various archives such as at WHO Geneva and 
authorities in Ulaanbaatar. Other docwnents were located after discussions with par- 
10 An Aimag is the primary administrative unit in Mongolia, i. e. province; it consists of several 
Soums 
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ticipants at the Brucellosis 2003 International Conference in Spain, through inter- 
viewing key persons and by searching through the files of experts. 
Networks of informants 
A network of brucellosis experts resulting from the previous study' 1 was reactivated. 
The contact with Dr. 0. CoSivi12 was crucial, facilitating access to the knowledge 
based at WHO headquarter. The richest source of information was gained from net- 
work of key experts in Mongolia. The collaboration with Dr. J. Kolar 13 was out- 
standing, and provided a basis for identifying key persons in Mongolia. 
3. Data sources 
Methods used for searching paper and electronic records, and for interviewing key 
persons, are described below. 
Systematic literature review 
Libraries 
Searching electronic catalogues of libraries in London 14 for the term "Mongolia! ' 
and such as "brucellosis", "agriculture", "development", "economies", "health", 
"governance", "policy", "livestock", "transition" "policy" provided good back- 
ground information. Besides books, various reports were provided from World 
Bank, IMF, TACIS Technical Dissemination Project, Asian Development Bank, 
11 Economic analysis of the brucellosis control in Mongolia (Roth F. et al, 2001) 
12 Dr. Otorino Cosivi was responsible project leader for brucellosis control in the Department for 
Communicable Disease, Surveillance and Response at WHO Headquarter. 
13 Dr. Jan Kolar, retired WHO-expert living in Prague, worked for WHO for about 10 years in Mon- 
golla from 1965 onwards. 
14 Consortium of Higher Education Libraries (M25 Consortium London) 
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UNESCO, and United Nations Centre for Regional Development. The search for 
"Brucellosis" covered the relevant scientific literature. 
Regular search on the web 
Web searches concerning "Mongolia" and "Brucellosis" have been conducted 
throughout to ensure information was up to date. Catalogues of scientific papers 
such as Pub med, Medline, Web of Science, SIGLE, IBSS 15 and BIDS 16 have been 
consulted. The catalogues of international organisations, WHO, FAO and O. I. E., 
were very important. References and citation searches have been applied to the pa- 
pers identified. This provided comprehensive and up to date information used in 
chapter 2 on the worldwide epidemiology of brucellosis, on the experiences with 
applied brucellosis surveillance policies and on the current discussion about this 
disease. 
The observation period of this thesis includes the transition, from a centrally planned 
country to market oriented economy in the 1990s. Strong impact of such economic 
transitions on public health have been documented for China, Russia, Eastern and 
Middle Europe countries, and Central Asian countries (Adeyi, 0. et al, 1997). There- 
fore, to consider this in the policy analysis, special consideration was given to the 
search of publications related to the topic of "Public Health in Mongolia following 
the transition". 
Processing the information 
The relevant publications, books, reports, documents etc. were entered in Reference 
Manager and filed with a continuous number. This allowed easy physical and elec- 
tronic access through the search by key words. 
'S International Bibliography of the Social Sciences 
16 Social Science data-base from LSE 
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Information from Dr. Jan Kolar 
Dr. Jan Kolar, retired WHO-expert living in Prague, worked for WHO in Mongolia 
for about 10 years from 1965 onwards. His task was to elaborate, implement and 
conduct a brucellosis surveillance strategy for Mongolia. Beside his wealth of ex- 
perience, which he could communicate as a key person during interviews, he pro- 
vided reviews, surveys and documents on the policy of brucellosis disease control 
and epidemiology of brucellosis before the transition. Most of the material provided 
by Dr. J. Kolar is neither published nor accessible in any archive. 
WHO Geneva 
Literature Identified at WHO headquarter In Geneva 
The search for "brucellosis" as well as for "Mongolia! ' within the WHO-Intranet at 
the headquarter in Geneva yielded electronic versions of working groups and com- 
mittees reports, as well as minutes from joint FAO/WHO expert meetings and mis- 
sion reports. This document search gave a comprehensive overview of the involve- 
ment of WHO in the fight against brucellosis in various parts of the world. 
In the archive of the WHO library the search within the card index boxes gave refer- 
ences to historical documents not available electronically. The material documented 
the involvement of the WHO in brucellosis control in Mongolia in the 1960s and 
1970s and addressed the first aim (epidemiological patterns) and the second aim 
(applied surveillance strategy). Most of these documents were assignment reports, 
mission reports and reviews, in other words internal or unpublished work, so-called 
66grey literature". 
Dr. Ottorino Cosivi 
Dr. 0. Cosovi, project leader for brucellosis control in the Department of Communi- 
cable Disease, Surveillance and Response at WHO Headquarter, made available his 
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files related to world-wide brucellosis control which contained relevant documents, 
such as memorandum, guidelines and notes from conferences or forums. 
Mongolia 
The -data sources presented did not provide all the required information. In order to 
close this gap, fieldwork was conducted in Mongolia in 2003. The aim of this field 
work was to get coherent information for the 1966 to 2002 time period for: (i) Ai- 
mag level prevalence of brucellosis in sheep, goats and cattle and the incidence of 
brucellosis for humans; (ii) numbers of produced doses of vaccines Rev. 1 and S-19 
and data concerning the vaccination process; (iii) information on the different strate- 
gies and applied policies in fighting brucellosis in animal and human, including is- 
sues concerning governance, share of responsibility, process and results. This was 
obtained through intensive searching of archives and interviewing key persons. 
Archive work In Mongolia 
Data on the prevalence of brucellosis in animals was obtained from authorities 
within the Ministry of Agriculture (MoA) and the Statistical Department. Data on 
human brucellosis incidence was extracted from authorities within the Ministry of 
Health (MoH) and the Statistical Department. 
Quantitative and qualitative data was used to provide an overview of surveillance 
policies. The qualitative data was backed up by quantitative data, such as data on 
testing and vaccination collected from authorities within the MoA. Two different 
methods were used to collect qualitative data: (i) documentary approach by review- 
ing published and unpublished literature, local reports, surveys, and government 
papers in the MoA, MoH, WHO local office in Ulaanbaatar, central Governmental 
archives, Medical University of Ulaanbaatar and by approaching key informants; (ii) 
interviewing key personnel, and visiting key sites such as hospitals, laboratories, 
vaccine production. 
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Interview with key persons In Mongolia 
The contacts with Mongolian authorities (MoH, MoA) and with the local WHO of- 
fice in Ulaanbaatar, established during previous work 17, were used for further iden- 
tification of key persons. Formal interviews with 18 key persons, responsible for 
brucellosis surveillance at different levels, provided information about the surveil- 
lance policy over the time periods. The appendix 3.1. lists the interviewees. They 
could also often provide hints about finiher sources of documents and data. 
4. Methodology used to obtain information during 
field work in Mongolia 
Research partnership 
The field work in Mongolia was embedded within a research partnership, that facili- 
tated approaching institutions and coping with the language barrier. 
Collaboration, organisation and setting 
As first part of this "University Exchange", Dr. M. Nansalmaa was a "guest re- 
searcher" at the STI in B asel/Switzerland for two months in summer 2003. Her focus 
was a scientific exchange with the research group "Human and Animal Health" on 
epidemiology and health policy. She was there for specific training to develop statis- 
tical methods and tools. 
As second part of this "University Exchange", the author carried out field work as a 
"guest researcher" at the MAS in Ulaanbaatar/Mongolia for one month, in autumn 
17 The author conducted in 2000 an economic analysis of the whole herd vaccination programme 
(Roth F. et al, 2001). This network amongst Mongolian policy makers and scientists could be com- 
pleted at the occasion of the presentation of this analysis at the Second National Workshop on 
Brucellosis Control in Ulaanbaatar in 2001. 
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2003. The field work in Mongolia served to establish further contacts with con- 
cerned authorities and scientific experts in order to complete gaps of information and 
data. Key persons were interviewed and unpublished material tracked down. 
Participation 
The collaboration with M. Nansalmaa was crucial for many types of data collection 
during the field work. With her participation, archives could be accessed in Ulaan- 
baatar and searched for reports, government documentation, data as well as all re- 
lated unpublished scientific material. As all scientific documents were in Russian, 
and all policy papers were in Mongolian, she translated them into English, after hav- 
ing traced and discussed with me which parts were relevant for the research ques- 
tions. 
Her broad network helped identifying further of key persons for interviews to fill 
information gaps. She also provided valuable support in establishing contacts with 
local authorities in Khuvsgol Aimag, where additional field work was conducted. M. 
Nansalmaa also acted as interpreter since the key persons interviewed in Mongolia 
were all non English speaking Mongolians. 
Interviews with key persons 
Selection of interview partners and Interview sites 
M. Nansalmaa complemented existing contacts within the authorities from her own 
network within the Mongolian Health System, and her knowledge of the organisa- 
tion of the authorities at different levels. The candidates for the interviews were se- 
lected jointly with M. Nansalmaa to include: Key persons from all the authorities 
responsible for the control of brucellosis in animals or in humans at three adminis- 
trative levels: central level, Aimag level, and Soum level, and patients ill from 
brucellosis were interviewed. Further interviews took place with herder families and 
scientific experts on brucellosis. This selection of interview partners provided a view 
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of the policy and actions taken concerning brucellosis control and treatment, from 
the perspective of the different groups. 
For the interviews on the level of Aimag and Soum, the AiTnag of "Khuvsgul" in the 
northern part of Mongolia along the Russian border was chosen. The choice was 
logistical, as M. Nansalmaa had worked there for 16 years 18 , and her broad network 
facilitated contacts with key persons. 
Khuvsgul Aimag has a surface of 100,600 km2 and a total population of 121,000 
(2002). The population density (1.21 person/km2) is slightly lower than the national 
average (1.58 person/km2). The prevalence of brucellosis was at 0.4% for sheep and 
1.1 % for cattle (all data are means for 2000 to 2002), close to the Mongolian average 
(0.5% for sheep and 1.1% for cattle). However, the data for the incidence of brucel- 
losis in humans differ between Khuvsgul Aimag (0.75 / 10,000 inhabitant) and the 
whole country (7.5 / 10,000). As we had noticed during the interviews with key per- 
sons from the Aimag Hospital in Moron, the reason for this was lack of test kits for 
serological diagnosis in this Aimag rather than the successful prevention of infection 
in humans. 
Interview technique 
The interviews were semi-structured. The questions were prepared in advance to 
meet the specific aim of the single interview. But depending on the circumstances 
and preferences of the interview partners, the single interviews were finally con- 
ducted in a structured, semi structured or open way. A brief description of the topic 
of interest had been given when arranging the appointment. Most interview partners 
were therefore prepared for the interview and sometimes even had some written ma- 
terial to show or to give. 
18 She worked first as physician, then as director and state senior inspector in sanitation and epidemi- 
ology. 
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Most interview partners were visited at work; two elder interview partners were pen- 
sioned and came to see us in the offices of the Mongolian Academy of Sciences. 
Most interviews lasted between one and two hours and were 9ften followed by a 
visit of the site, lunch or tea, Thus, the overall time of contact leading to ftu-ther dis- 
cussion was considerable. 
Documents and data search 
Organisation of the search 
The document and data search in Mongolia was based in Ulaanbaatar for practical 
reasons. Material from local Aimags was only included if reported to the Central 
Government in Ulaanbaatar. There are some decentralised archives in various De- 
partments and Ministries such as the Central Governmental archive, archive of the 
Veterinary Laboratory, archive of the Statistical Department, archive of MoH or 
archive of the Biocombinat 19. But it turned out that most of these archives had mate- 
rial on policy filed only from 1991 onwards. After 1989 the country had shifted from 
a socialist state to a democracy and from a centralised to a market economy. In 
1992, a new constitution was adopted based on democratic principles. Thus, for our 
field work, informal pathways were set up to search materials related to policy prior 
to 1992. 
As international Organisations have been involved in brucellosis control in Mongo- 
lia since the early stages of the fight against this disease, the local offices of UNDP 
and WHO were included in the archive search. UNDP keeps files for 7 years con- 
cerning financial matters, and 5 years concerning technical issues. There was no 
relevant technical report in the UN house library, and the archives of the WHO local 
office were not organised in a way that facilitated searching. As a result, WHO 
documentation is restricted to what could be found in the office rooms of WHO. 
19 Plant in Songino, close to Uaanbaatar, to produce vaccines against Brucellosis 
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Searches in the catalogues of the Medical University of Mongolia allowed access to 
all scientific work on the epidemiology of brucellosis in Mongolia, including re- 
search carried on before "transition". 
Procedure In finding policy and scientific documents and data 
Policy and scientific documents 
As stated above, generally, policy papers concerning the period prior to dernocratisa- 
tion could not be found in archives. So other informal ways had to be used to find 
them. 
In order to locate them, knowledge of the existence and identification of every single 
policy paper was needed. Some of our older interviewees could show us one or two 
governmental documents such as "Government Resolution" or "Order of the Minis- 
try". The number and date of the previous documents, which had to be replaced, 
were often mentioned in these documents. Reports referring on existing Governmen- 
tal papers gave further hints about their existence. But still, they mostly had to be 
found in someone's office or maybe in the local archive of a department. Documents 
had to be found in an informal way, which meant through older key persons or 
somebody knowing key persons having these documents. 
Out of the interviews and document search a list with 24 Governmental papers on 
policy and strategy for fighting brucellosis, covering the time frame between 1959 
and 2003 was compiled. Some of them we already had found and were crucial as 
starting points for further searches. Others, we only knew of their existence, or as- 
sumed that they must have existed in order to fill the policy gap supposing brucello- 
sis control was continuous. 
A second list of 12 items of scientific papers on brucellosis was compiled from hints 
from key persons and catalogues from the Medical University in Ulaanbaatar. 
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Some policy and scientific papers were identified during fieldwork. After fieldwork, 
M. Nansahnaa found the missing documents and translated them. She translated all 
documents but seven. These were translated by a colleague (Oyunaa Tsedendod). As 
some scientific papers were long, only extracts were selected for translation. 
Human data 
The data concerning the spread of brucellosis in humans was found from: (i) offi- 
cially published data from the MoH, or the State Statistical Office of Mongolia 
(SSOM), and (ii) from unofficial data mostly relating to data collected by the Infec- 
tious Disease Research Institute (IDRI). 
The official data from the MoH were published in various papers such as "80 years 
Health Sector of Mongolia" (Bayart B. et al, 2001), "Health Statistical Report 2002" 
(The Directorate ofMedical Services, 2002b), "Health Indicators 2002" (The Direc- 
torate ofMedical Services, 2002a), "Health Statistical Data in 1960 - 2002" (Health 
Development Centre, Mongolia, 2002), "State Hygiene and Epidemiological Statis- 
tics Data (1952 - 1997)" (State Statistical O)fice of Mongolia, 2000), and "Health 
Statistics of Mongolia 1960-1992" (Ministry ofHealth et al, 1993). 
There are two main problems with the officially published data: (i) the MoH, or 
SSOM data include only reports from the Aimags to the capital (MoH), and varia- 
tions may have occurred in case definition (clinical diagnosed, serologically con- 
firmed), in the reliability of reporting to the capital, and in the governance in the 
Aimags. (ii) The available datasets are not continuous for all Aimags from 1966 to 
2002. For the time period before 1993, there are missing data at Aimag level, and 
before 1980, there are nearly no continuous data available from the MoH, or SSOM, 
except a figure for "Brucellosis incidence 1958-2000" at national but not Aimag 
level (Bayart B. et al, 2001). 
The data gaps were filled mainly through the IDRI. This Institute has systematically 
collected data on brucellosis since 1966, but these data are not officially published 
and generally show a higher incidence (7he Directorate ofMedical Services, 2002b) 
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(Infectious Disease Research Institute, 2004) (Honhold N., 1995). These data result 
from surveys, and systematic investigations with the involvement of researchers of 
the IDRI (Infectious Disease Research Institute, 2004), or even particular studies 
carried out in one or two Aimags per year, in which people from high risk groups 
were selectively sampled (Honhold IV, 1995). 
Therefore the human data obtained of this research may result from a mixture of 
collection methods, of case defmitions, and of sampling methods. This was consid- 
ered when carrying out the analysis. 
The human population was taken from data provided by the Infectious Disease Re- 
search Institute (Infectious Disease Research Institute, 2004) for early years up to 
1990 and from officially published sources afterwards (State Statistical Office of 
Mongolia, 2000) (State Statistical Office ofMongolia, 1994) (State Statistical 0jf1ce 
of Mongolia, 1999) (National Statistical Qf1ce of Mongolia, 2003) (Mongolian 
Statistical Office, 2004). All sources seemed to correspond to each other where there 
was an overlap of reported data, thus these data appear to be consistent. 
Animal data 
The sources of animal data were not as varied as for human data. Official statistics 
provided the data on animal population (State Statistical Office of Mongolia, 1974) 
(State Statistical Ojjz'ce of Mongolia, 1996) (State Statistical Office of Mongolia, 
1999) (National Statistical 0jfIce of Mongolia, 2003). One main source provided 
data on the sample size of tested animals (cattle, sheep and goat) and the correspond- 
ing cases with brucellosis (Ministry of Agriculture, 2003c). These statistics were 
unpublished. The dataset was largely complete. As these data have been compiled by 
one single entity (Central Veterinary Laboratory of the Ministry of Food and Agri- 
culture), the consistency concerning case definition and methods of compiling the 
data are more reliable. However, uncertainty remained as to how the sample for test- 
ing the animals was designed. The other uncertainty related to how many herds were 
used. As described in chapter 2, the compilation by herd or area is important for 
considering the epidemiology of brucellosis. 
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Surveillance data 
The data concerning the planning and implementation of the vaccination in animals 
was obtained through an intensive archival search at the State Veterinary & Animal 
Breeding Department of the MoA. This department was responsible for implement- 
ing the vaccination campaign against brucellosis in Mongolia. The data however 
were not assembled and had to be collected from yearly files reported in different 
formats. 
The data concerning the production of the Rev. I vaccines have been used for verify- 
ing and crosschecking the plausibility of the data on vaccination implementation. 
They were obtained through archive search at the Biocombinat factory located in 
Songino-Mongoli2o (pers. Communication with ULZIITOGTOKH Tsedev, Vice- 
Director, 2.10.2003 (Roth F., 2003a)). All Rev. 1 vaccines used for the vaccination 
campaigns since mid 1970s had been produced at this factory. Data on the produc- 
tion of S-19 vaccines were only available for the years after 1996. Before then cattle 
were also vaccinated with Rev. l. All these primary data found in archives were 
drawn out of internal reports or production files. As they were in Mongolian, the 
archive search was conducted by a staff member according to our requirements. 
Recapitulation on obtaining information 
To recapitulate this section on data collection methodology, most of the documents 
and data uncovered during the Mongolia field work were unpublished, sometimes in 
the form of handwritten notes. Tracking down Governmental policy papers about 
brucellosis control turned out to be rich in impediments: they were not incorporated 
into a single archive, but were disseminated among various archives of the different 
authorities, within the MoA and MoH, and the Central Government Archive (CGA). 
As the access to this CGA was restricted to authorised persons, the research partner- 
20 This state-owned factory produces over 60 types of bio preparations and aims to satisfy 100 percent 
of the domestic market. 
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ship established with M. Nansalmaa and the MAS helped. Still, most of the govern- 
mental decision papers could only be obtained from key informants who had put 
their own copy at our disposal. A Nansalmaa played a key role in establishing con- 
tacts in Ulaanbaatar, accessing archives, tracking down the documents and translat- 
ing them into English. 
5. Quality assurance 
Data cleaning 
The collected data documented the prevalence in animals (sheep, goats, cattle) and 
the incidence in humans, at the Aimag level, for the period 1966 to 2002. This re- 
sulted in about 17,00021 single items entered inAccess to form unique and compre- 
hensive database. 
For data cleaning, the database was transferred to Excel and Intercooled Stata using 
Stat Transfer. This allowed for eliminating of mistakes made in data entry (check- 
ing) and to assure the reliability and validitY22 of the primary data. Crosschecks with 
plausibility calculations in Excel were done, such as calculation of prevalence, inci- 
dence and totals. Plots of the data with Intercooled Stata were made to show any 
unusual constellations caused by mistakes in data or data entry. If mistakes were 
identified the original data were checked for inconsistencies. 
The original data sources were cross-checked with other data sets or overlapping 
data sets. For example, the production of vaccines was checked with the imple- 
mented vaccine programme, and with the planned vaccination programme. The inci- 
21 Collected data for animals (cattle, sheep, goats) for every Aimag and all years (1966 to 2002): 
totals in population, samples, positives, prevalence, vaccinated (planned, effective, with Rev. 1 or with 
S19 vaccines). Collected data for humans for every Aimag and all years- population, number of new 
cases, incidence. Collected data on vaccine production: for Rev. I and S 19 during the observation 
period at central level. 
12 Reliability & validity: "the two key concepts that determine the accuracy of surveillance data are 
reliability and validity. Reliability refers to whether a particular condition is reported consistently by 
different observers, whereas validity refers to whether the condition as reported reflects the true con- 
dition as it occurs. " (Teusch Steven M. et al, 2000) 
68 
dence of brucellosis at national level had been calculated with the total Mongolian 
population as the denominator, however, for some Aimags the numerator was miss- 
ing for the period between 1979 and 1990 and could have caused published inci- 
dence rates to be too low (Bayart A et al, 2001). It appeared that "zero" and "miss- 
ing" were not distinguished. This was adjusted: the denominators representing the 
total Mongolian population have been diminished by the population of the Aimags 
with missing values (numerator). The aggregation used in the spatial analysis was 
not correctly weighted by the number of animals per Aimag to derive the number of 
cases. Instead, the aggregation was based on the samples of positive cases irrespec- 
tive of population in the Aimag. This was corrected. 
Quality assurance of grey literature 
Grey literatures provided a rich source of information and often gave indications 
about important discussions, controversial views or trends. However, this grey litera- 
ture did not undergo any scientific peer review. Numbers, implemented policies, and 
technical details included in this thesis work have been checked and verified by tri- 
angulation with other information such as published literature, confronting interview 
partners, or comparisons with other documents not quoting each other. Through this 
procedure, potential bias was minimised. 
Quality assurance of interview 
M. Nansalmaa acted as interpreter. Quality assurance of the translations was done 
through asking the same question differently when the question was crucial, or the 
answer given doubtful. This led several times to fiu-ther discussions, where the an- 
swers were refined or even changed. This was not always because of translation 
problems, the interviewee sometimes revised his or her opinion. Numbers mentioned 
during the interview were written down and shown to the interviewee. When appro- 
priate, sketches were drawn and developed during the follow up talks and the state 
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of knowledge shown on a graphic illustration. So during discussion the information 
gained in the interviews could be backed-up, qualified or rejected, which improved 
the quality of the content. Because of consecutive translations, there was enough 
time for taking notes about the conversations. After the interview, all notes were 
written down in a standard format and were discussed and revised with M. Nansal- 
maa. Missing or unclear information could be revised, sometimes by contacting in- 
terviewee. This process of triangulation was continued by comparing or completing 
the interview-information with official documents on brucellosis control. 
Quality assurance of translations 
A Nansalmaa scanned and sent the original documents together with her transla- 
tions by E-Mail. To assure quality, she worked through the translation with other 
English speaking persons living in Mongolia. The purpose of this quality control 
was to check the English and not correct the translation, as these persons were not all 
experts in the Mongolian or Russian languages. 
Working through these translations and having the originals allowed some plausibil- 
ity control, for example, with numbers and tables, but also by cross-checking the 
coherency of the content. Questions and comments were sent back to M. Nansalmaa. 
No doubt some weaknesses in interpretation remained, but this process provided 
documentary evidence of good quality and reliability. 
6. Analysis 
Plotting and mapping the data 
Various graphs have been created to get a first overview on the data. Graphs show- 
ing the spread of disease are included in chapter 4; graphs showing surveillance pol- 
icy and the course of disease are included in the chapter 5; comprehensive set of 
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graphs with human incidence and animal prevalence in every Aimag are in the ap- 
pendix 4.2.. 
The data have been mapped with a geographical information system (GIS, Map1nfio 
software) to get a view of the spatial distribution of brucellosis. Maps showing the 
population density of humans and animal as well as the spread of disease are in- 
cluded in chapter 6. Comprehensive sets with the incidence in humans, together with 
the prevalence in SR, and with immunisation process, are in appendixes 4.1. and 
5. L. As there is one map per year, the dynamic infection and recovery process over 
the whole observation period 1966 to 2002 are shown in short consecutive time 
slots, in the manner of a film presentation. The template map of Mongolia has been 
downloaded from interne ? 3. 
The illustrations of the worldwide spread of B. melitensis and B. abortus (see chap- 
ter 2) have been given on maps processed with MapInfo. The template map has been 
downloaded from interne t24. 
These graphs and maps provide the first overview of this collection of new data and 
establish the basis for the first qualitative and quantitative analysis to be carried out 
using it. 
Analysing the surveillance policy 
To assess the surveillance policy of the Mongolian authorities, a qualitative analysis 
has been performed (see appendix 6.1). A framework defining the basic elements of 
best practice in disease surveillance has been elaborated, based on literature concern- 
ing disease, and more specific, brucellosis surveillance (see chapter 6.1). This 
23 http: //www. cipotato. org/DIVA/data/DataServer. htm 
24 http: //www. rbgkew. org. uk/gis/tdwg/index. html 
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framework was applied to assess the surveillance policy of the Mongolian authori- 
ties. 
The first step of the analysis was to sort out the policy papers in chronological order. 
Missing papers could be identified as they were usually mentioned in the ensuing 
papers replacing them. The missing documents have been searched for according to 
the procedures described earlier. 
The second step was to identify the methods for control, eradication or prevention, 
as foreseen in the policy papers. The available methods for brucellosis surveillance 
are: "test and slaughter" of seropositive animals (T&S), "vaccination" of animals, 
and the application of "hygiene methods" or "management practices" (see chapter 
2). The methods planned by every single policy paper have been analysed. "Educa- 
tion campaigns " initially played an important role in the policy to preventing brucel- 
losis in Mongolia, and they were listed as a separate method item, although this is 
not really a separate method, but rather serves to reinforce other methods, such as 
implementing hygiene methods or managementpractice. 
In the third step, analyses of the policy papers have been entered into a grid contain- 
ing the basic elements of surveillance, This gold standard required the following 
elements: (i) definition of objectives; (ii) case definitions; (iii) data collections; (iv) 
data analysis; (v) dissemination; (vi) implementation; and (vi) evaluation (see chap- 
ter 6.1). As a result, the strength and weaknesses of the policy was evaluated. This 
allowed potential gaps in the Mongolian brucellosis surveillance system to be identi- 
fied, leading to fin-ther analysis. 
Mathematical and statistical analysis 
Mathematical and statistical methods were applied to meet the third aim, which was 
the analysis of possible interactions between the surveillance strategies applied and 
the spread of disease. 
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To capture the transmission between animal the Kermack-McKenrick Susceptible 
Infectious Recovered Model (short: SIR model) has been used. This epidemiological 
model computes host/parasite population dynamics over time, for a generalised con- 
tagious illness, in a closed population (Kermack 0 Wet al, 1927). This model in- 
volves coupled equations with no unique solution, relating the numbers of individu- 
als in the following three compartments: Susceptible, Infectious, and Recovered. 
Mathematical modelling process fitted the deterministic equations and gave esti- 
mates of the baseline birth and mortality rates, as well as on the transmission coeffi- 
cient. For this mathematical modelling the Ventana Simulation Environment Vensim, 
a system-analysis software was used. 
Statistical regression analysis has been used to identify the dependency of the infec- 
tion in humans on animals. To distinguish the infection source among the different 
kinds of animals, and to identify potential cofounders, use was made of multiple 
regression with both covariates cattle and SR. The Stata software was used for these 
analyses. 
This section described the methodology applied for the qualitative and quantitative 
analysis. Descriptive methods were used to grasp the spread of disease over space 
and time (aim 1). Qualitative analysis was used to assess the surveillance policy (aim 
2). Both provided the basis for further mathematical and statistical analysis, assess- 
ing the underlying interactions between the surveillance strategies and the spread of 
brucellosis (aim 3). From the results of the analysis, conclusions for further policy 
implications were drawn producing the final key output (aim 4). For this, results and 
implications of all three previous aims have been triangulated and combined, allow- 
ing the formulation of appropriate recommendations for further improvement in sur- 
veillance policy. 
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Chapter 4 
Epidemiology of Brucellosis in Mongolia 
Chapter 2 has provided the basis necessary for understanding the complex features 
of the zoonosis brucellosis, and placed Mongolia in the international context. The 
comparative analysis of the spread in SR and humans between Mongolia and the 
Near East Region, one of the most contaminated regions of the world, has shown 
that Mongolia has a relative low prevalence in animals and a high incidence in hu- 
mans. The speculation of this epidemiological facet was that it was due to the close 
animal - human contact, which might be encountered in a nomadic setting found in 
Mongolia. 
This chapter is dedicated to the first aim of this thesis, which is: "to establish epide- 
miological patterns of brucellosis in animals and humans in Mongolia from 1966 to 
2002. " The fulfilment of this first aim gives a basis from which to tackle the second 
aim: "to provide an historical overview on the different strategies applied to the con- 
trol ofbrucellosis in Mongolia". This will be treated in chapter 5. 
The empirical evidence on the spread of brucellosis in Mongolia was gained through 
intensive data collection, described in chapter 3, from diverse Mongolian authorities 
and archives in Ulaanbaatar. The collected data have been assembled in a unique and 
comprehensive database, covering the prevalence in animals (sheep, goats, and cat- 
tle) and the incidence in humans, on the basis of each Aimag, for the period 1966 to 
2002. 
The scientific evidence on the epidemiological patterns of brucellosis in Mongolia 
has been drawn from various sources, described in chapter 3: 
(i) Key persons, who had past or current involvement in policy or its application, 
have been interviewed2s. Besides members of the Mongolian authorities and Mongo- 
2s The list of all interviewed persons in Mongolia is given in the appendix 3.1. 
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lian scientists, Dr. Jan Kolar was a central source of information. His observations 
about the etiology of brucellosis have been considered in the second section of this 
chapter; 
(ii) Reports in English about brucellosis control in Mongolia. 
(iii) Little scientific work on brucellosis in Mongolia has been published so far in 
peer reviewed journals in the English language. However there was some scientific 
literature about brucellosis in Mongolia written in Mongolian or Russian and which 
has been tracked down by intensive search in Ulaanbaatar. 
This chapter begins with an account of the history and evolution of brucellosis in 
Mongolia. It provides the empirical and scientific evidence on the spread of brucel- 
losis. Comprehensive epidemiological studies had started in the 1960s, though the 
origin for this laid in the 1950s with the arising awareness of the problems caused by 
brucellosis. The epidemic situation described in this section were closely linked to 
the control policies and provided evidence for defining them. As the central research 
question of this thesis was to determine whether there was a relationship between the 
stated surveillance policy and the brucellosis prevalence in animals and the brucello- 
sis incidence in humans, it was necessary to consider first the spread of disease and 
then the control of disease. 
In the second section of this chapter the etiological aspects of brucellosis in Mongo- 
lia have been elaborated. In chapter 2 we have seen that adapted management prac- 
tices were crucial for preventing the transmission of brucellosis between animals, 
and that there were mainly two routes of brucellosis transmission from animal to 
human: the food borne transmission with unpasteurised infected milk and its prod- 
ucts, and the infection related to occupational hazard, such as respiration, cutaneous 
contact, conjunctival contact or auto-inoculation. Therefore the management prac- 
tices actually applied in Mongolian have been assessed in order to understand their 
role in spreading disease and the scientific literature exploited and the significant 
routes and modes of transmission relevant for the Mongolian context analysed. This 
section has provided important knowledge for assessing the brucellosis control poli- 
cies and considering whether the measures taken effectively met the etiology. 
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In the last section of this chapter the limitations of this epidemiological analysis 
have been elaborated and discussed. Though this chapter could meet the first aim of 
the thesis - it provided a broad and comprehensive knowledge on the epidemiologi- 
cal pattern of brucellosis in Mongolia, based on empirical and scientific evidence - 
there still remain some limitations. These concerned the identification of infection 
by individual animal rather than by herd and data quality. 
1. History and evolution 
Early case records and development before 1963 
With the assistance of the Soviet Union veterinary specialists conducted brucellosis 
surveys in Mongolia in 1924 and again in 1926 and they did not find any evidence 
for brucellosis (Enkhbaatar L et al, 2004). But in 1932, the first case of brucellosis 
was detected in cattle in Selenge Aimag (Dashdavaa J, 1969) (Damdinsuren L, 
1972). In the early 1940s, abortions in sheep and cattle occurred frequently in sev- 
eral farms, and brucellosis was confirmed by lab tests (Enkhbaatar L et al, 2004) 
(Damdinsuren L, 1972) (Baldanderj T, 1972). Eventually, in 1949, the first case of 
human brucellosis was officially registered (Enkhbaatar L et al, 2004). 
In 1950, the level of brucellosis infection was 17% in cattle, 3.5% in sheep and 
2.02% in goats (Enkhbaatar L et al, 2004). Since then studies on brucellosis have 
been implemented on a regular basis showing a continual high prevalence in animals 
(Dashdavaa J, 1969). Out of 700 samples taken from animals in the slaughterhouses 
in Ulaanbaatar (UB) in 1959,10% to 20% were sero-positive (Roth F., 2003b). 
However, only a few patients were treated during the 1950s for brucelloSis26 . The 
brucellosis incidence in humans was reported between 4 and 17.8 per 10,000 inhabi- 
tants throughout Mongolia during the 1950s (Baldanderj T, 1972). Surveys among 
26 In the Hospital for Infectious Diseases in UB from 3 patients in 1953 to 42 patients in 1957 
(Enkhbaatar L et at, 2004). 
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risk groups such as farm and slaughterhouse workers, or veterinary specialists 
showed the following dramatic infection' rates, using skin allergy tests (Burne and 
Huddleson): 1953: 24.5% to 37.3% (Dashdavaa J, 1969); 1956: 31.4%; 1957: 20% 
to 30%, 1956/57: 13.4% and 1958/59: 36.8%. As more than 70% of the population 
was working in the livestock sector (Enkhbaatar L et al, 2004) and 40% of the popu- 
lation had contact with animals (Dashdavaa J, 1969), this situation was alarming 
and led to a Resolution of the Ministers' Cabinet in 1959 (Molomjamts et al, 1959) 
to investigate finiher the epidemiology of brucellosis in cattle (Damdinsuren L, 
1972). Workers in factories processing animal products such as textiles and meat 
were threatened as well as the rural population. 
Epidemiological studies 1963 to 1968 
The proper attention to brucellosis was given when it became a serious human health 
problem. The Mongolian Government turned for assistance to WHO and the 
COMECON States. 
WHO project Mongolia 0001 on "Strengthening of Health Services (Epi- 
demiology)" 
The Mongolian People Republic (MPR) had become a member State of the UN in 
1962. Little was known about the health status of the population. A WHO epidemi- 
ological team initiated a study of the country's epidemiological problems with a 
view to instituting control measures the same year. The public health problems ap- 
peared to be mainly concerned with infectious diseases, spread all over the country 
(Jezek Z et al, 1969). With the industrialisation, potential for meeting people in- 
creased. Thus the modernisation of life styles favoured the spread of infectious dis- 
eases. 
A year later, the Mongolian Government launched an epidemiological analysis of 
infectious diseases with the assistance of WHO (Resolution of the Minister's Cabi- 
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net Nr. 52 on 14.02.1963) (Enkhbaatar L et al, 2004). That same year the WHO pro- 
ject Mongolia 0001 on "Strengthening of Health Services (Epidemiology)" started as 
a long-term project to (Jezek Z, 1970): 
(1) Undertake special epidemiological surveys of the prevailing communicable dis- 
eases to determine their nature and extent; 
(2) Draw up a programme of priorities for effective prevention and control meas- 
ures. 
As available routine morbidity data was of little value -- due to diagnostic difficul- 
ties, inadequate laboratory facilities and reporting failures -- multi-subject immu- 
nological surveys were performed. The purpose was to identify antibodies of the 
human population and of farm animals, and grasp the epidemiological situation to 
elaborate an epidemiological surveillance system. 
Epizootiological studies 
In 1963 - 1965, epidemiological teams headed by WHO experts, carried out wide 
scale brucellosis studies in animals (Damdinsuren L, 1972). The objectives were: 
(i) To assess the prevalence of brucellosis in livestock, as a necessary support to 
epidemiological investigations of brucellosis in humans. 
(ii) To explore the specific local factors arising from natural conditions and existing 
animal husbandry practices favouring the spread of brucellosis among livestock. 
(iii) To organise and carry out controlled field trials of A meUtensis Rev. 1 vaccine 
on small ruminants, and to assess its preventive value in immunising Mongolian 
livestock (Cvjetanovic V et al, 1968). 
They investigated the prevalence of brucellosis on a flock basis to assess disease 
occurrence and distribution and derive adapted control strategies, as it is essential in 
brucellosis surveillance to consider the flock or herd as the primary epidemiological 
unit, and to estimate its prevalence (as opposed to individual prevalence) (Food and 
Agriculture Organisation of the United Nations Rome, Italy, 1992). Because of the 
possibility of latent or dormant brucellosis infection, the entire flock should be re- 
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garded as infected, even if only one animal proves to be positive (see chapter 2). 
Sheep and goats were treated as one group (small ruminants, or SR) as they were 
raised together in common flocks usually with a sheep/goats ratio 3: 1 or 4: 1 
(Cvjetanovic V. et al, 1968). The study included 680 randomly selected flocks, con- 
sisting in 413 SR' flocks, 92 cattle flocks, 89 camels flocks and 86 horses flocks 
with a total of 16,479 animals in 6 Aimags 27 (Cvjetanovic V et al, 1968). The col- 
lected samples were examined with SAT and CFT. Interpretation of SAT was done 
in accordance with recommendation of the Joint FAO/WHO Expert Committee on 
brucellosis (Fourth Report) (Cvjetanovic V et al, 1968). This ensured an interna- 
tional standard and an international unitage system. Flock infection rates were 
43.0% for cattle, 16.2% for sheep, 13.4% for goats, 4.9 % for camels and 30.9% for 
horses (Damdinsuren L, 1972). Although, sheep and goats were kept together in 
common flocks and formed one epidemiological unit, infection rates were often 
given separately. 
This epizootiological. survey by the WHO assisted team provided the basis for the 
planning of control strategies. However, the seriousness of the situation prompted 
the MoA not to wait until the WHO assisted project had elaborated a control strat- 
egy. The MoA started the following year a separate action assisted by the COME- 
CON States and directed toward control of animal brucellosis by T&S method 
(Kolar J., 1995b). 
Brucellosis serological surygy in humans 
Although brucellosis was, as outlined above, first reported in 1932, it was difficult to 
assess the incidence and prevalence because of the immense number of very mild 
and therefore undiagnosed cases. The only reliable estimates were serological tests 
in populations sampled at random, carried out by the WHO epidemiological team. 
The survey was carried out during November 1966 - November 1967, during which 
the serum of 4,816 persons were simultaneous tested with SAT and CFT (Jezek Z, 
1970). The tests covered 0.5% of the Mongolian population. 
27 Central Aimag, Bulgan, Zavkhan, Uvurhangai, South Gobi, Domod 
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In urban population, 1.7 % of the persons tested were serum-positive, whereas in 
rural population there were 4.4 % serum-positives. There were significant differ- 
ences among the different Aimags and Sourns examined for this survey, which var- 
ied from 0.6% to 9.6% (Jezek Z, 1970). It was also found that the percentage of hu- 
man reactors depended on the occurrence of brucellosis in farm animals, particularly 
among sheep (Jezek Z, 1970). The infection rate with brucellosis was as follows: (i) 
in urban areas: 13.7% among meat workers, 2.3% for dairy workers, 2.1% for stu- 
dents employed in the Agricultural Institute; and (ii) in rural areas: 9.9% in shep- 
herds, 8.4% among farmers, and 3% in non-agricultural work (Jezek Z, 19 70). 
Brucellosis was confirmed as a serious public health problem, and it seemed worth- 
while to undertake a third study on special patterns of Brucella infection in human 
and farm animals (Jezek Z, 1970). These results 28 reconfirmed the grave influence 
brucellosis had on public health: nearly all the population living in endemic areas 
were under permanent risk of Brucella infection (Jezek Z et al, 1969). 
Test and Slaughter campaign with COMECON assistance 
During the WHO project -- independently from the planned elaboration of control 
strategies based on the surveys-- the MoA launched with the assistance of COME- 
CON States a large Test and Slaughter (T&S) national campaign from 1966 to 1968. 
The COMECON provided about 30 veterinary diagnostic teams equipped with mo- 
bile laboratories (Kolar J., 1995b)29. In collaboration with the Mongolian veterinary 
services, they examined 1,523,632 cattle and yak, 7,723,526 sheep, 2,582,398 goats, 
191,355 camels, 4,564 pigs, 4,160 dogs and approximately 800 reindeer with aller- 
gic skin test and partly with SAT and CFT during the first year (1966) (Tserendash 
Choijiljav, 1972). The identified reactors were immediately separated and slaugh- 
tered (Kolar J., 1995c). 
28 15.7% of the animal production workers were serum-positive, 14.7% of the plant production work- 
ers, and 10.7% of the non-agricultural professions. 29 Other sources report 40 teams (Kolar J., 1995a) or 18 detachments with between 84 to 124 sub- 
groups (Ariunaa 0,1996). 
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The Mongolian Government stated that the results of these examinations confirmed 
the surveys of the WHO team: (i) brucellosis was widely spread; (ii) brucellosis was 
unevenly distributed; (iii) the flock infection rate was extremely high (79% in 
sheep/goat and 87% in cattle) (Kolar J, 1995b). However there were no official re- 
lations between the COMECON funded project and the WHO funded project institu- 
tionalised at that time (Kolar J, 1970a), as the authorities were reluctant to present 
the epidemiological situation to the outside world because of the threat of loosing 
important markets for Mongolian meat and other animal products (Kolar J, 1972). 
Today, no results on the investigations of the COMECON are available. 
Epidemic situation and involvement after 1966 
The spread of Brucellosis in humans and animals on Aimag level in 
course of the time 
The data were collected during field work in Mongolia in autumn 2003 (see chapter 
3). A comprehensive database was then generated to describe and analyse, at Aimag 
level, the spread of brucellosis for the years 1966 to 2002 for sheep, goats, cattle, 
and humans. 
Figure 4.1. shows the incidence of brucellosis in humans, where every dot repre- 
sents the incidence within an Aimag30. The incidence of every single Aimag has 
been weighted with its population size to calculate the average incidence of the 
whole country (=showed as line in the plot). Thus, the yearly incidence of Mongolia 
varies from 0.67 and 14.33 per 10,000 inhabitants, and has an incidence with an av- 
erage of around 6 per 10,000. In an international context, this is a high incidence of 
human brucellosis. The map of the human brucellosis distribution in chapter 2 shows 
only such high incidences in the Near East Region and the Arabian Peninsula. Nev- 
ertheless, thefigure 4.1. shows that, on average, brucellosis in humans has remained 
steady, even though trends are noticeable during some decades; in the late 1960s and 
30 Two outlying Aimags with incidence over 80/10,000 are not showed in the plot: Gobisumber 2002 
inc. 93.6 and Suhbaatar 1990 inc. 85. However in the analysis they are included. 
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1970s, the incidence declined, but in the 1980s it was volatile and at a higher level, 
and finally, in the 1990s it rose again. 
Figure 4.1.: Brucellosis incidence in humans 
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Because the human infection has its origin in the animal disease, the animal preva- 
lence is of great interest. The figure 4.2. shows the prevalence in cattle, sheep and 
goats. As in figure 4.1., every point represents the prevalence within an Aimag 31 
and the average calculation (line) has been weighted with each Aimag's animal 
population. The prevalence in cattle varies over a broader range than in sheep and 
goats, and the average prevalence in cattle was much higher. It varied between 
0.97% and 9.08% for cattle, with an average of 2.9%, and varied between 0.18% and 
2.54% and 0.11 % and 2.7 1% in sheep and goats respectively, with an average of 
11 The outlying Aimags with prev. over 0.1 are not showed in the plot, but included in the analysis. 
It concern for cattle in 1987: Arkhangai (0.199), Bulgan (0.12), Domod (0.20). Selenge (0.16), Tuv 
(0.15), KhuvsguI (0.16), Hentiy (0.15). 
It concerns for cattle in 1988: Arkhangai (0.155), Bayanhongor (0.20), Sukhbaatar (0.16). 
In concerns for cattle in 1989: Bayan-Olgii (0.14), Dundgobi (0.198), Uvs (0.139), Khovd (0.119). 
For sheep it concerns: Sukhbaatar 1968 (0.168) and Bayankhongor 1969 (0.118). 
For goats the three oulying Aimags have been set at 0.1 for plotting (not for analysing): Bayank- 
hongor 1969 (0.109), Ulaanbaatar 1986 (0.136), Bayankhongor 1990 (0.105). 
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0.77% for sheep and 0.75%. for goats. In chapter 2, the worldwide incidence of 
brucellosis in animals is shown for B. abortus and B. melitensis, and has been classi- 
fied as "high" for B. abortus and "low" for B. melitensis in Mongolia. Thus in an 
international context, the spread of disease is less important in SR (B. melitensis) 
than in cattle (B. abortus). Prevalence fluctuations are similar for sheep and goats. In 
Mongolia, sheep and goats are flocked together, and are often presented as one epi- 
demiological unit called "small ruminants" (SR) (see above "epidemiological stud- 
ies'). Sheep and goats will be treated as one entity in this thesis. 
Maps showing for every Aimag on yearly basis the spread of brucellosis in SR and 
humans are put in the appendix 4.1. (see also chapter 3). An historical overview is 
provided this way, showing how brucellosis was spread all over Mongolia, with 
variations over time. 
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Figure 4.2.: Brucellosis prevalence in animals 
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In conclusion, brucellosis in humans and animals has been present over the entire 
observation period. Owing to its zoonotic nature, animal-human disease trends have 
mirrored each other: declines in the late 1960s and 1970s, and a volatile and unclear 
situation in the 1980s, and finally, an increase in the 1990s (figure 4.3). 
Figure 4.3.: Brucellosis in Mongolia: human incidence and animal 
prevalence 
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Brucellosis serological surveys in humans 
In the 1980s and 1990s, the authorities conducted several extended surveys among 
the population and particularly among the population at risk as herders and persons 
working with livestock. The survey conducted by the State Dispensary of Infectious 
Diseases, between 1984 and 1989 in 14 Aimags with 46,731 persons, confirmed that 
brucellosis in humans was a serious public health issue (Enkhbaatar L et al, 2004): 
16.5% of the persons tested were under suspicion of infection, 4.5% were confirmed 
as chronic brucellosis cases, and 3.83% were identified as new brucellosis cases. 
This high level of infection in humans still remained in the 1990s. Indeed, among 
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Brucellosis in Mongolia 
human incidence and animal pre\ralence 
43,758 persons tested between 1990 and 1998,25% were positive for antibodies and 
10% had active brucellosis (Garin-Bastuji B., 1999). The finiher testing of 40,000 
herders and persons working with livestock, in the second half of the 1990s, con- 
fmned this picture: 16.1 % showed seropositive reactions and 9.1 % had active infec- 
tions (State Veterinary & Animal Breeding Department of the Ministryfor Food & 
Agriculture et al, 2001). This indicates that the officially published incidence rate 
(see previous section), based on reported cases, only represented a small proportion 
of the real cases occurring each year. 
2. Etiology of Brucellosis in Mongolia 
Sources of infection 
How Brucellosis came to Mongolia and spread 
Mongolian researchers believe brucellosis was initially brought to Mongolia from 
movements of infected SR from China to the Aimag Bayan Olgii (far west of Mon- 
golia) in 1940 (Enkhbaatar L et al, 2004), and from Russia in 1945 (O'Rourke M et 
al, 2001) (Dashdavaa J, 1969), through the importation of rams and bulls in 1930s 
to improve the local breeds (Kolar J, 1995a) or with the importation of camels. Be- 
cause imported animals were not controlled, infected animals were brought in 
(O'Rourke Metal, 2001). 
The finther spread of brucellosis within Mongolia was made possible through cross- 
breeding between herds from different regions. Traditionally, the herders kept small 
private herds separate from each other, with little mixing or transfers of animals 
(Kolar J., 1995a). However, with collectivisation: small private herds were fused 
into larger herds, regardless of health status of the single flocks. In addition, the 
herders who had become workers of the collective farms still owned a few animals 
and took these along when changing work to other farms 32 . 
32 Each family was allowed to possess about 50 animals, the privately owned animals were not 
marked, but the best animals were considered as privately owned (Both F., 2003b). 
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Relevant animals for the spread of brucellosis In Mongolia 
General etiology of brucellosis has been described in chapter 2. The epidemiological 
studies of the 1960s (see previous section) provided a broad knowledge basis on the 
relevant animals for the spread specifically in Mongolia. The following were found: 
Sheep and goats (SR) were the most important. All strains isolated from SR have 
proved to be B. melitensis (biotype I and 3). The infection was chronic in most 
flocks with many latent caniers and excreters (Kolar J, 1995a). But the abortion 
rate and the prevalence was low (Kolar J, 1995a). In cattle and yaks, however, the 
infection was mostly caused by A abortw, although B. melitensis strain (biotype 3) 
has also been isolated occasionally in herds kept together with infected SR (Kolar J, 
1970b). Both B. abortus and B. melitensis were isolated in camels; however infected 
camels rarely aborted or showed any clinical signs of brucellosis (Kolar J, 1995a). 
There was little information on the importance of camels in the spread of brucello- 
SiS33 . The epidemiological importance of horses, as a source of 
brucellosis, is very 
limited. Clinical symptoms are exceptionally rare, regardless of contact frequency 
with ruminants (Kolar J, 1970b) (Kolar J, 1995a)34 . There seemed to be a clear 
relation between the dissemination of brucellosis in ruminants and in dogs. However 
the transmission to human is limited in Mongolia as the direct contact between the 
nomads and their dogs is very occasional (Kolar J, 1970b) (Kolar J, 1995a). Rein- 
deer showed an infection rate of 75% by serological testing in 1984 or 20% in 1985- 
1986, clinical symptoms could be observed in 13.5% of the animals 35. As reindeer 
are kept only in a limited geographical area (Khuvsgul Aimag) they do not play an 
important role in the countrywide epidemiology. Mongolian livestock and wild ani- 
mals live in a close ecological bond. Various antelopes and rodents live and graze on 
the same pastures as livestock, while wolves, jackals, foxes and vultures accompany 
33 A study carried out in 1966 in 15 Aimags showed an average infection rate of 1.6% among 65,074 
camels. The inter-Aimag range of infection was 0.6% to 5.1%. However, 48.9% of the farms had 
infected camels, with a range varying by Airnag from 11.1% to 81.8% (Tserendash ChoyiIjay, 1972). 
34 Brucellosis in horses was not common in most farms with infection rates in ruminants of between 
0.1% and 5%. A study in 1966 including 10,052 horses showed serological reactors in 121 horses 
(1.2%), which corresponded to a significant lower infection rate than in the other animal species 
(Tserendash Choijiljai; ý 1972). 
35 All reindeers (717) have been vaccinated with S19 in spring 1986 (EnkhbaatarL et A 2004). 
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the nomads to seize weak or sick animals and carcasses or foetuses. Nevertheless a 
report from 1970 on the principal epidemiological features of brucellosis under con- 
ditions of nomadic animal husbandry in Mongolia noticed no important significance 
of wild animals on the spread of brucellosis in livestock: "Although there are theo- 
retical assumptions and positive findings in many countries, the importance of wild 
animals in brucellosis epidemiology cannot be considered as high. "(Kolar J, 
1970b). 
Thus the epidemiological studies lead to the conclusion that the focus has to be set 
on SR and cattle (yaks). 
Animals relevant for the transmission of Brucellosis to human 
Scientific research carried out late 1960s and early 1970s concluded that the inci- 
dence of brucellosis in humans may be more closely linked to the prevalence in SR 
than in cattle and yaks. This conclusion had been drawn on the basis of observation 
rather than on sophisticated statistical or serological analysis: patients attending the 
brucellosis dispensary in UB between 1966 and 1971 were workers in farms breed- 
ing SR rather than workers in cattle farms (Tserendash Choiji1jav, 1972) 
(Baldanderj T, 1972). Another observation was that, in Aimags with high SR preva- 
lence rates, human infections seemed higher. This did not appear so clearly for cattle 
and yaks (Tserendash Choiji1jav, 1972). Further analysis showed also an association 
between human incidence and the population size of SR and their density in pasture 
(Baldanderj T, 1972). However there is also scientific research concluding that there 
was 4-5 times more transmission of brucellosis from cattle to human than from SR 
to human, but the infection got from SR was more important due to the severity of A 
melitensis (Dashdavaa J, 1969). In early 1980s it had been specified in scientific 
research the fact that the infection rate of herders dealing with SR (27.7 ± 0.96%) 
was higher (p<0.01) than of herders dealing with other types of animals (11.5 ± 
0.73%), even though the prevalence rate of SR was lower than in cattle and yaks 
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(Tovuugiin Gombosuren, 1982). This has been related to the greater number of SR36. 
In fact it was concluded that 40.5% of the patients were infected by SR, 11.0% from 
cows, and 29.4% from mixed herds. 
Factors influencing Brucellosis transmission 
Traditional Mongolian practices have controlled food bome transmission of brucel- 
losis from animal to human: milk was mostly not drunk in its natural state, but trans- 
formed to various typical drinks or foodstuffs, which have a preventive effect on the 
transmission of brucellosis. Usually milk is added to green tea and boiled (called: 
Suutei Tsai), or other milk products are pre-pared from heated milk (at 700 to 900 Q, 
and leavening is added. Examples are Urum (clotted cream), Tarag (sour milk), 
Byaslag (soft cheese), Aaruul (dried cheese). The only product prepared from fresh 
milk is Airag (fermented mares' milk, also called Kumys), but the high acidity aris- 
ing during the fermentation process (pH 4.2 - 3.9) destroys all Brucella organisms 
within 24 hours (Kolar J, 19 70a). Naturally, animal husbandry has played an impor- 
tant role in the transmission of brucellosis between animals and from animal to hu- 
mans. Even though modem husbandry methods have been introduced, such as dairy 
cattle fam-Ling, the bulk of animal production largely remains nomadic or semi- 
nomadic to this day. Crucial factors in this setting, from an epidemiological point of 
view, were (i) the close contact between animal and human, (ii) some specific man- 
agement practices and (iii) the possibilities and habits concerning hygiene. The vari- 
ous opportunities for transmission had been studied in the epizootiological survey in 
the frame of the "WHO project Mongolia 0001" (see above) and had been listed 
below (Kolar J, 19 70a) (Kolar J et al, 1968) (Cvjetanovic V el al, 1968). 
Limited data is available on the influence of ecologic changes on brucellosis trans- 
mission. This topic seemed to be neglected in literature and will not be treated in 
36 It confirms our analysis in chapter 2: we had compared the Mongolian epidemiological situation 
with this one of the countries in the Near East region. It became evident how in Mongolia the inci- 
dence in human was extraordinary high compared to the prevalence in SR. 
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depth in this thesis 37 . The pasture land in Mongolia is primarily and and semi-arid 
steppe. The climate is harsh and the growing season is short. The pastoral livestock 
system must be adaptive to these conditions and is very vulnerable to ecological 
changes. "High levels of climate variability in precipitation occur and it is likely that 
climate variability in terms of "Dzud"" and drought frequency and intensity will be 
increased as a result of climate change" (van Hezik C ME, 2002). Climate changes 
deteriorate both yield and biomass of pastures, which finally may lead to animal 
weight loss and to increasing the vulnerability for disease. 
Management Rractices 
(i) The transmission of infectious diseases from one kind of animal to the other was 
made easy by the fact that various kinds of farm animals were kept together in pas- 
tures or at watering places. In this context keeping sheep and goats in common 
flocks was for the transmission of brucellosis of great importance: the infection in 
such flocks was sustained, as goats had a higher susceptibility to brucellosis and the 
carrying and excreting of Brucella organism was latent and prolonged. 
(ii) Herders do not apply grazing control or fencing. As the pastures are circulating 
ground for the infectious agents, this favours also the transmission between livestock 
and wildlife. 
(ii) The animals had been moved from various parts of Mongolia to slaughterhouses 
in UB or to export bases at the border. This favoured the spread of communicable 
diseases, as the epizootiological situation of the territories passing through had not 
been considered. 
(iii) The animals had been mixed and regrouped frequently. For example the herders 
brought their private animals to the state herds when moving from one to the other 
37 However, Lin and Li (Lin D Xet al, 2000) reported on the possible links with the El Nino phe- 
nomenon in a Chinese paper (Dequi S et al, 2002). Based on animal and human brucellosis data from 
1949 to 198 1, they found higher incidences of SR and human brucellosis during La Nina year. They 
correlate this to atmospheric changes such as lower temperatures, heavier winds, snow, droughts, and 
flooding. These, in turn, can be responsible for lack of water or grass, and increased pressure on ani- 
mals whose resistance against diseases is lowered. 
38 Dzud, a Mongolian term, refers to a variety of winter conditions that destroys or prevents access to 
grazing material, preventing animals from eating and thus surviving during the winter months from 
October to May. Conditions that lead to Dzud include heavy snowfall (white Dzud), the formation of 
an impenetrable ice layer over pastures (ice Dzud), or a lack of sufficient winter fodder for animals 
following summer drought (black Dzud). 
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working place. Or the dairy cows had been held during summer time on pastures 
around the centres. However the health situation of the herds has never been consid- 
ered. 
(iv) Usually the aborting animals had not been separated from the flocks. 
(v) The rams and bucks had been kept in separate male-flocks and had been distrib- 
uted for the mating season: this had favoured the spread of brucellosis over large 
territories. 
(vi) Before the mating season the maternal flocks had been completed with year- 
lings: this had maintained the chronic infection. 
Close contact 
(i) To protect new bom animals from extreme frost it was the practice to bring them 
into the human habitation (ger). 
(ii) The herders skinned stillborn animals to get the pelt or applied the traditional 
way of slaughtering the SR by avoiding bleeding. Both practices created possibilities 
for transmission. 
(iv) Places as shelters, where animals were kept close together, were littered with 
dry faeces, contaminated when infectious abortions occurred. These faeces were 
transformed into fine dry dust, whirled by constant winds and creating a dangerous 
source of airborne infection. 
Hygienic habits 
(i) During the winter season the herder had only little water at its disposal, as it had 
first to be melted from ice. The water was used primarily for drinking and cooking 
and not for washing and cleaning. This lead to minimal hygienic measures just dur- 
ing the period when abortions occurred and mass-parturition happened. The equip- 
ment and shelters could not be cleaned and disinfected. Contact infection had been 
additionally favoured by hand, often chapped as a result of frost. 
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Routes of transmission 
Human Infection through animal contact 
Mongolian scientists, such as Smirnov S. A in 1958 (Dashdavaa J, 1969) had rec- 
ognised early the importance of animal contact transmission over food borne trans- 
mission for human infection. Later on, further studies confirmed this: 94.3% ± 0.6% 
of human infections were caused by animal contact and 5.7%-+0.5% by alimentation 
(Baldanderj T. 1972). The importance of contact transmission has again been con- 
firmed by later studies: 89.2% of human infection was due to direct animal contact 
(62.1% of these during animal birthing season), 4.3% was due to contact with con- 
taminated animal products and only 6.5% of the human infection had been identified 
as food borne (Dashdavaa J et al, 1981). Thus the main risk group has been identi- 
fied: people having close contact to animals or working with animal products. 
Occupational risks for Brucellosis Infection 
In the 1970s, scientific studies attested that 39% of the herders were infected with 
brucellosis, 6.6% of the students of Agriculture Institute and 2.2% of the workers of 
the plants processing wool, leather or meat (Damdinsuren L, 1972). Most of the 
herders were breeding SR or cattle (Baldanderj T 1972). A surveys in urban setting 
showed very high brucellosis prevalence among workers in plants processing animal 
products (50.8% ± 6.2% seropositive by allergic test; 20.3% ± 3.0% by SAT and 
CFT) and relatively low prevalence of 1.9% among unprofessional city residents 
(Baldanderj T, 1972). 
Surveys conducted in late 1980s reported that 13.5% of the herders were sero posi- 
tive (Minisoy ofAgriculture et al, 1991), and confirmed the severe contamination of 
persons working in finther high risk professions: 28.7% of the persons working in 
slaughter houses were infected with brucellosis, 17.8% working in dairy cattle 
farms, 19.6% working in leather industry and 22.5% working in the wool industry 
(Enkhbaatar L et al, 2004). 
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This situation seemed to become even worse in the late 1990s, when a survey con- 
ducted in 1996 among 42,000 members of the high risk group (herders, veterinarians 
etc. ) showed that 30.9% of them were infected (Ministry of Food and Agriculture, 
1996). 
Epidemiological characteristics 
Epidemic season 
The course of infection in SR was seasonal with a maximum in May (Dashdavaa J 
et al, 1981). Though most dangerous in epizootic and epidemiological relations was 
the lambing season, which was in February / March: "The morbidity in human popu- 
lation clearly coincides with the lambing and kidding season, where 80% of all cases 
of human infections are recorded" (Kolar J., 1970b). This goes in line with other 
analysis showing that 701/o of new human infections occurred between March and 
July (Baldanderj T, 1972). However intense human infection has been documented 
at autumn as well (Tserendash Choiji1jay, 1972). This confmned that apart from the 
lambing season further opportunity of humans to get infection by contact were also 
with milking or slaughtering of infected animals, both more relevant in late summer 
and autumn. 
Demography 
About two thirds of the patients were men (Damdinsuren L, 1972). In the urban con- 
text however, including the non-professional group into the study, the difference 
between sexes disappeared (Baldanderj T, 1972). In the urban context patients were 
on average 10 years younger than in rural context (Baldanderj T, 1972). This is be- 
cause students, involved in herding during summer time, belonged to the high risk 
group, and students were considered urban citizens (Dashdavaa J, 1969) 
(Tserendash Choiji1jav, 1972). The percentage of infected herder increases with their 
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age (Baldanderj T, 1972). However it has been observed that immunit? 9 of herders, 
who have permanent contact with animals, could be sustained for a longer period of 
time (Tovuugiin Gombosuren, 1982). 
Predominant strains 
The strains isolated from aborted foetuses and milk (Baldanderj T, 1972) were bio- 
types I of B. abortus in cattle (Tovuugiin Gombosuren, 1982) and all three biotypes 
(I, II & III) of B. melitensis in SR (Tserendash Choiji1jav, 1972) (Cvjetanovic V et 
al, 1968). Human studies from 1964 to 1966 and 1975 to 1976 confirmed that most 
infection in human belonged to B. melitensis (Dashdavaa J et al, 1981) (Tovuugiin 
Gombosuren, 1982). B. melitensis was common in SF, but the migration to cattle 
occurred sporadic (Tserendash Choiji1jav, 1972) or with growing role (Baldanderj T, 
1972). 
Chronic versus acute 
The analysis of patients diagnosed with brucellosis, between 1958 and 1969, showed 
that about 70% had chronic brucellosis at the time of diagnosis (Baldanderj T, 
1972). Later, in the early 1970s, 86.7% of the brucellosis patients had chronic dis- 
ease (Damdinsuren L, 1972). Brucellosis was often diagnosed too late, probably due 
to limited access to health facilities for diagnosis and treatment. More recently, be- 
tween 1999 and 2001,47.8% of the brucellosis patients, treated at the Infectious 
Disease Centre in UB, suffered from the chronic form of brucellosis, and a survey 
among 250 physicians resulted 56.4% chronic cases in their consultancies (16% 
acute, 20% sub-acute) (Badarch UL4MBAYAR, 2001). This high proportion in 
chronic cases reflected poorly on the quality of access to health care and diagnosis 
(Erdenchimeg G. et al, 2001). 
39 Immunity in the sense of not showing any symptoms of infection 
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3. Limitations and discussion 
A review of Mongolian scientific work on human and animal brucellosis was pub- 
lished in 2004 (Enkhbaatar L et al, 2004) by Mongolian scientists. Comparing their 
listing of Mongolian scientific work with the literature we have traced, it confirmed, 
that we had compiled a comprehensive piece of Mongolian literature on this topic. 
However, the aspects of epidemiology had been reproduced in a narrative or descrip- 
tive way, with little analysis. A contribution of this chapter was to make the Mongo- 
lian scientific literature accessible to the English speaking scientific world, and to 
use it as basis for understanding and analysing the control policy, which is the topic 
of chapter 5. A fiuther contribution of this chapter was to assemble a comprehensive 
database providing empirical evidence about the spread of brucellosis in humans and 
animals at the Aimag level. This database provides the basis for the statistical and 
mathematical analysis in chapter 6. The current chapter however describes the data 
with maps and graphs. The data has been cleaned (methods described in chapter 3) 
to make it sound and consistent; however, uncertainties remain concerning data col- 
lection methods and epizootiological entities. 
Limitation and discussion on data quality 
Systematic data collection on the spread of brucellosis in Mongolia began in the 
mid-1960s onwards, during the T&S campaign aided by COMECON and the WHO 
epidemiological studies. Most of the collected data for this thesis are generated from 
so-called "grey" literature, such as unpublished or internal reports of various units 
within the departments of human and veterinary medicine. This method had to be 
used for lack of available official statistics, and data consistency therefore suffered. 
The quality of data for the animal disease was much better than for the human dis- 
ease. Livestock farming was traditionally a very important economic factor in Mon- 
golia, so there was strong concern about animal health. In the late 1960s, for in- 
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stance, livestock accounted for over 83% of the GDP of the MPR (Ministry of 
Health et al, 1970). 
A limiting factor in the consistency of data could be the mixing of data gained from 
surveillance with reported data. This could be confirmed for the prevalence in cattle 
in the years 1987 and 1988. Striking were the variations in the 1980s for prevalence 
in cattle and the incidence in humans (seefigure 4.3. ). The same graphs but on Ai- 
mag level are shown in the in the appendix 4.2. and help in the further analysis of 
these variations. Looking at the policy papers intense testing 40 of cattle in 7 Ai- 
magel in 1987, with isolating or slaughtering the positive reactors and vaccinating 
the others42 could be confirmed (Ministry ofAgriculture, 1987) (Ministry qfAgricul- 
ture, 1988). The following year additional four Aimags 43 have been added to this 
campaign (Badarch P., 1988b). Finally infigure 4.4. it became obvious, that the 
stated prevalence in the Aimags, where surveys have been conducted, is considera- 
bly higher than prevalence in the other Aimags. The numbers infigure 4.4. show 
that by including all Aimags the prevalence in 1987 increased to 9%, while with 
excluding from the calculation those Aimags, where testing had been conducted, the 
prevalence rate remained at 1.2%. Therefore it can be concluded that the data from 
the testing are included in the reference material and mixed with the reported data 
from other Aimags. In 1988 the prevalence rate dropped again, because of the 
slaughtering of positives the previous year. 
40 The diagnostic tests have been performed using SAT, CFT and RB (Badarch P., 1988b) 41 Khuvsgul, Arkhangai, Bulgan, Selenge, Tuv, Dornod, Khentee 
42 The cattle in two Aimags (Tuv and Selenge) have been vaccinated with S 19, the cattle in the other 
Aimags have been vaccinated using Rev. 1 (Badarch P., 1988b). 
43 Zavkhan, Uvurkhangai, Bayankhongor, Sukhbaatar 
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Figure 4.4.: The influence of surveys on the prevalence stated 
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Bulgan 0.129 0.018 
Domod 0.208 0.034 
Selenge 0.160 0.022 
Tuv 0.153 0.035 
Khuvsgol 0.165 0.045 
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Bayankhongor 0.204 
Sukhbaatar 0.163 
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Derived from material collected for this thesis 
A further important issue explaining the variations of the prevalence rate in animals 
are the so-called "storms of abortions". This is a typical phenomenon when herds are 
infected with Brucella. With the increasing abortion rate caused by brucellosis, large 
numbers of Brucella are spread into the environment, further increasing the infection 
risk. Due to high level of susceptibility of the herd, the infection is accelerated until 
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a certain level is reached, where the proportion of susceptible animals is diminished 
and the fin-ffier spread slowed down (Ganzalez-Guzman J et al, 1994). Thus, the 
cause of these variations is not bad data quality; they portray the real course in the 
spread of disease. 
A difficulty in analysing the epidemiology of brucellosis seemed to be the poor re- 
porting, or under-reporting of the disease in humans (see chapters 2 and 3). Difficul- 
ties in obtaining reliable data on human brucellosis are quite common for former 
communist countries, such as Tajikistan or Romania, where poor reporting of the 
disease in humans has been noted (Jackson R et al, 2003) (Dobrean V et al, 2002). 
Two features stand out in the data set compiled for this work: 
(i) Nearly every human case had its origin in animal infection (see chapter 2). Com- 
paring human incidence and animal prevalence at Aimag level (see appendix 4.2. ) 
showed that the disease in humans did not follow the course of disease in animals. 
This phenomenon has also been observed and described in Tajikistan (Jackson R et 
a4 2003) and in China (Dequi S et a4 2002). In China it has been called as "sepa- 
rated phenomenon of human and animal brucellosis". The reason given for the 
66separated phenomenon" was, that the time, place, tests and sampling methods of 
surveys on human and animal brucellosis were not standardized and uniform (Shang, 
1996) (Dequi S et a4 2002). This may explain why this close link of the disease 
spread in humans to the disease reservoir in animals seemed to be missing. Further 
statistical analysis on this will be done in chapter 6.2. 
(ii) Other phenomenon could also be observed (see appendix 4.2. ): in 1987 and 1988 
enormous increases occurred in some Aimags in both cattle prevalence and human 
incidence. As we will see in chapter 5, it mostly concerned Aimags which had been 
involved in T&S and vaccination campaigns in cattle. In all but two Aimags 44 the 
reported incidence in humans reflected the onset of control activities in cattle 5. This 
was shown for the Aimags Dornod, Tuv, Zavkhan, Ovorhangay and with a time lag 
44 Arkhangai, Bayankhongor 
45 In Selenge the inc. in human was a year previous to the control activities, so in the preparation 
phase. 
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of one year for Bulgan, Khuvsgul, Hentiy and Sukhbaatar (time lag of two years). 
Policy activities in animals could have lead to more rigour in reporting human data. 
On top of it, this augmented awareness led, in some cases, to surveys being con- 
ducted in humans 46 (Enkhbaatar L et al, 2004). The results of these surveys may 
have been mixed with reported cases, which lead to a sudden enormous increase on 
human incidence, which did in fact not correspond to the real course of disease. 
Discussion on the epidemiological entity 
In the chapter 2 it was shown that each infected flock poses a risk for public health 
and therefore the entire flock should be regarded as infected, even if few animals 
proved to be seropositive. If, for example, there are 10 cases in an Aimag drawn 
from 10 different herds then because of the contagious characteristics of brucellosis 
it is likely that all animals are infected or exposed. If the sample was of 10 cases 
from one herd it provides no information about the prevalence of the disease in the 
other herds (Question of herd infection). Therefore in brucellosis control, the entity 
of interest should be the infected herd rather than the infected individual animal. 
However, the data collected and analysed were related to the reported prevalence in 
the individual animals. 
Some Mongolian scientific literature published figures on the prevalence in herds, 
and these showed how serious the brucellosis contamination was (seefirst section of 
this chapter). The prevalence in SR seems to be low (<2%, seefigure 4. Z), but the 
surveys conducted in the late 1960s showed that 80% of the SR flocks were infected 
with Brucella (Kolar J, 1970b). As shown in the appendix 4.3., the situation was 
similar in cattle: surveys conducted in 1966 in 307 farms showed that infected cows 
had been identified in 284 (92.5%) farms. Also on Aimag level, the percentage of 
farms with infected cattle was very high, and varied from 71.4% to 100% 
46 According to the results of an epidemiological study and reports from the State Dispensary of In. 
fectious Diseases, the prevalence of human brucellosis was 20.7% in Arkhangai, 31.8% in Selenge, 
23.4% in Bulgan and 20.3% in Dornod Aimags between 1987- 1988(Enkhbaatar L et al, 2004). 
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(Tserendash Choijiljav, 1972). The contamination of herds was evenly spread 
throughout the country. Another survey conducted in 1983, among cattle farms, 
showed an individual prevalence between 0.1 and 6.4%, but 52% of all tested farms 
had infected cows (Khohoo A. et al, 1995). "Brucellosis researchers have long been 
aware that the real epizootiological entity is not an animal population scattered over 
an entire area, but an animal herd, whereas man as the real contact with the animal 
reservoir must always be evaluated as an individual single case. However, in areas 
where the common grazing of herds is practiced, the area or village are more like an 
epizootiological entity than the separate herds" (Thimm Bernhard M, 1982). In no- 
madic conditions, it is difficult to arrange strict isolation of infected herds, and thus 
the high number of infected herds is a constant danger to the healthy ones. There- 
fore, animals roaming an area as extended as an Aimag could very well be consid- 
ered as a single herd entity from the point of view of control policy. 
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Chapter 5 
The policy of Brucellosis control in Mongolia 
The previous chapter discussed the epidemiology of brucellosis in Mongolia. The 
spread of brucellosis over space and time in cattle, SR and humans was chartered. 
The etiological factors determining the sources, factors and routes of transmission in 
Mongolian context were analysed. This created a comprehensive picture of the 
brucellosis in Mongolia and allowed an assessment of appropriate control strategies 
to be made. 
This chapter tackles the second aim of this thesis: "to provide an historical overview 
on the different strategies applied to the control of brucellosis in Mongolia. " 
Data on the effective vaccination level of cattle and SR had to be traced down from 
yearly activity books found in the archives of various authorities within the MoA 
and out of the yearly production books found at the Biokombina t47. So the following 
analysis of the policy of brucellosis control in Mongolia was based on a unique and 
nearly complete set of Governmental policy papers and on a unique and complete set 
of data on testing and vaccination. 
This chapter begins with a discussion of the relative importance of brucellosis con- 
trol. This is followed by an historical overview of the policy of brucellosis control, 
based on policy papers of the Mongolian Govenu-nent, completed by consulting 
"grey literature", published literature, and personal communication. 
The changes in the political and economic organisation, during the transition period, 
when the economy changed from a planned one to a more market oriented one, were 
amount to the analysis. The effects of these upon the spread of disease and the sur- 
47 Biokombinat is the Mongolian factory near UB producing the vaccines for animals. 
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veillance policy have been included. In the third section the historical policy over- 
view is underpinned with data on testing and vaccination. 
1. Brucellosis and other animal diseases 
Mongolia controlled, eradicated or kept out many animal diseases, that occurred in 
neighbouring countries (see chapter 4). Three elements helped to achieve this 
(Honhold N., 1994a): (i) the extensive grazing systems and low animal density had a 
favourable effect on the surveillance of rapidly spreading infectious diseases; (ii) the 
field veterinary services, large and well organised, focusing preventive treatments, 
had enabled full treatment of all herds; (iii) the Biokombinat factory, producing a 
wide range of good quality vaccines meeting the needs of the country. 
An FAO mission, visiting Mongolia in 1976, stated that there were no official peri- 
odic animal disease reports, despite the importance of animal health for the well- 
being of the country (Food and Agriculture Organisation of the United Nations, 
Rome, 1977). However, the animal health situation encountered had been assessed 
by this FAO mission as generally good. Foot-and-mouth disease, anthrax and rabies 
had only low sporadic incidence. The last outbreak of foot-and-mouth disease had 
been brought under control in 1964. Rinderpest, contagious bovine pleuropneumo- 
nia, contagious caprine pleuropneumonia and sheep/goat pox had been brought un- 
der control thanks to efficient measures applied during many years. Bovine tubercu- 
losis is said to be not present in Mongolia (Honhold N., 1994a). Parasitic and tick- 
bome diseases were not well documented, but still occurring. Important disease 
problems however were seen in glanders in horses and brucellosis in various species 
(Food and Agriculture Organisation of the United Nations, Rome, 1977). 
For decades, brucellosis has been challenging authorities responsible for disease 
surveillance. Chapter 4 illustrated how this disease is still not under control. In the 
1950s, the disease was studied at random in animals and humans. But still there were 
no coordinated surveys and no effective prevention and control measures taken. 
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Since the 1960s, brucellosis has been studied systematically, to enact effective con- 
trol measures. 
2. Review of the Brucellosis control policy history 
First attempts at Brucellosis control during 1950s and early 
1960s 
Nearly every year since 1953, the Minister's Cabinet has issued resolutions to fight 
brucellosis (Enkhbaatar L et al, 2004). In the early 1950s, the focus was on treat- 
ment of patients infected with brucellosis, and on prevention for people at risk. The 
main interest for research was the transmission from animal to human. Brucellosis 
cases in humans had to be notified to the authorities from 1956 onwards (Dashdavaa 
J, 1969). The following methods were applied to protect herders, veterinarians and 
workers during the lambing seasons from infection: (i) introduction of hygienic 
measures such as supplying protective clothing and disinfectants; (ii) vaccination of 
people with dry and live vaccine (19-BA) before the lambing season (according to 
common procedures already applied in the Soviet Union). 
Later on, from 1957 onwards, the MoA began fighting the disease in animals by 
applying appropriate management practices and improving hygiene. Measures car- 
ried out included screening tests in milk and milk products, testing of all imported 
animals (mostly for breeding) and supplying of the required manpower and equip- 
ment for laboratory facilities (Enkhbaatar L et al, 2004ý 
The first comprehensive measures to fight brucellosis both in humans and animals, 
followed in 1959 (Molomjamts et al, 1959). Both ministries, MoH and MoA, had 
been ordered to launch a broad public advocacy campaign about the harm of brucel- 
losis and about methods of prevention. This was accompanied by vaccination of SR 
with the S-19 vaccine. 
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In 1960, the government decided to plan epidemiological surveys of brucellosis in 
animals and humans to fight brucellosis (Dashdavaa J, 1969). These were put into 
action between 1963 and 1968 with the assistance of WHO and COMECON (see 
chapter 4). 
First attempts to adapt governance structure for Brucellosis 
control 
Meanwhile in 1961, the MoA had established a brucellosis laboratory within the 
Veterinary Research Institute (VRI) (Enkhbaatar L et al, 2004). Nevertheless, the 
application of veterinary measures in the control of zoonoses was hampered by the 
fragmentation of agriculture and animal husbandry into four different areas of exper- 
tise: animal husbandry, veterinary, agronomy and agricultural mechanisation. This 
resulted in overlapping and overstaffing of the state administration of collective 
farms and led to governmental agencies being unclear of their responsibilities 
(Cvjetanovic V et al, 1968). 
Additionally, the MoH had taken some organisational measures and had established 
in 1962 a Division for Brucellosis within the Infectious Disease Research Institute 
(IDRI); the purpose was to establish a unified system responsible for fighting and 
preventing human brucellosis (Enkhbaatar L et al, 2004). Before this the various 
responsibilities for fighting brucellosis, such as investigating, diagnosing and pro- 
viding therapy, were spread over different institutions. The following year the Divi- 
sion for Brucellosis expanded and became the National Epidemiological Unit which 
acted as the cooperating counterpart of the WHO epidemiological group (see chap- 
ter 4). In 1966, the government established the National Dispensary against Brucel- 
losis within the MoH (Ministers cabinet of Mongolia, 1966a), which was responsi- 
ble for the methodology and organisation of prevention and treatment of brucellosis 
(Khohoo A. et al, 1995) (G. Kupul, 1972). 
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Though it was well-known that the major public health problems were zoonoses and 
food borne infectious diseases, there was still little organised cooperation between 
the veterinary and public health services in the areas of health legislation, environ- 
mental sanitation, control of zoonoses, food hygiene, production of biologicals, sci- 
entific work, and training of public and veterinary health personnel (Cvjetanovic V 
et al, 1968). And so the Mongolian Government had continuously taken decisions 
for developing adequate governance structures to ensure the quality and methodol- 
ogy of prevention, diagnosis and treatment of brucellosis and improving the man- 
agement of brucellosis control. Still it seemed that these efforts went on and on, and 
no optimal solution for intersectoral governance could be found and implemented. 
"Test and Slaughter" policy from 1966 to 1968 with COME. 
CON assistance 
The first widespread large-scale control measures began in 1966 (Khohoo A. et al, 
1995) with assistance given by COMECON States whose purpose was to combat the 
three main zoonoses: brucellosis, tuberculosis and glanders. At that point, the Mon- 
golian authorities had fully realised, that prevention of human brucellosis lay mainly 
in the control and eradication of the disease in animals (Jezek Z et al, 1969) 
(Tsedenbal, 1965). The programme started in 1966, and continued for three years 
during the summer and autumn. 
The goals given to the COMECON veterinary groups, working in close cooperation 
with the local veterinary services, were (Jezek Z et al, 1969) (Kolar J, 19 70a): 
(i) to examine all the susceptible adult animal population for brucellosis, tuberculo- 
sis and glanders; 
(ii) to isolate the reactors if possible or to slaughter them; 
(iii) to work out plans for control measures for each Soum and Aimag. 
The mobile laboratories of the COMECON groups were well-equipped for carrying 
out serological investigations, especially SAT and CFT. 
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The eradication campaign was based on the opinion, that repeated testing and 
slaughtering or isolation of reactors would lead to reduction and finally to eradica- 
tion of brucellosis in livestock. To conduct this enormous work, between 1966- 
1968,10 to 12 millions animals were tested yearlY48 (Kolar J., 1977). As a result, the 
number of individual sero-positive reactors was reduced by 54.4% in sheep and 
31.2% in goats (Baldanderj T, 1972). But the decrease in the number of infected 
flocks was much slower as re-infections occurred often (Kolar J, 1977). Until 1973, 
data from this campaign was evaluated to implement hygienic measures and to train 
persons at risk (Ministers cabinet of Mongolia, 1969). Sadly, it became obvious, 
given local conditions and the limited reliability of the diagnostic tests used, that no 
permanent success could be expected (Kolar J, 19 70a). 
The T&S method, applied by the COMECON States proved to be ineffective and 
failed to control brucellosis. The available diagnostic tests (allergic skin test, SAT, 
CFT) had limited reliability, as they had difficulties to reveal infected animals in the 
latent phase of disease (Kolar J, 1995c). The allergic skin test had been used, as it 
was easy to perform in nomadic and semi-nomadic conditions, and did not require 
identification of tested animals; furthermore, the result can be read after two days, 
and the reactors could immediately be marked. In doubtfid cases, the examination 
could be repeated in SAT or CFT (see also chapter 2.4. on testing methods). The 
T&S method applied to individual reactors may have resulted in considerable reduc- 
tion of them within the tested flocks, but not in the definite elimination of the disease 
from the flock itself. For the T&S method to be effective, the slaughter should have 
been applied to the entire flock. Such a radical procedure would have been suitable 
to get rid of brucellosis when implemented into a previously non-infected region (for 
instance by imported animals) (World Health Organization et A 1986). It would 
have meant an immediate eradication at any cost. However, in the Mongolian con- 
text, with large flocks and high prevalence of brucellosis, this was not practical due 
to high costs and the difficulty of replacing stock with healthy animals (Kolar J, 
48 Between 1966 and 1968 totally 37.5 million animals had been tested (Ministers cabinet ofMongo- 
lia, 1969). 
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1995c). The Mongolian Government decided therefore, after the failure of the T&S 
method, to abandon it and to switch to whole herd vaccinations (Kolar J, 1995c). 
WHO project "Mongolia 0001": surveys 
Epizootiological surveys, assisted by WHO experts, have been carried out since 
1963 (see chapter 4.1). An objective comprehensive analysis of the complicated 
epizootiological situation in animal brucellosis had considered the practices and hab- 
its of local animal husbandry, the possibilities with the available manpower, and the 
economical constraints. This led to the conviction that in the prevailing conditions 
only systematic large-scale vaccination simultaneously with other basic control 
measures would be effective (Kolar J, 19 70a). 
Since there was practically no experience in the vaccination of SR against brucello- 
sis in Mongolia, this conviction was confirmed after three vaccination field trials, 
undertaken during the period 1966-68 in the frame of the WHO project "Mongolia 
0001". The aim of the trials was to study the immunological value of B. melitensis 
Rev. 1 vaccine in Mongolia against sheep and goats vaccinated with B. abortus S19 
vaccine, as well as against an equal group of non-vaccinated animals (Jezek Z, 
1970). Thus, both vaccines used in the trial showed significant protection, but more 
significant results were obtained with the Rev. 1 strain compared with S19, and the 
conclusion was that the protective efficacy of Rev. 1 vaccine in local breeds of SR 
was considered as satisfactory. 
The immunisation of cattle (calves, heifers and cows) with S19 vaccine against B. 
abortus was only satisfactory in some herds. Isolations of B. melitensis in other 
herds, where abortions continued to occur after vaccination with S 19, led to the con- 
sideration of the Rev. 1 vaccination instead of S19. A controlled comparative trial on 
200 heifers was carried out in October 1968 in order to dispel the fears that Rev. 1 
may cause infection in cattle and in subsequent excretion in milk. It was proved that 
the Rev. 1 vaccine was effective against both strains, while S19 provided signifi- 
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cantly less protection against B. melitensis (Kolar J, 1995c). This result led to the 
subsequent application of Rev. 1 vaccine for the immunisation of cattle and yak 
population, without any negative effect. In addition, in connection with the planned 
brucellosis vaccine production in Mongolia, it was desirable, to avoid laboratory 
complications and to simplify production procedures, to produce only one vaccine, 
namelyRev. 1 (Kolar J, 1970a). The Mongolian application of Rev. 1 for the 
immunisation of cattle was unique in an international context (see also chapter 2.4. ): 
"Wide use of Rev. 1 vaccination in cattle, with the unique intent of obtaining protec- 
tion against B. melitensis infection, has been applied only in Mongolia" (Banal M, 
2002). 
Summing up, the trials had produced clear evidence that vaccination, especially with 
Rev. 1, was highly effective in local Mongolian breeds and in nomadic fanning con- 
texts. This method of control was also more reliable, simpler and cheaper than the 
repeated examination of flocks, and isolation of animals (Cvjetanovic V et A 1968). 
Considering these facts, the MoA decided to approve mass vaccination of cattle and 
SR. This decision represented an important milestone and a qualitative change in the 
achievement of control of brucellosis in Mongolia (Cvjetanovic V et al, 1968). 
WHO Project "Mongolia 0013": vaccine production and vac- 
cination campaign 
Assuring Rev. 1 vaccines 
The Rev. I vaccine used in the above vaccination trials had been provided by profes- 
sor Sanford S. Elberg (Roth F, 2003b), one of the developers of this vaccine (Elberg 
S. et al, 1956). The B. abortus S19 vaccines could be acquired from the USSR 
(Tserendash ChoijiIjav, 1972). But no laboratory in the world could assure the pro- 
duction of the required amount of Rev. 1 vaccines at a reasonable price. Finally, in 
1973, the UNDP agreed to assure financial support for building up a local brucello- 
sis vaccine production unit, when WHO took over the responsibility of its technical 
realisation (Kolar J, 1995b). The whole herd vaccination programme had a long- 
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term projected existence of 11 years, until 1985. WHO & UNDP assured fmancing 
and technical assistance for 5 years until 1977, to build up local vaccine production 
and to start the vaccination campaign. After overcoming some difficulties, the Mon- 
golian production of Rev. 1 vaccines finally began in 1975 in the buildings of the 
Biokombinat (Kolar J, 1995b). 
The dried Rev. 1 cultures for preparing local stocks of cultures for seed material had 
been provided by two reference laboratories (World Health Organization et al, 
1964): (i) from the Central Veterinary Laboratory in Weybridge, England in 1974 
and (ii) from the Department of Bacteriology at the University of California (Prof. 
Elberg) in Berkeley, USA in 1976 (Kolar J, 1977). Quality assurance was per- 
formed within the country by the independent State Control Laboratory for veteri- 
nary biologicals, and also performed abroad in Moscow 49 and Weybridge (Kolar J, 
1995b). The number of living Brucella organisms per dose was kept between I- 
3* 109, which corresponded to the FAO/Yv'HO recommendations (World Health Or- 
ganization et al, 1964). It was planned to increase the vaccination production ac- 
cording to the requirements of the vaccination scheme, with a production peak of 5.5 
million doses in 1980 (Kolar J, 1977) (Kolar J, 1984). The vaccines were stored 
below zero, and transported to the Aimag Centres by Airplane. The distillate water 
needed for dilution was brought by lorries. The plan was to vaccinate about 31 mil- 
lion animals with Rev. 1 during the period of eleven years (1975 to 1985) (Kolar J, 
1995c). The territory covered by the immunisation process expanded gradually de- 
termined mostly by the vaccine's availability. The maps in appendix 5.1. show the 
yearly vaccine programme's expansion. 
Strategy for eradication of Brucellosis 
The vaccination programme concerned the immunisation of mainly SR and few cat- 
tle (Ministry ofAgriculture, 1975) (Ministry ofAgriculture, 1976). The trials carried 
out in 1968/69 with the immunisation of cattle with Rev. 1 were taken to a larger 
scale in 1977 with the vaccination of 80,000 cattle with Rev. 1 and produced good 
49 WHO Brucellosis Reference Laboratory, Institute of Microbiology and Epidemiology, Moscow 
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results (Kolar J, 1977) (Dashdavaa J et al, 1981). The vaccination of cattle (with 
S19 and Rev. 1) was only at low and decreasing levels. However, the whole herd 
vaccination campaign concerned the immunisation of SR and started in year 1975 in 
two Aimags (Bulgan & Selenge). The maps in the appendix 5.1. show how every 
year additional Aimags were added to the programme, until 1980, when all female 
SR were immunised nationwide. 
The vaccination scheme included in the first year all female SR, and in the following 
5 to 6 years, replacements and new born animals, until the flocks were completely 
renewed. At this stage, the immunised flocks would be tested and the reactors elimi- 
nated; the control method would then switch to T&S (Kolar J, 1977). 
Introducing new procedures in vaccination 
There was general agreement that Rev. 1 was the best available vaccine against B. 
melitensis infection. However, the methods for using this vaccine in whole-herd vac- 
cination campaign were a continuous source of controversy (Mustafa et al, 1993). 
The specific Mongolian natural and ecological conditions, the local animal hus- 
bandry practices, and the considerable countrywide level of brucellosis prompted the 
project team and Mongolian authorities to apply previously un-validated procedures 
in the following ways (Kolar J, 1995c): 
(i) All female animals, regardless of age, pregnancy, and brucellosis status, had been 
considered for vaccination. The conventional way of immunisation with live 
Brucella vaccines however were limited to young animals. This was to minimise the 
diagnostic problems of stimulated post-vaccine antibodies confusing the interpreta- 
tion of diagnostic tests, and also to prevent possible abortions induced by the vac- 
cines. However, this was not important in Mongolia because nearly all the flocks 
were already infected and the control was no longer based on T&S policy (Kolar J., 
1995c). To avoid vaccination during pregnancy, which could provoke abortion in 
infected animals, the vaccination period had to be chosen carefully: under extensive 
management conditions, SR have known lambing seasons, offering an ideal time 
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window for vaccinations (Blasco J M, 1997). Breeding takes place in Septern- 
ber/October, and lambing in February/March. Therefore, the vaccination of young 
and adult animals can take place four months after birth and before breeding, in 
July/August. To limit vaccination to sexually immature female animals was imprac- 
ticable in Mongolia, and could not minimise the source of infection, allowing it to 
spread freely among non-immunised adult animals, prolonging the recovery period 
in flocks, and complicate the control process (Kolar J, 1995c). 
(ii) In common practice pre-vaccination testing would have been applied. But this 
was unfeasible with nomadic husbandry, and did not increase efficacy and safety. It 
was therefore abolished in 1977 (Kolar J, 1977). 
(iii) It was generally proposed as the only reasonable method in terms of safety and 
efficacy to use conjunctival route of vaccination in whole herd vaccination of SR 
(Blasco JM, 1997). This vaccine administration method has the advantage over the 
subcutaneous administration that is does not induce a lasting serological reaction and 
allows therefore the serological monitoring of vaccinated flocks (Food and Agricul- 
ture Organisation of the United Nations Rome, Italy, 1992). Under Mongolian envi- 
ronmental conditions however using the conjunctival route would have resulted in 
unacceptable potential exposure of the people involved in the vaccination because of 
permanent strong winds and inappropriate safety equipment (Mikolon A. B., 2000). 
Therefore the subcutaneous route of administration had been applied and not the 
conjunctival. 
(iv) Traditionally it was unusual to vaccinate breeding males with Rev. I. However 
after studying in field trials, the effect of the Rev. 1 vaccine to spermatogenesis, fer- 
tility and orchitis risk (Kolar J, 1977), the vaccination of breeding males two 
months before breeding season had been applied countrywide (Kolar J, 1995a). 
Breeding males were kept strictly separated in male flocks, but became infected with 
brucellosis when put into infected flocks for breeding (Kolar J, 1995c). Because of 
the importance in the epizootiology of brucellosis the immunisation of breeding 
males was strongly demanded (Kolar J., 1995a). 
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(v) A dose of one billion bacteria (1 * 109) for young SR (Mustafa et A 1993) was 
recommended for subcutaneous administration at that time (between one and two 
billion bacteria per dose before (World Health Organization et al, 1964)). In an ef- 
fort to use less vaccine, trials with reduced doses of Rev. 1 were carried out in 1975 
in 5000 animals among 8 flocks. This would enable the speeding up of the immuni- 
sation process, reduce the cost of production, and lessen the risks of abortions, 
shorten excretion time, and persistence of post-vaccination antibodies (Kolar J, 
19 77). Results showed no difference between a doses of two billion bacteria (2* 109) 
and doses reduced 10 times or even 100 times. However, the Mongolian expert's 
panel refused to apply such a reduced dose. This proved prescient, as control testing 
of batches stored at temperature of 10-15*C for 1-3 months showed a decrease in 
viable cells of 1/3 to 1/12 of the original level (Kolar J., 1995b). Vaccines with re- 
duced dose would have lost their efficacy. 
From 1975 to 1997/98 Biokombinat produced Rev. 1 vaccines with 2 billions bacte- 
ria/dose (2 *I e). After 1998 they reduced it to (I * 10 9 ). Noteworthy since the middle 
of 1980s WHO has recommended this reduced dose (1*109) and has always asked 
the Mongolian Government to follow this recommendation. But the Mongolian au- 
thorities did not follow this recommendation until 1997/98 for the following reasons: 
(i) the vaccination period is in the warin season, and the Mongolians had problem 
with the cold chain; (ii) also the veterinarians were not feeling responsible enough to 
care about the correct storage and application of the vaccine; (iii) there was also the 
practical problem of not working precise enough and so the potential risk for the 
veterinarians applying instead of I ml vaccine liqiiid only 0.8 ml by mistake. Finally 
in 1998 the WHO recommendation had been followed for two reasons: (i) because 
of the decreasing economical situation (reduced dose is cheaper) and (ii) because of 
political reasons, the WHO was steadily insisting to follow its recommendation and 
Mongolia had joined WTO in 1997 (personal communication with Sodnorn 
BYAMBA, former leader of Brucellosis vaccine production at Biokombinat (Roth 
F., 2003a)). 
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Summing up, the Mongolian whole herd vaccination campaign provided new infor- 
mation concerning the effective application of Rev. 1, which became an important 
basis for future vaccination campaigns worldwide (Kolar J, 1995c). Since, the vac- 
cination of all susceptible animals, irrespective of age, gravidity and serological 
status, has been widely proven and generally accepted. Vaccination was expanded in 
the 1990s to sexually mature females, using reduced doses 50 51 (Banai M, 2002). 
The immunisation of breeding males in heavily infected areas has been considered if 
they are used for natural service. Otherwise, it is not recommended as vaccine 
strains can be localised in the genital tract (Banai M, 2002). Additionally, other 
Mongolian practices, such as the use of Rev. I in cattle, have not been approved for 
common practical use (Banai M, 2002). 
Governance 
The Mongolian Government established an inter-ministerial committee between the 
MoH and MoA for coordination and periodic control of the programme's accom- 
plishments. The animal health control was centrally organised and supervised by the 
Veterinary Department (MoA). A new Brucellosis Unit had been established within 
this department for the management, implementation and supervision of the field 
vaccination work (Kolar J, 1995b). The large-scale vaccination was executed by 
veterinary brigades, composed of veterinary assistants and assisted by Sourn veteri- 
narians. This organisation seemed to be efficient for the vaccination campaign (Food 
and Agriculture Organisation of the United Nations, Rome, 19 77). The unit to fight 
human brucellosis become an independent medical preventative organization, a State 
Dispensary of Brucellosis, with mobile group branches (Ministers cabinet ofMongo- 
lia, 1977) (Ministry of Health, 1977). Thus, the responsibility for the execution of 
50 The lowered doses resulted in lower antibody titres which receded rapidly, and therefore do not 
disturb testing. Diagnostic tests, such as ELISA, are able to differentiate antibody classes 
ýErdenebaatar Jet al, 2004). 
1 Recommended cells per dose: 
Rev. I in SR at age 4-6 months by subcutaneous administration or conjunctival instillation: (I * 10); 
Rev. I in adult SR by subcutaneous administration: reduced at (5- 10* 10); 
S19 in calves at age 4-12 months by subcutaneous administration (3*108 to 3*10); 
S19 in adult cattle by subcutaneously administration (3*108 to 10*108); 
S 19 in adult cattle by conjunctival instillation: (5- 10* 10). 
(World Health Organization et al, 1986) 
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the project's activities had been distributed between the MoH and the MoA. How- 
ever, the overall responsible executing agency was the MoH as counterpart of the 
WHO, and the MoA was left as collaborating agency. This mixed system led to 
some conflicts in determining the duties and competence of both ministries (Kolar 
J, 1977). 
Conflicting too was the collaboration among the international funding organisations. 
The withdrawal of UNDP's assistance, in mid 1976, had a great impact, but the pro- 
ject was rescued by WHO until the end of 1977. The FAO then took over fmancing 
technical assistance in 1978 (Kolar J., 1978). The vaccination campaign started later 
than planned, so there was only 2 1/2years left for WHO's assistance (1975 to 1977). 
Evaluation 
WHO experts affirmed in 1978 that the immunisation campaign had had a positive 
impact. They noticed a drop in abortion rates in the vaccinated Aimags, compared to 
those Aimags not yet included in the vaccination campaign. The best evidence of the 
vaccination's benefit seemed to be the drop in human brucellosis incidence in an 
vaccinated Aimags (Kolar J., 1977). Strict post-vaccination controls were carried 
out in about 15% of the flocks (randomly selected) to fight against faulty vaccination 
or cheating, but also to evaluate the vaccine's quality. This revealed rather different 
percentages of reactors, depending on which team carried out the vaccinations. On 
average, the vaccination coverage was lower than 95%, owing to improper vaccina- 
tion (Kolar J., 1977). It was admitted however, that for more advanced analysis on 
the evidence, effectiveness and benefit of the vaccination campaign longer observa- 
tion period, further sampling, and more information based on facts would be needed 
(Kolar J., 1995c). 
In 1977, an assessment financed by FAO reported problems possibly compromising 
the programme (Kolar J, 1978): (i) The vaccination programme had remained with- 
out central project leadership and responsibility, as the counterpart and local project 
leader, Dr. Basan, had been transferred to the countryside; (ii) the newly created 
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Brucellosis Unit at the Central Veterinary Laboratory was entrusted only with the 
control of a few dairy farms around UB, limiting its nationwide access; (iii) no evi- 
dence on the effectiveness was available because no post-vaccination controls had 
been performed; (iv) The 1978 vaccination campaign had not been appropriately 
prepared. 
Since 1978, no further official information on the achievement of this immunisation 
campaign is available. However looking at the maps in appendix 5.1. or at the figure 
4.2. (chapter 4) one notices the success of this campaign, and while it lasted, the 
prevalence of brucellosis in SR was generally lowered nationally. 
Surveillance 1978 to 1990 
Continuation of the vaccination campaign in SR 
This research found no ftirther Government resolutions or reports concerning the 
animal vaccination campaigns launched by WHO and LTNDP in 1975. The campaign 
was supposed to continue from 1978 onwards without international assistance, up 
1985. However, key persons interviewed did confirm that this vaccination campaign 
had been followed up. Our data search in the archives of the MoA brought us the 
only written evidence proving that the vaccination campaign had actually been fol- 
lowed up: in the yearly activity books, which contained unpublished material, we 
could trace the yearly planned, as well as the effectively executed, vaccination for 
cattle, sheep and goats for every Aimag. It gave evidence that the campaign had 
been continued with the vaccination of about one fifth of the SR-population, which 
might correspond to the new born animals as the key informants confirmed (personal 
communication with Dr. P. CHULLTLNBAATAR (Roth F., 2003a)). A different key 
informant stated that all young animals had been vaccinated once a year and addi- 
tionally all adult female animals for many years (personal communication with Prof 
Dr. A. YONDONDORJ (Roth F, 2003a)). But this did not correlate with the data on 
the effective vaccination found in the activity books. 
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Protecting humans 
The MoH strived in 1977 to establish a mutual exchange of experiences in fighting 
brucellosis with the Kazakh State (Ministry ofHealth, 1977), then part of the Soviet 
Union. Two years later, this exchange was to be expanded to a scientific collabora- 
tion with the Research Institute of Microbiology and Infectious Diseases (Ministry of 
Heath, 1979). This collaboration has been initiated from the human medical sector. 
It was aimed to protect workers exposed to infection risks with measures such as 
vaccination and improving hygiene by providing protecting equipment. 
Excursus: Preventative vaccine against Brucellosis In human 
Today, vaccination of humans plays only a small role worldwide in the prevention of 
human brucellosis infections (seefootnote in chapter 2.4). In the past, however, 
various vaccines have been used in humans, mainly in the former Soviet Union and 
China, but also in France (Corbel MJ, 1997). Since 1952, workers in the USSR ex- 
posed to A melitensis have been immunised using the live vaccine B. abortus 19- 
BA, derived from B. abortus strain 19 (World Health Organization et al, 1986). The 
Chinese used B. abortus strain 104M, a more virulent strain. In France, to protect 
exposed people, non-living vaccines had been administered, but the efficiency and 
the duration of the resulting immunity were not satisfactory. In cases of live vac- 
cines, serious potential risks, such as reactions in individuals sensitised by previous 
exposure to Brucella, led to limited applications. The Mongolian authorities applied 
the live attenuated A abortus strains 19-BA, which has been provided from Russia, 
and also used there. The good results of the first survey, carried out in 1957 with 200 
workers in animal livestock, were of great epidemiological importance: the immuni- 
sation had shown to be successful, and was then applied broadly (Enkhbaatar L et 
al, 2004). The prevention of human brucellosis by immunisation of humans at risk 
was seen as very important as about 70% of the Mongolian population were working 
in the livestock sector (Enkhbaatar L et al, 2004). The brucellosis prevalence rate of 
people working in high risk areas with infected animals was estimated between 30- 
40%, and it was reported that 95% of the vaccinated people had not been infected 
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(Enkhbaatar L et al, 2004). The success of human vaccination in Mongolia was fur- 
ther reported in the 1960s (Baldanderj T, 1972) and the 1970s (Dashdavaa J et al, 
1981) (Tovuugiin Gombosuren, 1982). Today there is no human vaccination re- 
ported in Mongolia, and it remained unclear, when this vaccination was actually 
given up. 
Russian assistance to fight Brucellosis in cattle 
The policy of fighting brucellosis during the 1980s had mainly been focused on pre- 
venting food borne infection of the urban population: From 1970 until 1990, dairy 
farms were established, each containing between 200 and 1200 dairy cows. Since the 
animals were cramped closely together, special care was necessary to avoid brucel- 
losis transmission (Khohoo A. et al, 1995). In 1979, the government ordered the 
separation of cows infected with brucellosis (Resolution of Minister's Cabinet Nr 
29,26.1.1979, cited in (Enkhbaatar L et al, 2004)), as well as hygienic measures for 
handling the milk (Resolution of the Minister's Cabinet Nr 307,1979, cited in 
(Enkhbaatar L et al, 2004)). In 1982, the MoA established a special committee re- 
sponsible in monitoring brucellosis tests to certify farms free of brucellosis (Ministry 
ofAgriculture, 1982). In 1986, Mongolia and the Soviet Union concluded an agree- 
ment about technical, economic and scientific collaboration from 1986 to 1990 to 
fight brucellosis in dairy farms in Mongolia (Ministry of Agriculture, 1986) 
(Ministry of Agriculture, 1987). Joint Mongolian and Russian expedition teams 
tested 1.312 million cattle between 1987 and 1989 all over the country to identify 
the level of infection on Aimag and Soum level and to get proper basis for defining 
the methods to fight brucellosis (Enkhbaatar L et al, 2004). The suspicion that the 
results of these surveys in dairy farms were mixed with the reported prevalence data 
on brucellosis in cattle has already been expressed in chapter 4.3.. This would ex- 
plain the peak of brucellosis prevalence in the years 1987 to 1989 as shown infigure 
4.4. (chapter 4.3). As a result 1.218 million healthy cows had been vaccinated with 
Rev. I or S 19 (Ministry of Agriculture et al, 1991) (Ministry of Agriculture, 1988) 
(Badarch P., 1988b). 
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Surveillance during transition period (1990 to 1993) 
National programme to fight Brucellosis in animals and humans 
The MoA and MoH had jointly elaborated a programme in 1990, including inputs 
from the Ministries of Finance, of National Development and of Trade & Industry, 
to reduce the incidence of brucellosis by encouraging cooperation between the 
medical and veterinary sectors and using modem technologies and science 
(Enkhbaatar L et al, 2004). In 1991 a national programme for 1992 to 1995 for hu- 
man and animal was implemented (Ministry of Agriculture et al, 1991). This pro- 
gramme included T&S, vaccination, hygienic and management methods training of 
veterinarians and medical staff, and improved treatment of patients (Ministry qfAg- 
riculture et al, 1991) (Ministry ofAgriculture et al, 1992a) (Ministry ofAgriculture 
et a4 1992b) (Ministry ofAgriculture et al, 1992c). It also planned to test all female 
animals (cattle, sheep & goats) in Aimags and Soums (Enkhbaatar L et al, 2004). 
Restructuring the economy 
However, due to lack of funds, this programme was not implemented as foreseen 
(Ministry of, 4griculture, 1976): with the collapse of the former Soviet Union in 
1989, Mongolia had suddenly lost its traditional source of economic assistance and 
traditional external trading partners, the Council for Mutual Economic Assistance 
(COMECON). Until then, the assistance from the former Soviet Union had 
amounted to 30% of GDP. This marked the beginning of the transition era for the 
Mongolian economy from centrally planned to market oriented. Cornerstones of this 
transition process were the privatisation in agriculture, livestock, industry and ser- 
vices such as health services or veterinary services. Thus there were two difficulties, 
(i) the impact of the external shock and (ii) the internal economic transition, which 
had major consequences on the economy and social situation: GDP dropped by 
about 20% between 1990 and 1993, and unemployment reached 20% (World Bank, 
1997b). The State took rigorous austerity measures to stabilise its budget and public 
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expenditures declined from 52% of GDP in 1990 to 28% in 1993, all this against a 
background of declining GDP (World Bank, 199 7b). 
From 1991 onwards, the Government introduced a series of structural reforms to 
liberalise the economy which included the privatisation of livestock. By the end of 
1992,18 out of 25 million livestock had been privatised (World Bank 1997b). The 
Government's budget shrunk to match the Government's reduced market role. The 
Government focused on its core business and improved the efficiency of service 
delivery. This restructuring process affected the public health and livestock sector as 
well. Public health expenditures declined from 5.5% of GDP in 1991 to 4.0% in 
1993, producing unfortunate impacts on health indicators such as maternal mortality 
and infant mortality (World Bank, 1997a). On the other hand, Veterinary Services 
had been relatively unscathed as restructuring had been done for the time being on 
the level of central directorate and laboratory, but not in field services (Honhold N., 
1994a). Preventive disease measures were still a major focus of veterinary interven- 
tions, and vaccinations were still provided free of charge -- except for a small nomi- 
nal injection fees. The privatisation. process however split the herds among a large 
number of herders. This meant that the area the vets had to cover was ten times lar- 
ger than that covered prior to the transition period; this created a lack of veterinary 
services (Honhold N., 1994a). The resulting ratio, one veterinarian to 70 herders, 
was low given the terrain and the nomadic livestock breeding. Additionally, the live- 
stock numbers have increased with 34.5% from 1989 to 1998 52 . The reasons for this 
were the privatisation, an increase in herders, social insecurity (Honhold N., 1994a) 
and a reduced market for animal products, reflected by meat processing plants work- 
ing at 20% capacity by the end of the 1990s. 
Impact of transition on Brucellosis 
52 (State Statistical Office ofMongolia, 1999 
Number of cattle in 1989: 2'692'700; in 1998: 3'725'800; increase: 38% 
Number of sheep in 1989: 14'265'200; in 1998: 14'694'200; increase: 3% 
Number of goats in 1989: 4'959'100; in 1998: 11'061'900; increase: 123% (because value of 
cashmere wool) 
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Several aspects favoured the ftirther spread of brucellosis during the market transi- 
tion period. They can be subsumed under the failure of hygienic measures and poor 
prevention. During privatisation of the livestock infected and uninfected herds had 
been mixed. Animal movement was no longer under veterinary control and there 
was no longer any identification system (tagging) in place for any livestock species 
(Garin-Bastuji B., 1999). The animals had been distributed irrespective of whether 
people knew anything about livestock (Jefferies 1., 1996). Dairy products delivered 
to consumers in urban areas, industrially pasteurised in the centrally planed econ- 
omy, had been delivered directly to the consumers without pasteurisation during the 
transition period (Veterinary state general supervisor, 1992). On the human side, the 
Public Health services were no longer able to investigate brucellosis infection and to 
provide early diagnosis (Ministry of Agriculture, 1976). The costs for the treatment 
of brucellosis grew rapidly. 
Surveillance during post-transition period (1994 to 1999) 
Combined policy with Test and Slaughter and vaccination 
In 1997, Mongolia joined the WTO, as the first country in transition outside Eastern 
Europe (World Bank, 1997a). The elimination of brucellosis was an important con- 
dition to access free foreign markets. "... the most cattle in Mongolia have brucello- 
sis resulting in Russian's refusal on meat imports from Mongolia" (bizMongolia, 
2002). As a member of WTO, Mongolia had to follow international standards of 
hygiene and safety and to ensure registration, monitoring and prevention from 
zoonotic diseases. With increasing international trade the movements of animals and 
animal products had augmented the exposure of animals and humans to infectious 
diseases (zoonoses). As a result, a new programme was decided to fight brucellosis 
in human and animals between 1996 and 2000 (Ministry of Food and Agriculture, 
1996). It was a combined policy between slaughtering infected animals and provid- 
ing vaccines for healthy animals after testing. 
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Factors hindering Test and Slaughter 
However, privatisation and inflation had adverse effects on this combined policy 
(Enkhbaatar L et al, 2004), because it required accurate animal identification, herder 
cooperation and an expensive compensation scheme for slaughtered animals. Fur- 
thermore, slaughtering of positives was voluntary, and nearly a third of the identified 
infected animals were left in their flocks, (Khohoo A. et al, 1995). Privatisation of 
Veterinary Services had increased in 1999, despite concerns about the ability of the 
Mongolian economy to support an adequate supply of private veterinary services. 
This had threatened the sustainability of veterinary services, especially in the rural 
areas (Garin-Bastuji B., 1999). As consequence most of the laboratories in rural ar- 
eas closed down. But testing was an important factor in the strategy applied and 
timely response of case information by laboratories was crucial. Additionally, qual- 
ity problems occurred; for instance, the locally produced antigens used for brucello- 
sis testing (RBT, CFT, SAT and MRT analysis) did not fulfil the O. I. E. international 
requirements, even when officially tested by the Mongolian Veterinary Quality and 
Control Laboratory (VQCL) (Garin-Bastuji B., 1999). The latter was compounded 
by the reality that approximately every fifth infected cattle does not show antibodies 
in its serum until after abortion (Honhold N., 1994b). 
Moving away from Test and Slaughter 
The understanding was that in Mongolian context a strategy based at least in part on 
a T&S approach could very unlikely be able to control brucellosis to a significant 
low level and to prevent the further increase of human incidence (Garin-Bastuji B., 
1999). The prevalence in the infected herds had been estimated to be too high. 
Socio-economic changes such as privatisation of the livestock and increasing herd 
size, the nomadic structure of ownership, privatisation of veterinary services and 
poor laboratory infrastructure were unfavourable factors to such an approach. It had 
therefore been considered to change the strategy and turn back towards a whole herd 
vaccination strategy (Garin-Bastuji B., 1999). It was the only feasible approach to 
brucellosis control during this period in Mongolia. 
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Recent surveillance strategy after 1999 and implementing of 
whole herd vaccination strategy 
National programme on "Animals Health" 
With the aim to protect livestock animals from zoonotic; diseases the Mongolian 
Government approved, in 1999, the national programme on "Animals' Health" 
(Ministry of Agriculture, 1999), to improve the quality of veterinary services, pre- 
vent enormous socio-economic losses and increase the export rate of animal prod- 
ucts. Brucellosis was included in this "Animal's Health National Programme" 
among other diseases such as TB, leucosis, glanders, infectious anaemia of horses, 
foot & mouth and plague. The programme is supposed to eliminate brucellosis from 
Mongolia by year 20 10. The MoA was charged to conduct surveillance of brucello- 
sis in animals and to elaborate mid and long term projects on prevention. Based on 
this, the MoA has ordered monitoring testes to investigate the prevalence of brucel- 
losis in camels, cattle, sheep and goats (Ministry ofAgriculture, 2000c). The screen- 
ing involved 793,600 animals all over the country, and showed an average brucello- 
sis infection rate of I%. But the spread was very unequally dispersed over the single 
Soums and reached peaks of 21.9% (State Veterinary & Animal Breeding Depart- 
ment of the Ministryfor Food &. 4griculture et al, 2001). The high rate of a quarter 
of all identified infected animals had not been slaughtered but had remained with the 
herders. 
Whole herd vaccination campaign 
Based on these data, the MoA implemented in 2001 (Ministry ofAgriculture, 2001) 
a whole herd vaccination plan calling for (Mikolon A. B., 2000) (State Veterinary & 
Animal Breeding Department of the Ministryfor Food & Agriculture et al, 2001): (i) 
10 years yearly vaccination of the new born female kids and lambs with Rev. 1, and 
calves with S19; (ii) the vaccination of all breeding adult females cattle within 3 
years (with S19), sheep and goats (with Rev. 1), and repeat of this vaccination 3 
years later; (iii) the assessment of the vaccination success through a survey before 
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repeating vaccinations; (iv) the marking of all vaccinated animals (ear tag); (v) the 
testing of breeding males twice a year and the slaughtering of reactors; and (vi) the 
surveillance -- through infection level detection -- of herders and other risk groups. 
Thus, it was planned to vaccinate 5.3 million animals in II Aimags that same year. 
The vaccination coverage could be realised with 86% to 95% (Ministry of Agricul- 
ture, 1999). 
National Programme to Control Communicable Diseases 
From the human side, the fight against brucellosis has been put into a wider context: 
The "National Programme to Control Communicable Diseases" declaring in 2002 to 
decrease communicable diseases and mortality, focused in one of its sub pro- 
grammes on infectious diseases with natural foci and zoonosis (Prime Minister of 
Mongolia et al, 2002). The following measures were foreseen to fight brucellosis; (i) 
education and dissemination on brucellosis prevention methods; (ii) improvement of 
brucellosis surveillance on an intersectoral level and (iii) the improvement of inter- 
sectoral collaboration and participation. 
3. Reviewing policy with quantitative data 
The review of the governmental policy papers and grey literature has given an in- 
sight to the different elements, stages and causes of the policies applied. However 
the policy papers were on intention or plans. No progress reports of implementation 
activities were available, uncertainty therefore remained as to the real nature of sur- 
veillance activities. Only one Governmental order insisted on the implementation of 
a previous order, because its implementation has been judged as poor (Ministry of 
Heath, 1979). Data collection on testing and vaccination allowed screening the cur- 
rent policy implementation with quantitative data and to illustrate this with graphs. 
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Overview on small ruminants 
In figure 5.1. brucellosis prevalence in sheep and goats is compared to testing and 
vaccination for the time period 1966 to 2002. The figure shows average data: all 
Aimags are put together and give a country-wide aggregate. 
Figure 5.1.: Prevalence and control in small ruminants 
Prevalence and control in sheep and goat in whole Mongolia 
control: testing and vaccination 
Co / 
I' 
0- 
19 70 19 80 19 90 20 00 
year 
tested vaccinated 
sheep goat 
Derived from material collected for this thesis 
CN 
CD 
From this rough overview, the following stages can be made out: vaccination in SR 
began in 1975, after a considerable prevalence decline, from 2.5% in mid 1960s up 
to less than 1% from the mid 1970s onwards. As soon as vaccination started, the 
percentage of animals tested dropped from nearly 60% to about 10%. The average 
vaccination coverage increased over the years up to about 30% in 1980, and levelled 
out at about 20% in 1985. During the same period of time, the prevalence dropped 
constantly to less than 1%. However, after 1985 the vaccination coverage, as well as 
the prevalence rate (around nearly 1%), became quite volatile. The whole SR flock 
vaccination campaign 1975 to 1985 is well reflected byfigure 5.1. and it shows how 
the prevalence in sheep and goats was at its lowest level in 1985, after II years of 
vaccination. However, the prevalence started to increase in 1986, the sarne year vac- 
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cinations stopped. The prevalence continued to increase until the vaccination cover- 
age increased between 1988 and 1991; following this, only sporadic vaccination 
took place. We have seen, that the policies could not be implemented in early 1990s 
because of lack of funds, and in later 1990s privatisation and inflation had adverse 
effects on the implementation of the planned policies. During this time, prevalence 
levels become incoherent; it can be supposed that data collection was inconsistent 
and irregular in the 1990s. 
Overview on caftle 
A similar situation for cattle is illustrated byfigure 5.2.: 
Figure 5.2.: Prevalence and control in cattle 
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The prevalence rate declined from above 6% in the mid 1960s to about 2% in early 
1970, and stayed there up until 1986. A little fewer than 10% of the cattle had been 
vaccinated, from 1976 to 1985, with S 19 and Rev. 1, confirming that the whole herd 
vaccination was in SR flocks and actually not in cattle. During the same time, the 
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percentage of animals tested was more or less constant (about 50%). Then, matching 
with the review on the policy papers, the whole picture suddenly completely 
changed in 1987 as the testing had been reduced to very low levels, vaccination cov- 
erage had risen to a level of around 20%, occasionally reaching 40%, and the preva- 
lence rate rose fourfold to over 8%. The vaccination campaign in cattle (using 
mostly Rev. 1) lasted until 199 1, and completely stopped after 1993. During the pe- 
riod of more intense vaccination the prevalence rate dropped slowly to a level of 
around 2%. This figure shows how the data have to be interpreted carefully: it can be 
supposed, that the prevalence showed for the time period before 1987 contained re- 
ported data. However, as elaborated in chapter 4, it seemed to be obvious that from 
1987 onwards, the reported prevalence might have been mixed with data from sur- 
veys. This is likely because it can be assumed that vaccination campaigns were ac- 
companied by surveys, at least during the first years of the campaign. 
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Figure 5.3: Control in cattle, and prevalence in cattle without Mmags 
with vaccination 
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The figure 5.3. shows the level of prevalence in cattle after having taken out those 
Aimags where vaccination had taken place in year 1987 and 1988. The course of 
prevalence rate remained within the range 1% to 2%, confirming the analysis in 
chapter 4 on the influence of surveys on the prevalence stated. 
This historical overview of the different policy strategies will lead us, together with 
the overview of the epidemiological patterns, to the third aim: "To analyse the pos- 
sible interactions between the strategies applied to control brucellosis and its 
spread". This will be treated in next chapter 6. 
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Chapter 6 
Analysis 
Given evidence on the spread of brucellosis over space and time (see chapter 4), and 
knowledge on the surveillance policy applied to fight this disease (see chapter 5), 
the next step was "to analyse the possible interactions between the strategies ap- 
plied to control brucellosis and its spread", the third aim of the thesis (see chapter 
3). This chapter is divided in two parts; first a qualitative analysis of the Mongolian 
surveillance policy; and second a quantitative analysis of the surveillance policy and 
spread of disease. The findings of these analyses will be used to address its fourth 
aim, "to make recommendations about surveillance policies for brucellosis " (see 
chapter 7). 
1. Qualitative analysis 
In the current section, we assess the Mongolian policy for brucellosis control against 
the basic steps required for an epidemiological surveillance system, according to 
best practice. All governmental policy papers have been included in this analysis, 
despite different levels of completion, and included resolutions, orders, guidelines, 
methodology papers, project plans, reports or minutes of Cabinet meetings. The de- 
tailed analysis is presented in appendix 6. L; results only are presented here. 
Basic elements of surveillance 
Epidemiological surveillance entails the use of epidemiology and continuous sys- 
tematic surveys, analyses and interpretations of health-related data (Krdmer A. et al. 
2003). The purpose is the determination of needs for immediate or longer range ac- 
tions in response to diseases. Changes in the occurrence of diseases and the risk fac- 
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tors of contagious diseases are tracked to estimate future risks of infection, environ- 
mental or behavioural. Epidemiological surveillance is the basis of an evidence 
based fight against infectious disease. 
The development of an epidemiological surveillance cycle requires the following 
consecutives steps (Krdmer A. et al, 2003) (Teusch Steven M. et al, 2000): (i) the 
objectives of the surveillance system; (ii) the set of case definitions; (iii) the meth- 
odology and mechanisms of data collection; (iv) the tools for data analysis and in- 
terpretation; (v) the dissemination of results; (vi) the implementation and finally (vii) 
the regular evaluation to ensure the defined objectives are met. 
Analysis of the Mongolian surveillance policies 
(i) Definition of the objectives 
The first step in the establishment of a surveillance system is the definition of strate- 
gic objectives and the intervention programme to meet these objectives. The three 
main general strategies against a disease condition are control, eradication and pre- 
vention. 
A control programme includes measures to reduce the frequency of an illness al- 
ready present in a population. The aim is to reduce the impact and frequency of this 
disease on the health status of a population. The organism will not be eliminated 
completely but an acceptable level of infection will remain. Thus the control pro- 
grammes will continue indefinitely. 
Eradication is conceptually different from control and is achieved by different meas- 
ures. An eradication programme aims to eliminate a species of infectious organism 
from a territory. If limited to an area, the term "regional elimination" is used, as 
there is the risk of reintroduction of the pathogen from other geographical areas, thus 
continuing need for control measures (Dowdle WR et al, 1997). New outbreaks are 
due to the importation of the disease from infected territories. Therefore quarantine 
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of imported animals can prevent disease introduction. Introduction of disease can be 
controlled by isolation and slaughter of diseased and exposed animals. For humans 
none of these measures are applicable. Therefore the objective of eradication of a 
disease in human is the global elimination of the occurrence of this given disease. 
Preventive measures aim to exclude an infectious organism from a geographical area 
in which it is absent or to protect a population from a disease that already occurs in 
its geographical area. These three main strategies can form an overall strategy, be- 
ginning with control programmes, then changing to eradication and ultimately mov- 
ing to prevention of the reintroduction of the disease. Unless accurate and current 
epidemiological information is available, the decision-making by those charged with 
policy making is likely to be intuitive. 
Definition of objectives for brucellosis surveillance 
The definition depends on many factors, such as (i) the prevalence in herds and 
flocks; (ii) the type of husbandry; (iii) available economic resources; (iii) impact on 
public health and (iv) potential international trade implications (Robinson A, 2003a). 
Mongolian policy anLlysis 
The analysis showed that the Mongolian policy papers have defined the objectives as 
control, eradication or prevention. The related intervention programmes were de- 
scribed as T&S, vaccination and implementation of hygienic management practices. 
The majority of the stated strategic objectives aimed at preventing the further spread 
of the disease. The vaccination campaigns however, in the 1970s in SR, in the 1980s 
in cattle and currently SR and cattle, aimed at eradicating brucellosis. 
(ii) Case definition 
Of crucial importance for any epidemiological surveillance system is a clear case 
definition, defining which appearance of a disease is under surveillance (Teusch Ste- 
ven M. et al, 2000). The degree of certainty regarding diagnosis should be catego- 
rised as "suspected" or "confirmed. The case definition should assure the application 
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of a congruent standard over time and space. But as knowledge of a disease and its 
associated laboratory testing improves over time, alterations in case definitions often 
lead to changes in sensitivity and specificity. These changes must be taken into ac- 
count in analysis and interpretation of trends. 
Case definition in brucellosis surveillance 
WHO recommends the following case definition for brucellosis in humans (cited out 
of (WHO, 1999)): 
escription: An illness characterized by acute or Insidious onset, 
ued, intermittent or irregular fever of variable duration, profuse 
sweating particularly at night, fatigue, anorexia, weight loss, 
headache, arthralgia and generalized aching. Local infection of 
various organs may occur. 
Laboratory criteria for * Isolation of Brucella spp. From clinical specimen or 
diagnosis: 0 Brucella agglutination titre (e. g., standard tube agglutination 
tests: SAT>160) in one or more serum specimens obtained 
after onset of symptoms or 
ELISA (IgA, IgG, IgM), 2-mercaptoethanol test, complement 
fixation test, Coombs, fluorescent antibody test (FAT), and 
radiolmmunoassay for detecting antilipopolysaccharlde anti- 
bodies; and counterimmunoelectrophoresis (CIEP). 
Case classification 
Suspected. A case that is compatible with the clinical description and is epi- 
demiologically linked to suspected or confirmed animal cases or 
contaminated animal products. 
Probable: A suspected case that has a positive Rose Bengal test. 
Conrirrned., A suspected or probable case that is laboratory-confirmed. " 
So for humans a specific set of symptoms, together with laboratory tests, are needed 
to describe possible, probable and confirmed cases. However, this definition may 
require modification depending on the availability of medical and laboratory re- 
sources. 
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With animals, isolation of Brucella spp. is used, with or without serological evi- 
dence (Robinson A, 2003a). With this it must be possible to categorise animals as 
positive, negative and uncertain. Abortion is an unreliable case defmition as it can 
be multi-causal. Brucellosis is a herd or regional epidemiological problem rather 
than an individual animal problem. Therefore group data are a more accurate meas- 
urement of progress. 
Mongolian policy analysis 
A case deffi-fition was mentioned for animals in 1964, and again in 1976, but without 
yielding concrete guidelines. In fact, case deftition was only in policy papers con- 
cerning the vaccination campaign of the late 1980s, when methodology was de- 
scribed for testing as well as the epidemiological entity (dairy cattle farm). The cur- 
rent whole herd vaccination campaign represented an element of uncertainty as far 
as case definition was concerned, because cross-reactions of the attenuated vaccines 
with live cells of Brucella interfere with the testing results. 
For humans no case definition was included in the policy papers. Nevertheless, from 
interviews with key persons it was clear that the WHO laboratory confirmation case 
definition is currently applied in Mongolia (personal communications with Dr. Tser- 
endolger, director Sourn Hospital in Khutgul, and Dr. Baigal, Clinic for Brucellosis, 
Central Aimag Hospital in Moron) (Roth F., 2003a)), But only Aimag central hospi- 
tals were able to diagnose brucellosis by serology, and if the necessary laboratory 
kits were available (personal communication with Dr. Narantsetseg, general epide- 
miologist in the Public Health Organisation of Khuvsgul Aimag (Roth F., 2003a). 
Because of the long distances from remote areas to the Aimag centres, most patients 
infected with Brucella remained non laboratory confirmed cases. This confirmed the 
speculation of under-reporting of brucellosis incidence, emanating from the ex- 
tremely high contamination rates reported by various surveys (see chapter 4). 
The applied case definition did not consider the actual situation as access to sero- 
logical confirmation of brucellosis was very limited. There were fiirther indications 
confirming the assumption of under-reporting of human brucellosis: (i) various sur- 
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veys reported extremely high contamination among risk groups, which is however 
not represented in the reported incidence rates (see chapter 4); (ii) most of the pa- 
tients treated for brucellosis suffered from the chronic form of disease, reflecting late 
diagnosis and poor access to diagnosis (see chapter 4); (iii) the reporting of human 
cases to the central authorities, which compile the data on human incidence, is weak 
(see further down : 61.6% of the physicians were not aware that they should report 
brucellosis cases (Badarch ULAMBAYAR, 2001), and personal communication with 
Dr. Narantsetseg, general epidemiologist in Public Health Organisation of Khuvsgul 
Aimag (Roth F., 2003a)), confirmed that Souin authorities often do not send their 
files to Moron, the Aimag Centre. 
This is strong evidence for the reported brucellosis incidence in humans being far 
below the current level of contamination. This is problematic as it meant that only a 
small fraction of the infected population was treated. In addition, the past under- 
reporting hinders the monitoring of current and future surveillance activities, as an 
increase of reported human cases does not necessarily mean a current increase in 
contamination, but could mean an improvement in diagnosis and reporting. 
(iii) Data collection 
The different procedures or mechanism in data collection follow different objectives 
and are applied in different circumstances. Common to all is that they can only grasp 
a part of the real infections of populations. That means that under-reporting of the 
true infection rate is always the case. This fact is described as the iceberg principle 
of surveillance of infectious diseases, illustrated by figure 6.1. (Krdmer A. et al, 
2003). 
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Figure 6.1.: The iceberg principle of surveillance of infectious diseases 
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Source: (Krdmer A. et al, 2003) 
The dynamics of infections in populations involves different levels, which have to 
be approached by different strategies of data collection. It is obvious that with dis- 
ease reporting only the top of the iceberg is concerned. The confirmation by labora- 
tory test is very specific, as only clinically diagnosed cases are followed by labora- 
tory tests, whereas not all clinically diagnosed cases are examined by laboratory 
tests. Thus, a surveillance system considering clinically diagnosed cases would be 
more sensitive but less specific. A population survey gives information on the dis- 
ease outbreak rate within a population, but since not all infected persons have signs 
of disease, serological surveillance provides the final stage of information on the 
infection rate within a population. 
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Data collection in brucellosis surveillance 
The recommendations of the WHO include the surveillance of specific defined risk 
population (population surveillance), the declaration of a notifiable disease and the 
cross-sectoral information between the human and the animal sector. 
WHO recommended types of surveillance for brucellosis: 
"Routine surveillance must be undertaken, particularly among high-risk groups (farmers, 
shepherds, workers in slaughterhouses, butchers, veterinarians, laboratory personnel). 
Mandatory early case-based reporting by health care providers or laboratory to upper levels 
of the public health sector as well as to the appropriate level of the animal health sector. In 
endemic countries where investigation of all reported cases may not be feasible, a represen- 
tative proportion of reported cases should be investigated routinely. " (WHO, 1999) 
Estimates of current or baseline levels of infection in the primary animal reservoir 
are traditionally based on "... data passively acquired from the results of bacteriologi- 
cal and serological data from: (i) abortion submissions to a diagnostic laboratories, 
(ii) routine testing of on-farm samples, such as milk or blood, (iii) notifications from 
veterinarians if brucellosis is reportable to the authorities, and (iv) off-farm sampling 
from markets or slaughterhouses. " (Robinson 4,2003a). As these results may be 
biased, active surveillance should be undertaken to provide more reliable estimates. 
This can best be done by a random sampling programme (Robinson. 4,2003a). 
Intersectoral collaboration at this stage is appropriate, as surveillance data on human 
brucellosis can be a sensitive indicator of the status of animal infection, therefore 
human epidemics may direct veterinary epidemiologists to foci on animal infections. 
"Animal brucellosis, especially when caused by B. melitensis, can often be identified 
through investigations of cases in humans. So cooperation with public health au- 
thorities is importanf '(Corbel M. et al, 2000). 
Often, existing data sets such as administrative systems, risk-factor surveys, health 
interviews, can provide surveillance data. The recommendation of the WHO for 
minimum data elements defines three levels (cited out of. (WHO, 1999)): 
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and reporting 
Case classification 
Unique identifier, age, sex, geographical information, occupation and ethnic group if 
appropdate 
Date of clinical onset, date of reporting 
Exposure history 
Outcome 
Aggregated data 
e Number of cases by case classification (probable / confirmed), age, sex, geographical 
area, occupation' 
Data on the animal sector are of ftwther interest for the human sector too and should 
therefore include the following: (i) data from census in livestock and human, 
whereas on the animal side the unit of interest is both the individual animal and the 
herd; (ii) activities performed such as vaccinations, blood samplings, etc., and the 
recorded results such as vaccinations given, number tested, number posi- 
tives/negatives; (iii) animal movements; (iv) geographical data. 
Mongolian policy analy Lis 
Most policy papers have described the data collection methods in considerable detail 
according to the requirements described above. Nevertheless, uncertainty of the es- 
timates remained due to mixing of the reported data with the data gained from sur- 
veys (see chapters 4.3. and 5.3). 
(iv) Data analysis 
An integral part of a surveillance system is the determination of the appropriate ana- 
lytical approach. For most conditions an assessment of the number of cases or rates 
is followed by a description of the population, place, time and the period over which 
the condition occurs. Therefore, the first step in the conversion of the data into in- 
formation is a descriptive analysis on population, place and time. Explorative data 
136 
analyses involve techniques to make the overall dataset more understandable. Visu- 
alisation can be made with charts. The analyses of epidemiological data by means of 
various factors over groups of persons may lead to the identification of risk groups. 
An important procedure in this step is the validation of data, where it is assessed if 
the data are congruent and consistent. This can be performed through automatic pro. 
cedures, through expertise and existing knowledge. 
Data analysis for brucellosis surveillance 
WHO recommends graphs, tables and maps with distinguished case classification: 
"Graphs: Number of probable / confirmed cases by month. 
Tables: Number of probable / confirmed cases by age, sex, month, place. 
Maps: Number of probable / confirmed cases by place. "(WHO, 1999) 
Indicators, defined as "..... a synthetic bit of information able to describe both state 
and dynamic of a particular aspect of the system studied" (Giovannini A. et al, I 
A. D. ), could give further useful information for surveillance. Specific indicators of 
brucellosis surveillance can be identified as the percent variation of incidence in 
humans and prevalence in animals by territorial and time unit, or the change of herd 
incidence. But it is important to know and describe the inherent limitations of the 
data. 
Mongolian policy anýflysis 
Data analysis is completely missing in all policy papers reviewed. The only excep- 
tion was 1988, where a methodology paper planned to study infected cattle data. 
This lack of analytical approach has also been noted during the review of Mongolian 
scientific literature, which included very little analyses (see chapter 4). it seemed 
that this was the weak spot of the epidemiological surveillance policy. Policy makers 
usually had to implement new surveillance activities without having data analysis 
and evaluation reports of the previous surveillance activities. 
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(v) Dissemination 
Technical reports on health conditions, activities performed and progress aim deci- 
sion-making authorities and should be presented accurately that the implications of 
the information can be clearly seen by central policy makers and field operators. So 
the surveillance should guide the initiatives for control, eradication or prevention to 
those who need to take action (WHO, 2001). 
Dissemination of results in brucellosis surveillance 
WHO recommended the following principal uses of data for decision-making: 
liance data 
Estimate the magnitude of the problem in humans and animals 
Monitor the distribution of the diseases in humans and animals 
0 Monitor and evaluate Impact of prevention activities in humans, and of control / elimina- 
tion measures in animals 
Investigation data 
" Identify populations at risk 
" Identify potentially contaminated products of animal origin 
" Identify potentially infected animals sources (herds or flocks)"(WHO, 1999) 
Mongolian policy analysis 
Many of the Mongolian policy papers have included these requirements, insofar as 
the results of the surveys are collected from the Aimags and reported to the central 
and local authorities. Sometimes, intersectoral information exchange activities have 
been promoted at conferences, meetings, seminars or workshops. 
(vi) Implementation 
A surveillance system should ensure activities are planned, implemented, directed to 
the objectives defined, and be based on evidence. The implementation plan should 
include (i) methodology (surveillance activities needed), (ii) governance (responsi- 
bilities, structures, cooperation, organisation and dataflow), (iii) resources (human, 
equipment, financial and logistic supports) and (iv) scheduling. 
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Implementation of brucellosis surveillance 
The FAO Guidelines for coordinated human and animal brucellosis surveillance 
(Robinson A, 2003a) stress the importance of political and legal factors in brucello- 
sis surveillance. Strong political support is needed to avoid the under-funding of 
programmes. Laws have to be enforced for the identification or compensation of 
infected animals. The FAO Guideline suggests the surveillance activities should be 
administratively separated from other control activities within government veteri- 
nary services to ensure surveillance information in an unbiased format. Other impor- 
tant factors to consider in surveillance are culture, motivation and education. Social 
pressures may discourage reporting brucellosis infected animals. Educational efforts 
have to be established and positive motivation could be achieved by a reward system 
giving incentives for being involved in surveillance activities. 
Mongolian policy analysis 
The Mongolian policy has met these requirements, as the methodology for fighting 
brucellosis, such as T&S, vaccination, hygienic methods and management practices 
were described. However, the concrete implementation of the measures reveal some 
managerial weaknesses threatening the effectiveness of the immunisation cam- 
paigns, as reported about the 1975/1985 vaccination campaign (see chapter 5.2. ) or 
the 1987/88 cattle vaccination campaigns (see further down). Observations made 
during field work concluded that the current vaccination campaign (which started in 
2001) suffered ftom. managerial omissions critical for ensuring the success of the 
immunisation: (i) The vaccines have been stored within the private veterinarian sec- 
tor on Souni level from delivery in April/May onwards up to the administration in 
August/September during the hot season without cooling, and there has been no 
subsequent quality controls after storage and before administration. (ii) The 
vaccinated animals have not been marked and there is currently only a self-control 
requirement placed on the private veterinary sector concerning the vaccination 
coverage, without the possibility of the inspectors of the Aimag's Veterinary Offices 
to perform controls. (iii) To monitor the vaccination efficacy serological testing has 
been foreseen but not implemented. 
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The "education campaigns" seemed to play an important role and are listed in the 
analysis, separately from other hygiene methods and management practices. These 
education campaigns played an important role in the 1960s and 1970s, but a less 
important role in the 1980s, and only a minor role in 1990s. Within a study on the 
"population knowledge level on brucellosis" a country-wide survey among 650 per- 
sons was conducted and attested to poor knowledge on brucellosis (Badarch 
ULAMBAYAR. 2001). Among those questioned were 260 physicians, of which 
61.6% were not aware to notify human cases of bracellosis to Central level, 64.4% 
had wrong knowledge on the endurance of Brucella in environmental conditions, 
90% wrongly interpreted the skin allergic test (Bume test), and only a few (8%) 
knew how to treat acute or sub-acute cases of human brucellosis, or how to treat 
chronic cases (4%). 83.2% of the physicians thought that food bome transmission 
would be the main route of brucellosis infection to humans, while direct animal con- 
tact would only cause 7.2% of the infection, and aerosol transmission 9.6%. In fact, 
according to an analysis from 1985, food borne transmission caused only between 
5.7% and 6.7% of the human infections, and the main route of infection was direct 
animal contact (between 89.2% and 94.2%), while aerosol transmission was 3.9%. 
Most of the remaining 400 study participants 53 thought that the sources of human 
brucellosis were cattle, horses and camels, but not sheep and goats, only 55.6% 
boiled milk, and the general knowledge to prevent humans from brucellosis infection 
was, according to this study, insufficient. 
Currently, the prevention efforts aimed at herders are focused on the health of the 
animals rather than on human health 54 . The conclusions reached on the occasion of 
the Brucellosis Conference in UB, in June 2003, concerning the prevention of hu- 
man brucellosis have, due to lack of funds, not been implemented. Only the animal 
portion of prevention has been implemented (whole paragraph: personal communi- 
53 Profession among these 400 study participants: 24.5% herders, 23.7% workers with animal prod. 
ucts, 20% workers with dairy products, 10.7% unemployed; 
Education among these 400 study participants: 20% university, 16.25% college, 35.5% high school, 
17.75% secondary school, 10.5% primary school. 
54 Advice was given to wash hands BEFORE helping in lambing, but not to wash hands AFTER 
helping in lambing. 
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cation with Dr. Narantuya, General Director of the Public Health Institute, MoH 
(Roth F., 2003a). 
There is strong evidence to conclude that there is a need for disseminating more in- 
formation concerning the prevention of brucellosis in humans. This should be done 
adequately for the general population, to the risk group (herders, workers with ani- 
mal products) and to the physicians. 
Regulations on governance issues have been provided on a regular basis and have 
carefully considered the interaction between the MoH and MoA. However, this 
could well be improved (personal communications with Dr. Altantsetseg, deputy 
director of Public Health Organisation of Khuvsgul Aimag, and with Dr. Baigal, 
Clinic for Brucellosis, Central Aimag Hospital in Moron (Roth F, 2003a)). 
During the period of the planned economy, the allocations of resources were de- 
scribed in detail, and there seemed to be strong political support for brucellosis sur- 
veillance, reflected by considerable funding of surveillance activities. After the shift 
to a market-oriented economy, in the 1990s, such detailed descriptions of resources 
supply were replaced by instructions to search for "international cooperation and 
financine' (Ministry ofFood and Agriculture, 1996). 
Legal concerns, affecting compensation rules for animals infected and slaughtered, 
have never been included in policy papers. Obviously, this was not an issue during 
the period of planned economy since the animals belonged to the state, but with the 
privatisation of the herds this topic has become crucial to ensure surveillance work. 
(vil) Evaluation 
An epidemiological surveillance system should be evaluated regularly to ascertain 
its utility and relevance to public health. This can be measured and evaluated in 
quantitative terms by objective criteria such as incidence, prevalence, mortality, pro- 
ductivity losses, and medical costs. Common difficulties in the evaluation of surveil- 
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lance systems are under-reporting, diagnostic misclassification and no standardised 
case definition or production of data which are not consistent or comparative. 
Evaluation in brucellosis surveillance 
An effective brucellosis surveillance programme should fulfil at least three major 
requirements (Robinson A, 2003a): i) Sensitivity, detecting high percentage of field 
events compatible with brucellosis; ii) Specificity, providing a definitive diagnosis 
for a high percentage of brucellosis-compatible field events; and iii) timeliness, ena- 
bling prompt field responses to situations identified. 
Mongolian policy anglysis 
The Mongolian surveillance policy have usually foreseen the assessment of the 
spread of disease and described the managerial aspects. Evaluation of surveillance 
activities such as the application and implementation of the guidelines and measures, 
the supervision of veterinary specialists, herders, and other people at risk was often 
carried out. However, the missing data analysis, and the application of a case defini- 
tion not adapted to the circumstances, as pointed out above, had an impact on the 
evaluation, as no demonstrable conclusions could be drawn from the reporting sys- 
tem. 
Evaluation reports could not be traced. The exceptions were two reports on the work 
of the Mongolian-Russian expedition in 1987 and 1988 (Ministry of Agriculture, 
1988). These concluded that the surveillance activities had not been properly imple- 
mented. The expedition teams had encountered conditions favourable to the spread- 
ing of brucellosis such as: (i) no plans for vaccination of animals; (ii) no systematic 
policy for preventing brucellosis in humans; (iii) no coordinated implementation of 
management practices preventing infection; (iv) under-staffed medical and veterinar- 
ian sectors; and (v) lack of modem laboratory equipment and technology 
(Enkhbaatar L et al, 2004). 
Further indication of improperly implemented policy can be found in the Norinpil 
article "Do we bother to eradicate brucellosis in sheep and goats or not? " (Khohoo 
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A. et al, 1995). Conditions preventing successful surveillance activities are listed 
here, such as (i) the lack of effective supervision due to insufficient manpower; (ii) 
the poor quality of information; (iii) the uncertain quality of vaccines due to over 
storage and breaking of the cold chain. 
The analysis showed that there was a discrepancy between the policy papers indicat- 
ing the measures to be implemented, and the actual measures implemented. The 
managerial and organisational deficits lead to poor quality of the control measures 
with critical effects decisive as consequence about the success or failure of disease 
eradication. 
The surveillance policy indicated that the policy papers regularly considered govern- 
ance issues between the MoA and MoH, as these were crucial to assure the success 
of surveillance activities. Nevertheless, the inter-sectoral collaboration between 
MoA and MoH to fight brucellosis was traditionally difficult (personal communica- 
tion with Dr. J. Kolar, former WHO expert in Mongolia (Roth F., 2003a)), as the 
need for the MoH to fight the disease in humans was stronger than the need of the 
MoA to fight the disease in animals. The losses in animals due to brucellosis was not 
perceived as very important, however, the goal to prevent human infections made 
the intervention in the animal sector indispensable. It was therefore not surprising 
that the demand for better inter-sectoral collaboration was expressed by members of 
the MoH (personal communications with Dr. Altantsetseg, deputy director of Public 
Health Organisation of Khuvsgul Aimag, and with Dr. Baigal, Clinic for Brucellosis, 
Central Aimag Hospital in Moron (Roth F., 2003a)) and not by members of the 
MoA. 
A multi-sectoral approach analysing the losses due to brucellosis infection in hu- 
mans and in animals showed that losses in animals were considerable and that strict 
surveillance would be, also from a monetary point of view, in the interest of the 
MoA (Roth F. et al. 2003). 
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Summary of Findings 
The qualitative analysis has pointed out four potential weaknesses of the surveil- 
lance policy: 
(i) The most important was the missing data analysis. This had depressing effect on 
dissemination and evaluation. 
(ii) The case definition for human brucellosis was not adapted to the circumstances 
and resulted in under-reporting of human diseases because of lack of access to 
proper laboratory diagnoses. 
(iii) Education campaigns, necessary part of control programs, were missing in the 
1980s and 1990s, and there was strong evidence for poor knowledge on brucellosis. 
(iv) The actual implementation was not satisfactory, threatening the effectiveness of 
surveillance measures. 
These four topics will be addressed in chapter 7 as basis for formulating recommen- 
dations for surveillance policy (fourth aim of this thesis). 
2. Quantitative analysis 
The discussion in the first part concluded that there were two specific questions, 
which should be fiu-ther analysed by quantitative methods: (i) the impact of the im- 
munisation campaign in SR from 1975 to 1985 which has never been analysed, 
whether with laboratory methods nor with statistical methods. The data collected for 
this thesis on the epidemiological spread and vaccination process facilitated the ap- 
plication of mathematical modelling to assess the effect of the immunisation process 
on disease transmission. This could yield important knowledge for defiming the vac- 
cination coverage in future immunisation campaigns. (ii) The surveillance policy 
shifted in the 1980s from fighting brucellosis in SR to fighting brucellosis in cattle, 
mainly in dairy farms. No etiological evidence could be found justifying this policy 
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shift. Statistical analysis of the animal - human transmission was Possible using the 
data collected for this thesis. 
Mathematical analysis on the vaccination campaign 1975 to 
1985 
SIR Model 
The first task was to determine the fraction of the animal population, in the different 
regions of Mongolia, which should have been vaccinated in order to eliminate 
brucellosis. The second step was to compare this with the historical data. The trans- 
mission of an infectious disease such as brucellosis is a non-linear process governed 
by the interaction and respective sizes of susceptible and infectious animal and hu- 
man populations. Vaccination interventions reduce, depending on vaccine efficacy 
and vaccination coverage, the size of the susceptible population. If the size of the 
susceptible population drops below a certain threshold, the transmission of the dis- 
ease can be interrupted. To capture such processes, mathematical models have been 
developed. The Kermack-McKenrick Susceptible Infectious Recovered Model (short: 
SIR model) (see figure 6.2) is a simple epidemiological model that computes the 
host - parasite population dynamics of a generalised contagious illness in a closed 
population over time (Roth F et al, 2003). This model involves coupled equations 
relating the number of individuals in the three compartments: 
(i) Susceptible S(t), 
(H) Infectious I(t) and 
(iii) Recovered R(t) which can also be called Immune 
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An individual moves during the course of natural infection from the susceptible state 
through the infectious state, and becomes eventually immune. A susceptible individ- 
ual is removed, if it is vaccinated, artificially to the immune state. The effect this has 
on the whole population is investigated through the SIR Model. 
The model has 3 parameters: 
(i) mortality rate (g), assuming constant population size by equal birth rate 
(a), 
(ii) recovery rate (y) and the 
(iii) transmission coefficient (3). 
Thus the basic equations in this SIR Model for the three compartments are: 
SIR Model) 
dS 
dt 
(2 SIR Model) 
W 
dt 
(3 sm m,, dl) 
dR 
= ýf -pR dt 
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Figure 6.2.: The basic SIR Model 
To quantify the relationship between "infectiousness" and "ease of eradication" 
(through vaccination), the concept of the basic reproductive ratio Ro is introduced to 
the mathematical model: 
Ro (= basic reproduction ratio) encapsulates the different dimensions of infectious- 
ness in a single number: 
(4 sjR mdj) Ro 
PS 
+ P) 
R,, is defined as "the number of secondary cases that would arise as a result of intro- 
ducing one infectious individual into a wholly susceptible population" (McLean A R, 
1994). In other words: & determines the mean number of individuals infected by 
contact with a single infected individual before his death or recovery, whereas: 
I duration of infectiousness) represents details of the physiology of the (Y + 
host - parasite interaction, 
S (= total population in the sense of a wholly susceptible population) the host de- 
mography and 
0 (= contact rate) the parasite biology. 
The infection is at its equilibrium when it does not spread nor diminish. This is at: 
R. = I 
A vaccination strategy has to change any aspect of the host - parasite interaction in 
the matter to bring the effective reproduction ratio (R, ) to less than 1, which will lead 
to elimination. This can be done by reducing the pool of susceptible population. 
Through immunisation of the fraction p the number of susceptible becomes: 
(I-P)S 
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Immunisation p is defined as the vaccination coverage vc times vaccine efficacy ve. 
The immunisation level has to be linked with the degree of infectiousness (R, ), 
which is based on epidemiological and demographic data, to set the target level for 
eradication. This level p,, called as the critical immunisation levelfor eradication, is 
found at 
(I -P, )& =I 
and can be solved to yield: 
SIR Model) PC '1-1 Ro 
The above conditions show that it is not necessary to vaccinate every individual to 
achieve elimination. Thus, the critical immunisation level for eradication is of great 
interest to know the fraction of the population which has to be vaccinated to achieve 
the goals. However, this model leaves out complexities such as age structure, sea- 
sonality, or heterogeneity (McLean A R, 1994) (see discussion in chapter 7). 
In real life situations, populations are not closed and may change by reproduction, 
mortality and transfers. Waves of infectious disease may be partially explained by 
population dynamics. For example, a population decimated by a highly mortal dis- 
ease below the threshold of transmission may slowly recover to reach the size allow- 
ing an epidemic outbreak of the disease. 
The SIR Model has already been used as basic underlying model in modelling 
brucellosis infection on various occasions: Gonzales (Ganzalez-Guzm6n J et al, 
1994) has applied this model for the description of the evolution of bovine brucello- 
sis in Chile. Zinsstag (Zinsstag J et al, 2005a) has modified and extended this 
model for developing a dynamic model of livestock-to-human brucellosis transmis- 
sion in Mongolia to assess the future benefits of improving animal health, and hu- 
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man health through the control of brucellosis by vaccination of livestock (Roth F. et 
al, 2003ý 
In our data analysis, we applied some of the modifications already introduced to the 
basic SIR Model during the previous work on brucellosis transmission in Mongolia 
(Roth F. et al, 2003) (Zinsstag J et al, 2005a). The modifications as seen infigure 
6.3. were as the followings: 
(i) Brucellosis affects fertility, which has been well thought-out by considering a 
seroprevalence-dependent effect on the birth rate: 
a(eff. vti,. ) = a(b.. H.. ) (I -(il(I/(S +I+ R)))) 
where il is the prevalence-dependent reduction of birth rate a, including abortions, 
among the seropositive animals. 
(ii) because only data on seropositive animals are available, only one compartment 
for the Seropositive animals is defined, instead of two for Infectious and Recovered. 
In other words, the recovery rate or immunity-loss parameter y is put to zero. In the 
compartment for Immune there are only animals immunised through vaccination and 
none through recovery. 
(iii) The new parameter X is introduced, defining the proportion of infectious ani- 
mals, which are in the stage of infecting other animals. In other words: among the 
seropositive animals in compartment Infectious only a fraction X is excreting bacte- 
ria, and is therefore infectious. Thus, adding this to the formula for incidence in ani- 
mals, the new definition is derived as: 
incidence = %PSI 
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This leads to the slight modification of our equations for the three compartments and 
to the modification of the parameter R,, basic reproduction ratio: 
(I brucel model) (dS/dt) = (ct(brelje) (I -(il(l/(S +I+ R))))(S +I+ R)) - gS - 
XPSI 
(2 b,. m di) (dt/dt) = XPS I- III - YI 
(3b,,,, 
ýý, dl) (dR/dt) = pS - gR 
(4 bnjcel model) R() = 
The parameter for p, critical immunisation levelfor eradication remains unmodified 
as above: 
brucel =W) Pc 
Thus, to set the target levels of immunisation for elimination (defined as critical 
immunisation levelfor eradication (p, )) estimates of the effective reproduction ratio 
(R, ) were needed based on the epidemiological and demographic data. We needed 
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Figure 6.3.: The Brucellosis SIR Model 
therefore, derived from the equations (1 brucel model) to (5 brucel model)9 results for the 
following seven parameters: 
g (mortality rate) 
a (birth rate) 
ý (transmission coefficient) 
I (recovery rate) 
71 (prevalence-dependent reduction of birth rate), and 
X (proportion ofinfectious) 
ve (vaccine efficacy) 
The equations for fitting demography and parasite biology, and for defining the criti- 
cal immunisation level for eradication, are summarised as follows: 
Nr. Equation Content 
(1) dU/dt = g(U+W+V) - gU - PUW susceptibles 
(2) dV/dt = PUW - gV - -fV infectious group 
(3) dW/dt = yV - gW immune group 
(4) Ro = PU / (y+g) Basic reproduction 
ratio 
(5) p, =I- (I/Ro) Critical immunisa- 
tion level for eradi- 
cation. 
As these equations have no unique solution, estimates were obtained by a mathe- 
matical modelling process. Table 6.1. gives an overview on the parameters used to 
fit the brucellosis trmsmission. 
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Table 6.1.: List of fitted parameters to transmission in small ruminants 
Parameter Simulation 
Symbol Description Initial value reference 
The susceptible population From database Data collected for 
S (= all sheep & goats minus this thesis55 
the sero-positive and minus 
the vaccinated animals) 
The infected populations From database 
the number of sero-positive 
sheep & goats calculated out 
of the prevalence, which has 
been calculated out of the 
sampling) 
The immune population From database 
R (=the vaccinated sheep & 
goats) 
Vaccination efficacy 0.65 (Zinsstag J. et al, ve 2005a) 
Per capita annual birth rate 0.8 (Zinsstag J. et al, a 2005a) 
Per capita annual death rate 0.8 (Zinsstag J. et al, p 2005a 
0 Transmission coefficient 1.56e-' (Zinsstag J. et al, 
2005a) 
Per capita annual recovery 0 Pnsstag J. et A Y rate of infected animals 
Proportion of infectious sero- RANDOM UNIFORM (Zinsstag J. et al, 
positive animals (0.2,0.8) 2005a) 
Prevalence-dependent re- RANDOM UNIFORM (Dnsstag J. et a/, 
duction of birth rate (0.15,0.5) 1 2005a) 
In a first step, a and g (birth(ba,, jj,,, ) and mortality rate) have been optimised for N, 
representing all animals, the Susceptible, Infectious and Immune. In other words, the 
55 (Food and Agriculture Organisation of the United Nations, Rome, 1977) (Kolar J, 2003) 
(Ministry of Agriculture and Food, 1998) (Ministry of Agriculture, 2003b) (Ministry of Agricul- 
ture, 2003a) (State Statistical Office of Mongolia, 1996) (Ministry of Agriculture, 2003c) 
(State Statistical Office of Mongolia, 1974) (State Statistical Office of Mongolia, 1999) 
(National Statistical Office of Mongolia, 2003) (State Veterinary & Animal Breeding Depart- 
ment of the Ministry for Food & Agriculture, 2003) (State Veterinary & Animal Breeding De- 
partment of the Ministry for Food & Agriculture, 2002; State Veterinary & Animal Breeding 
Department of the Ministry for Food & Agriculture, 2001) (State Veterinary & Animal Breed- 
ing Department of the Ministry for Food & Agriculture, 1999) (State Veterinary & Animal 
Breeding Department of the Ministry for Food & Agriculture, 1998) (Agriculture Organisation, 
Ministry of Agriculture at al, 1997) (State Veterinarian Administration Office, 1996) (State 
Veterinarian Administration Office, 1994) (State Veterinarian Administration Office, 1993) 
(State Veterinarian Office, 1991) (State Veterinarian Office, 1990a) (State Veterinarian OA 
rice, 1990b) (State Veterinarian Office, 1989) (State Veterinarian Office, 1988) (State Veteri- 
narian Offlce, 1987) (State Veterinarian Office, 1985) (State Veterinarian Office, 1,984) 
(State Veterinarian Office, 1983) (State Veterinarian Office, 1982) (State Veterinarian Office, 
1981) (State Veterinarian general Office of the Ministry of Agriculture, 1980) (State Veteri- 
narian Office, 1979) (State Veterinarian Office, 1978) (State Veterinarian Office, 1977) 
152 
baseline birth rates were expressed proportionally to the total populations. The mor- 
tality parameters in livestock included natural mortality and off take. In a second 
step 0 (transmission coefficient) were fitted by fixing the demographic parameters 
that resulted from the demographic fit. As shown above y (recovery rate or immunity 
loss parameter) was set at zero: a seropositive animal remains seropositive for the 
rest of its life (Mcoletti P. in (Madkour M., 2001)). The parameter 11 (prevalence- 
dependent reduction of birth rate) was expressed as uniform probability distribution 
(0.15,0.5) (Zinsstag J et al, 2005a). The parameter ), (proportion of infectious) was 
set at 0.8, which is the upper limit of the estimate of the previous work (Zinsstag J 
et al, 2005a). That leads to a more conservative estimate of the critical immunisation 
level for eradication. For the fitting of the deterministic equations to the data we 
applied VensiniTm system-analysis software 56 using the Powell nonlinear maximum- 
likelihood optimisation algorithm (Zinsstag J et al, 2005a). The parameters were 
fitted on the basis of the goodness-of-fit 57 comparing the log likelihood of the cur- 
rent model with the log likelihood of a perfect model (Zinsstag J. et al, 2005a). 
Fitting the model to the data 
The mathematical analysis on the vaccination has been done for 8 Aimags 58 , se- 
lected because they were the first 8 Aimags participating in the whole herd vaccina- 
tion programme in SR, which took place during 1975 to 1985 (see chapter 5). The 
initial vaccination in these Aimags has been undertaken with the assistance of WHO 
experts in the year 1975 to 1977. These Aimags are located in East, North-East, 
North and West of Mongolia. Both human and animal population density are higher 
than in the southern part of Mongolia with the Gobi desert and lower than in the cen- 
tral part of Mongolia (figure 6.4. ). The selected Aimags belonged at that time to the 
most endemic areas of the country (figure 6.5. ). 
56 Ventana Systems Inc., 60 Jacob Gates Road, Harvard, MA, USA; www. vensim. com 
57 In VensimTm "goodness-of-fit" is called "payoff'which is the same as the deviance in maximum 
likelihood estimation. The best model is the one with the smallest payoff. 
so Selenge, Bulgan, Bayan-Olgiy, Domod, Suhbaatar, Hovsgol, Hentiy and Tov. 
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Figure 6.4.: Population densities in humans and animals, 1970 
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In a first step of the mathematical analysis, the brucellosis transmission rate (P) and 
the demographic parameters birth rate (a) and mortality rate (g) among sheep and 
goats have been fitted. Because sheep and goats are always kept together, the data 
for these two species have been pooled. The underlying assumption was that the 
respective species have no difference in their demographic parameters, and that their 
transmission process and their susceptibility were equal (see chapter 4.1). 
The demographic fit to the real data was done with the compartment N representing 
all small ruminants. Three different time periods have been considered: (i) from 
1966 to 1990, the Soviet period with regular off take of meat for sale to the Soviet 
Union. In this period, the animal population was relatively stable; (ii) from 1991 to 
1999, the post Soviet period, where livestock production has been privatised and the 
Soviet Union could not any longer import meat from Mongolia, the annual SR flock 
rose by approximately 4% annually over this period; (iii) from 1999 to 2002 three 
consecutive Dzud catastrophes killed altogether about 7 million animals in Mongo- 
lia, the effect these time periods had on the total number of animals can easily be 
seen in the appendix 6.2.. For the further mathematical modelling, the demographic 
parameters estimated from the fit of the first time period (1966 to 1990) was rele- 
vant. The initial birth rate (a) was set at O<= a=0.8<--2, and the initial mortality 
rate (p) at 0<-- ji = 0.8<--1. With this the most likely range was defined according to 
the previous work (Zinsstag J et al, 2005a). The contact rate (P) was kept at zero, as 
the baseline birth and mortality rate have been optimised for N, representing all ani- 
mals. The results presented in table 6.3. lead to a good fit of the real animal data as 
shown in the appendix 6 Z. 
The results for a and ýt obtained for the demographic fit for the year 1966 to 1990 
was used for the mathematical fit of the transmission rate (P). P was fitted to the 
data of the susceptible (S) and infected (I) SR for the time period with no disease 
control interventions, to best observe the natural spread of disease. The test and 
slaughter campaigns came to an end in 1968, and the whole herd vaccination cam- 
paign started gradually in 1975 (see chapter 5). Table 6.2. shows the time period 
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with no intervention which could be used for fitting the transmission rate (P) in the 
different Aimags. 
Table 6.2.: Time period used to fit transmission rate 
Aimag T&S 
up to: 
Start 
vaccination 
campaign 
Observation period 
used to fit 
(tl - t2) 
Bulgan 1968 1975 1969-1974 
Selenge 1968 1975 1969-1974 
Bayan-Olgly 1968 1976 1969-1975 
Dornod 1968 1976 1969-1975 
Suhbaatar 1968 1976 1969-1975 
Hovsgol 1968 1977 1969-1976 
Hendy 1968 1977 1969-1976 
IToy 
_ 
1 1968 1977 1969-1976 
0= transmission rate between animals 
The initial data for the compartments of the susceptible (S) and infectious (1) animals 
were derived with help of the following equations: 
(6) St = Nt - It - P,. wm 
(7) It = prevt * Nt 
(8) &ýum = Rt (I +(I _g) +(I _g)2+ (I _g)3) 
This underlines the loss of vaccination immunity. The vaccinated animals are becom- 
ing susceptible again four years after their vaccination (Zinsstag J. et A 2005a). 
(9) prevt = (seropositive sheept + seropositive goatsý) / (sample sheept + sample 
goatsý 
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This equation (9) has been applied under the condition that the data were available 
for the seropositive and sample size for both sheep and goats. Otherwise, the follow- 
ing equation has been applied: 
(9. jtý. &. 1) prevt = ((seropositive sheep, ) / (sample sheep, ) 
or 
(9alWmdve 2) PreVt"ý ((seropositive goatst) / (sample goatst) 
The data collection contributed to feed the following compartments: 
Nt = all sheep and goats 
Rt = all vaccinated sheep and goats 
seropositive sheep; 
seropositive goats; 
sample size of sheep; 
sample size of goats. 
In the modelling process the payoff variables S and I were weighted by 
I /Std(IStj w t2) 
against 
I/Std(Vtj to 059 
according to the manual of the Vensim Software 60 
The most likely range was defined with 
O<= animal contact rate = 1.56e -7 <-- 0.1 
59 tl is the first year of observation (1969), t2 is the last year of observation see table 62. 
60 In the fitting process the different compartments have different sizes with 100 or 1000 fold differ- 
ences. To account for these differences in the fitting process parameter estimates are done by account- 
ing for a weighting between compartments at different size. The weighting is done by dividing com- 
partment size by I/Std.. 
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considering the previous work (Zinsstag J et al, 2005a). The summary of the results 
is presented in table 6.3.. The appendix 6.3. illustrates this fit of P for all eight Ai- 
mags. 
Assessing the vaccination coverage 
In a second step of the mathematical analysis, the target levels of vaccination for 
elimination of brucellosis in the various Aimags (pj were calculated in Microsoft 
Excel. For this, the effective reproductive ratio (Re) was calculated for every year 
during the observation time period as shown in the table 6.2.. The equations applied 
were as defined above: 
(4,,,,, ) Ret = ), PSW(y+g) 
(5 new) pC1l(1fRe1) 
(6) St = Nt - It - Rw. 
The parameters X (proportion of infectious seropositive animals) and y (recovery 
rate of infected animals) were set as shown in table 6.1. and described above on 
page 149 (k = 0.8; y= 0). The parameters transmission rate (0) and mortality rate 
(g) resulted from the mathematical fitting process with Vensim"4 system-analysis 
software. 
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Table 6.3.: Results on demographic and transmission parameters, and 
on critical immunisation level for eradication 
Al Demogra hic parameters Transmis ion parameter PC mag obs. year cl u s6 obsE ar b-E , 'or average cl 95% 
Selenge 1,966-90 0.80 0.79 
r 
It 1969-74 7.36E-06 53.74% 0.16% 
Bulgan 1966-90 0.80 0.80 ft f 969-74 2.76E-06 48.00% 0.10% 
Bayan-Olgly 1966-90 0.81 0.80 It 1969-75 1.74E-06 38.15% 0.08% 
Dornod 1966-90 0.80 0.80 f 969-75 2.61 E-06 49.42% 0.05% 
Suhbaatar f 966 - 90 0.79 0.80 1969-7.5 2.01E-06 35.28% 0.12% 
Hently 1966-90 0.81 0.80 1969-75 1.73E-06 40.55% 0.05% 
Hovsgol 1966-90 0.80 0.80 f 969-76 1.38E-06 39.60% 0.82% 
Tov 1966-90 0.81 0.80 1969-76 1.68E-06 37.70% O. f 1% 
a birthrate 
p mortality rate 
p transmission rate between animals 
pc critical immunisation level for eradication 
Finally, in a third step of the mathematical analysis, the effective vaccination policy 
for the time period 1975 to 1985 (and later up to 2002) was compared with the target 
level of vaccination for elimination (p,, ). Thus, the difference between the proportion 
ofprotected (pp) and the threshold vaccination coverage (p,, ) was calculated in Mi- 
crosoft Excel. The proportion of protected (pp) was calculated out of the vaccine 
coverage (Rw.. ), as in equation (8), and corrected by the vaccine ejficacy. The vac- 
cine eTicacy indicates the power or capacity of the vaccine to protect from infection. 
The vaccine efficacy was set at 65%, as in the prior studies (Zinsstag J et al, 
2005a). With this the vaccine specificities of Rev. 1, and the local conditions such as 
losses due to cold-chain deficiency were considered. As benclunark for assessing the 
vaccination policy, new calculated threshold vaccination coverage (p,, tj to t2) was 
used, taken from the average of the observation period as shown in table 6.2.. 
(10) p, tj w t2 = (I: pr tj t. t2) /n 
n= number of observation years, so between 6 and 8 observation years (1969 to 
1974, or 75, or 76). 
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This benchmark defined the fraction of the animal population which needed to be 
vaccinated to eliminate brucellosis. Thus, to assess the yearly vaccination policy, the 
effective yearly proportion of protected (pp, ) was compared with the target level of 
vaccination for elimination (p, tj - t2). 
(11) Discrepancy of vaccination level from required vaccination levelt --= ppt - pct, -t2 
The results of the equation (11) are given in table 6.4. and as a graph infigure 6.6.. 
This finally gave the hint on the appropriateness of the chosen vaccination policy, 
compared to the effective local demographic and epidemiological situation. The 
graphical view with the development of the brucellosis prevalence, the vaccination 
policy, and the corresponding result about the policy assessment is given in the ap- 
pendix 6.4.. 
Table 6.4.: Discrepancy from actual to required immunisation level 
Al pc 
(tl - t2) p p pp - pc (tl - t2) mag 
average VI v2 - 1985 V1 v2 - 1985 
Selenge 53.74% 43% 16% -10% -37% 
Bulgan 48.00% 50% 14% 2% -34% 
Bayan-Olgly 38.15% 47% 16% 9% -22% 
Dornod 49.42% 55% 18% 6% -32% 
Suhbaatar 35.28% 48% 20% 13% -15% 
Hently 40.55% 52% 16% 11% -24% 
Hovsgol 39.60% 48% 18% 8% -21% 
ITov 37.70% 1 53% 1 16% 1 15% 1 -21% 
pc (H - t2) critical immunisation level for eradication in observation period 
pp, proportion protected = vacc. cov. * vacc. efficacy (here 659"o) 
pp-pc(d - t2) discrepancy of immunisation level from required Immunisation level 
V1 first year of vaccination 
v2 - 1985 average for second year of vaccination up to end of vacc. campaign (1985) 
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Figure 6.6.: Discrepancy from actual to required immunisation level 
(graph to table 6.4. ) (from left to right: Selenge, Bulgan, Bayan Olgii, Domod, Sukhbaatar, 
Khuvsgol, Khentii and Tuv) 
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Discussion on the results 
The results among the Ainiags are close together and consistent, the threshold vacci- 
nation coverage was between 35% and 53% (table 6.3). Only the initial vaccination 
level at the first year of the vaccination campaign was high enough to eliminate the 
disease, considering a vaccine efficacy of 65% (table 6.4. ). The effective immunisa- 
tion level in the first year of vaccination was between 2% and 15% over the critical 
immunisation level for eradication. The exception was in Selenge Aimag, where 
there was the highest transmission rate between animals (0) and the immunisation 
level remained even in the first year of immunisation still 10% below the critical 
level for eradication. 
Important are the years following the first year of vaccination, when the vaccination 
campaign was dropped to a level which was distinctly under the required benchmark 
for elimination (table 6.4. ). This resulted to an insufficient proportion of protected 
animals of between 15% and 37%. The vaccination campaign considered only the 
vaccination of the replacements (new born, animals added to the herd) during the 
following years. However, in nomadic livestock breeding the identifying of all re- 
placements (animals added to the herd) might not be practical. "An altemative prac- 
tical approach could be whole-flock vaccination repeated every 2 years for the whole 
population for at least 8- 10 years" (Blasco JM, 1997). 
A further remarkable fact is that the low vaccination level in year 1986, just after the 
whole herd vaccination campaign, provoked a distinct increase in brucellosis pTeva- 
lence rate during the successive year 1987. The exception was in Bayan Olgii Ai- 
mag, where the vaccination was increased after 1986 close to the benchmark (critical 
vaccination level for eradication), and the brucellosis prevalence rate did conse- 
quently not increase after 1986. 
This mathematical analysis demonstrated that neither the vaccination campaign 1975 
to 1985 nor any of the following vaccination activities in SR considered vaccination 
coverage sufficient to eradicate brucellosis. To fight brucellosis successfully vacci- 
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nation level like that of the first year of the vaccination campaign in SR (1975 to 85) 
would have been required, but this was not kept up in the following years. On the 
assumptions as described in table 6.1., and vaccine efficacy 65 %. 
Statistical analysis on the animal human transmission 
The qualitative analysis of the surveillance policy in the first part of this chapter has 
shown that the first vaccination campaign, starting in the 1970s, focused on the im. - 
munisation of SR. This seemed to be justified, as most etiological analysis con- 
cluded B. melitensis as the major source of brucellosis infection in humans. The SR 
had been identified as the relevant animals for the spread of infection in humans. 
Occupational activities have been recognised as by far the most important route of 
transmission. In the 1980s, the focus of surveillance had shifted to cattle in dairy 
farms. With this policy change the prevention had then to be set to prevent food 
borne infection, so to assure that cow's milk was not contaminated with Brucella. In 
none of the policy papers or publications, could evidence for this policy shift be 
found. Because Russian experts were considerably involved in developing this new 
policy, the original motivation may have been based on external trade opportunities, 
and the sale of milk and meat products to the USSR. 
Multiple Regression Analysis 
This thesis has provided empirical evidence on the spread of brucellosis in animal 
and humans and opened up the possibility to test, using statistical regression analy- 
sis, the dependency of the infection in humans upon the infection in the different 
kinds of animal. It was expected with this analysis to get a clearer view about which 
kind of animal the disease in humans came from and to therefore know where to put 
the focus for disease control. 
Bivariate negative binomial regression analyses have been applied to assess the rela- 
tion between human incidence (outcome) and animal prevalence (cattle, SR). Let xi 
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be the number of human brucellosis cases for year i, and Ni be the human population 
size during year i. We assume that xi has a negative binomial distribution, that is x 
- NB(pi, r), where r is the extra-Poisson variation, and pi is related to the mean pa- 
rameter gi via the equation pi = (r/ (r+gi)). We model the relationship between human 
incidence and animal prevalence by the equation log(pi) = a+PZj+log(Nj), where Zi 
is the annual prevalence in animals, a is the constant, and P quantifies the magnitude 
of the association between human incidence and animal prevalence. 
The logit transformation was applied to the animal prevalence to make the relation- 
ship with human incidence more linear (figure 6.7. ). 
Figure 6.7.: Correlation between human incidence and animal preva- 
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Significance was assessed at 5% significance level using the likelihood ratio test 
(LRT). The results (table 6.5. ) show a significant positive association between hu- 
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man incidence and prevalence in cattle (incidence rate ratio IRR 1.24,95% CI 1.14, 
1.3 5) as well as prevalence in SR (incidence rate ratio IRR 1.16,95 % CI 1.08,1.24). 
Table 6.5.: Results on animal - human transmission 
Negative binomial regression to assess the relation between the prevalence (logit 
transformed) In animal (cattle, SR) and Incidence In humans 
Sivarlate regression Multiple regression 
variable 
Inc. Rate 95% Cl LRT P-valuq 
Inc. Rate 
95% Cl LRT P-value 
Ratio (IRR) Ratio (I RR) 
cattle 1.24 1.14 1.35 22.44 <0.0001 1.21 1.09 1.34 12.23 <0.0001 
ISR 1 1.16 1.08 1.24 15.32 <0.0001 1 1.07 0.98 1.17 2.14 0.140 
Negative binomial regression to assess the relation between the prevalence (logit 
transformed) In animal (cattle, SR) and Incidence In humans of the following year 
Bivariate regression Multiple regression 
variable 
Inc. Rate 95% Cl LRT P-value 
Inc. Rate 95% Cl LRT P-value Ratlo (IRR) Ratio (IRR) 
cattle 1.13 1.03 1.23 7.18 0.007 1.11 1.00 1.23 4.02 0.045 
ISR 1 1.08 1.01 1.16 4.6 0.032 1.04 0.95 1.13 0.61 0.436 
Source: collected datafor this thesis 
Multiple binomial regression with both covariates, cattle and SR prevalences (in 
logit scale) indicated, however, that only the cattle prevalence was significant 
(LRT= 12.23, Nvalue < 0.0001) but not the prevalence of SR (LRT= 2.14, P- 
value=0.14). This evidence did not change considering a time lag of one year be- 
tween the prevalence in animals, representing the disease reservoir, and the inci- 
dence in humans, representing the new infections. The prevalence in cattle was sig- 
nificant (LRT= 4.02, P-value= 0.045) but not the prevalence in SR (LRT= 0.61, P- 
value= 0.436). 
This is strong evidence, as both multiple regression analyses showed only cattle 
prevalence being significant for the infection in humans. 
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Discussion on the results 
The etiological analysis had concluded that, in the Mongolian context, SR rather 
than cattle were the source of infection in humans (see chapter 4). This was based on 
observations and analysis carried out in the late 1960s and early 1970s, as well as 
research in the 1980s, which all had come to the conclusion, that the incidence of 
brucellosis in human was more closely linked to the disease reservoir (prevalence) in 
SR than in cattle (see chapter 4). 
Relying on this, the control policy from the mid 1970s onwards had been based for 
10 years on the whole herd vaccination of SR. Only in the late 1980s, was the focus 
changed and put more on the control in cattle, mainly in dairy farms. However, sci- 
entific evidence for this policy shift was not found in the Mongolian papers. It could 
therefore be assumed that the motivation was related to assure trade opportunities 
with Russia. 
The data allowed a multiple regression analysis to be applied. This suggested that 
the data quality was good, as a clear and consistent pattern was indicated in the re- 
sults. The results showed that only the prevalence in cattle but not the prevalence in 
SR was significantly linked to the incidence in humans. This may have given evi- 
dence for explaining the policy shift as described above. But still, an inconsistency 
remained. 
A contradiction appeared between the traced Mongolian scientific literature, and the 
data collected in Mongolia. The scientific literature concluded that the SR and B. 
melitensis were the main source of infection in humans, and that the contact with 
animals rather than alimentation was the route of transmission. The data on the other 
side proved that cattle were the source of infection, so mostly B. abortus, and that 
the route of transmission was most likely food bome. 
In fact both results are plausible, as the source of human brucellosis infection can be 
both, SR or cattle, and the route of transmission can be food borne or related to oc- 
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cupational. activities (see chapter 2). Looking at the different possibilities leading to 
this apparent inconsistency provided better understanding. 
The etiological analysis was based on surveys among high-risk population groups. 
So the surveys focused mainly on herders, workers in slaughterhouses or processing 
animal products such as hides or wool, and on veterinarians. These surveys provided 
the evidence for the main source of disease being in SR more than cattle, and the 
main route of transmission being contact rate over food borne pathways. Studies 
among herders from the 1970s up to the 1990s described an infection rate in herders 
of about 30% over decades (see chapter 4). 
On the other side, the data used in the multiple regression analysis of this work has 
been generated in a different way: the rates on human incidence, applied in this 
analysis, had been calculated from laboratory confirmed cases reported from the 
Aimag centres to the central authorities in Uaanbaatar. Only brucellosis cases con- 
firmed by serological laboratory were included in the reporting (personal communi- 
cation with Dr. Altantsetseg, deputy director of Public Health Organisation of 
Khuvsgul Aimag (Roth F., 2003a)). And the present analysis of this data leads to the 
identification of cattle as the source of infection. Thus, we conclude, given this "con- 
tradictory" finding that the most vulnerable and concerned group, the herders, were 
not represented in the reported data used in this thesis's analysis. 
This has important policy implication, for only confirmed cases by serological labo- 
ratory would have had access to appropriate treatment with drugs (personal commu- 
nication with Dr. Tserendolger, director of Sourn Hospital in Khutgul (Roth F., 
2003a)). The data analysis showed that the cases represented in the reported data, 
were patients infected through cattle. It can be assumed that they had most likely 
been infected by the consumption of milk, and that they were most likely living in 
urban areas buying the milk in uncontrolled markets. Being registered in the files 
meant they had been diagnosed with laboratory serology and had access to treat- 
ment. We have seen that the access to diagnosis and health care was very limited, as 
nearly half of the brucellosis patients already suffered from the chronic form of dis- 
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ease (see chapter 4). The multiple regression analysis has suggested that the main 
risk groups, the herders, were not included in the data. Therefore, the access to 
brucellosis diagnosis and appropriate treatment was likely limited or non existent for 
these groups. This is in line with observations made during the field work in the 
Sourn Hospital in Khutgul, and in the Aimag Hospital in Moron, both in Khuvsgol 
Aimag. 
Human brucellosis was a considerable problem in this area. To access treatment, the 
patients had first to come to the Sourn hospital, Khutgul Hospital, for clinical diag- 
nosis and referral to the Aimag Centre Hospital in Moron for serological laboratory 
tests (personal communication with Dr. Tserendolger, director of Sourn Hospital in 
Khutgul (Roth F, 2003a)). This meant several days of horse riding, or very expen- 
sive car drives - unrealistic for most patients. The waiting lists to get treatment were 
long, as only five beds were allocated to patients ill from brucellosis in Moron hos- 
pital (personal communication with Dr. Narantsetseg, general epidemiologist in 
Central Aimag Hospital, Moron (Roth F., 2003a)). But before getting treatment, 
serological laboratory diagnosis was needed. Because of lack of funds and proper 
diagnostic tools, the Aimag Centre Hospital in Moron could only diagnose B. abor- 
tus (personal communication with the bacteriologist, Central Aimag Hospital, Mo- 
ron, and with Dr. Narantsetseg, general epidemiologist in Central Aimag Hospital, 
Moron (Roth F., 2003a)). If the patient succeeded in getting to Khutgul for clinical 
diagnosis, and then to Moron for laboratory diagnosis, and if the patient had the 
"luck" to suffer from B. abortus, and not from B. melitensis (more likely as the pa- 
tient was a herder), and was properly diagnosed, then she or he would have needed 
further luck to get one of the five beds available. The treatment could then start 
which could last for 45 days, but patients were treated only for 10 days in the hospi- 
tal, and had to finance the drugs for the remaining 35 days themselves. Thus, most 
patients stopped treatment after 10 days because of lack of money (personal com- 
munication with Dr. Tserendolger, director of Sourn Hospital in Khutgul, and con- 
firmation by Dr. Narantsetseg, general epidemiologist in Central Aimag Hospital, 
Moron (Roth F., 2003a)). These documented observations shows at what point the 
access to treatment against brucellosis was limited for herders. 
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It is important, when interpreting the data, to consider that the limited access to 
treatment (and with this the reported data) may also have existed under the socialist 
regime. Thus, the "data collection" may be consistent over the different regimes. 
This was illustrated with the following testimony (personal communication with Dr. 
Altantsetseg, deputy director of Public Health Organisation of Khuvsgul Aimag 
(Roth F., 2003a)): In 1988/89 Dr. Altantsetseg was working as physician in a Sourn 
hospital. Physicians coming from Ulaanbaatar had conducted a serological survey on 
human brucellosis; among others, all herders of her Sourn were included, however, 
they never reported the result of the survey to her hospital. As consequence, none of 
the sero, positive brucellosis patients could be identified and treated. Even when the 
identities of the sero, positive cases were known, they could not be treated, as the 
official confirmation, from the authorities conducting the surveys, were not avail- 
able. This happened to four member staff of the Souni hospital. 
Summary of Finding 
The quantitative analysis has pointed out two potential weaknesses of the surveil- 
lance policy: 
(i) the vaccination coverage did not reach the critical vaccination level for eradica- 
tion; 
(ii) the applied case definition for humans (laboratory confirmation) did not consider 
the limited access to laboratories. The consequences were untreated patients and 
under-reporting. 
The findings of the qualitative and quantitative analysis are further discussed in the 
next chapter 7 to make recommendations for surveillance policy (aim 4, see chapter 
3). 
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Chapter 7 
Discussion and recommendations 
1. Overview 
The aim of this thesis was to estimate the effectiveness of the brucellosis surveil- 
lance policies applied in Mongolia to provide recommendations for future surveil- 
lance policies. Historically, Mongolia has had a long tradition of efforts to control 
this disease, but until now little was known about its degree of success. The intent of 
this work, therefore, was to address this critical gap and create an evidence base to 
formulate policy recommendations. 
To achieve its major aims, this thesis had four investigative steps: The first step 
(Aim 1) was to compile the evidence of the epidemiological patterns of brucellosis. 
The second step (Aim 2) was to establish an historical overview of the different 
strategies applied to control brucellosis. Aimag based information, from 1966 to 
2002 onwards, was therefore obtained, using intensive archive searches and inter- 
viewing of key persons, to assemble a comprehensive database on the spread of 
brucellosis in cattle, sheep, goats, and humans, and the brucellosis control policies. 
The etiology of brucellosis in Mongolia was elaborated from Mongolian scientific 
works and reports from international technical experts. Together, the knowledge on 
the specific etiology and the empirical evidence, provide a comprehensive picture of 
the epidemiology of brucellosis in Mongolia (see chapter 4). Policy papers, reports, 
as well as testing and vaccination data accumulated over the years by the author 
have provided a comprehensive and historical review of the Mongolian surveillance 
policies (see chapter 5). The data collections on the epidemiology of brucellosis and 
the surveillance policies have been mainly carried out in Mongolia, and were as- 
sisted by a Mongolian researcher partner 61 to assure access to the archives, facilitate 
the translations of documents, and interpret the interviews with key persons. 
61 M. Nansalmaa, MAS 
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Using this collected evidence, the next step (Aim 3) entailed a retrospective analysis 
of the interactions between the spread of brucellosis and the applied surveillance 
strategies. The analysis was qualitative and quantitative. The qualitative analysis 
assessed the surveillance policies along the elements of best practice to point out 
policy gaps. The quantitative analysis identified policy gaps and merged applied 
surveillance policies with the epidemiology of the spread of disease. This was car- 
ried out using whole SR flock vaccination campaign (1975 - 1985) data: the effec- 
tiveness of the vaccination campaign was evaluated with the SIR-model, producing 
important results. Multiple regression analysis was applied to analyse the signifi- 
cance of the disease reservoirs of the different animals on the infection in humans. 
Knowledge on the animal-human transmission was needed to evaluate the efficacy 
of surveillance policies. New insights on the data quality and related policy implica- 
tions have now been provided. 
The last step (Aim 4) called for an overall assessment to sum up the "lessons 
learned" from which to formulate policy recommendations about future brucellosis 
surveillance policies in Mongolia. 
This final chapter includes five elements: (i) a discussion on the limitations and con- 
tribution of this thesis; (ii) a review of major lessons learned, (iii) a discussion of 
their validity; (iv) policy recommendations for future brucellosis control in Mongo- 
lia, and (v) a short outlook for future brucellosis control policy in Mongolia. 
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2. Discussion of the methodology 
Methodological difficulties 
Data collection 
Language barrier 
The language barrier was an important issue for the data search in Mongolia as it 
was difficult, time-consuming and costly to search, identify and translate scientific 
papers and policy documents in Mongolia. However, research partners assisting the 
author in this work established a high level of data quality and consistency which 
minimised potential bias. 
Difficulties in accessing information 
There were difficulties in tracing the surveillance policies dating from the era of 
centrally planned economy, as the archives within the MoH and MoA contained 
only documents from 1991 onwards. With help of the key informants it was possible 
to get very precise information on missing documents that was needed to fmd them 
in the Central Governmental Archive (CGA). As this archive had strictly limited 
access, the research partners were vital. 
Data gualijy 
Review of the dataset indicated concerns about the way the data had been compiled. 
Errors were found, for example, in data for cattle in the years 1987 and 1988 in some 
Aimags (see chapter 4): the data obtained from active surveillance had been mixed 
with reported data. It was shown that the regularly reported prevalence rates might 
have been topped up with data from surveillance activities. 
A ftu-ther problem arose concerning the epizootiological entities: the data on animal 
prevalence represented the infected individual animals, but the epizootiological en- 
tity in brucellosis surveillance should be the animal herd rather than the individual 
animal (see chapter 2). However, in nomadic livestock breeding conditions, animals 
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roaming an extended area such as an Aimag could easily have been considered as a 
single herd entity from the surveillance point of view (see chapter 4). 
Analysis 
Qualitative analysis: 
The surveillance policy has been analysed against the basic steps required for a sur- 
veillance system according to best practice (see chapter 6.1. ). However, the policy 
documents contained orders and plans for surveillance, but not details of the activi- 
ties finally implemented. It tamed out that there were only few evaluation activities 
giving information on the actual implementation. These details could only be ob- 
tained through interviews with key persons and personal observations. 
Quantitative analysis: 
A SIR-model has been applied to compute the host - parasite population dynamic 
(see chapter 6.2). This is a strictly deterministic model, which does not consider 
random events, such as geographical distribution of the disease occurrence or demo- 
graphic dependence. The model used time steps of one year, but could become 
smoother by reducing the time steps to half-year or quarter-year intervals (Zinsstag 
J. et al, 2005a). Stochastic events, spatial dependencies between neighbouring Ai- 
mags and different sample sizes, could be considered using a Bayesian model 
(Staubach C et al, 2002). 
Fitting the demographic parameters to the real data considered three different time 
periods according to fundamental changes in the course of time influencing the ani- 
mal populations' records. However, for fitting the transmission rate to the real data 
of the susceptible and infected SR, a time period with no disease control activities 
had to be used to observe the natural spread of disease (see chapter 6.2). The only 
time slot was after the end of the T&S campaign in 1968, and before the immunisa- 
tion campaign from 1975 gradually onwards. Potential changes of the natural trans- 
mission rate over time could not be considered because of interference coming from 
permanent disease control activities. The initial values applied for the mathematical 
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fitting process (see table 6.1., chapter 6.2) were based on previous work (Zinsstag 
J et at, 2005a). The efficacy of the Rev. 1 vaccine was set at 65%, as in prior stud- 
ies, though literature reported higher potential efficacy of Rev. I up to 95% (Zinsstag 
J et al, 2005a). This led to a higher critical vaccination level for eradication, but 
considered local conditions such as losses due to poor cold-chain deficiency. The 
analysis was done at the example of data out of 8 Aimags, chosen as they were the 
first included in the vaccination campaign. However, the southern and eastern parts 
of Mongolia were underrepresented because of this (seefigure 6.4. & 6.5., chapter 
6.2) but the results of the analysed Aimags fell within a narrow range, therefore it 
was not expected to get new insights by adding ftirther Aimags into the analysis. 
We used negative binomial regression analysis, rather than the usual Poisson regres- 
sion for incidence rates, to take into account the large degree of variation in human 
incidence rates (see chapter 6.2). The logit transformation was applied to the animal 
prevalence to make the relation with human incidence more linear. The analysis did 
not consider spatio-temporal effects, as the association was highly significant (P- 
value < 0.0001), and we did not expect a spatial/temporal analysis would influence 
the results (see chapter 6.2). Suspected heterogeneity in the data collection, which 
may have possessed a limiting factor to the validity of the analysis, had only been 
confirmed with prevalence rates of cattle in II Aimags in the years 1987 and 1988. 
Thus this was an infinitesimal part of the data and did not affect the analysis. 
Contribution 
This thesis presently addresses gaps in the knowledge of brucellosis and its control 
on various levels, which are outlined below. 
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Contribution to current discussion In Veterinary Public Health 
In the current discussion on the role of Veterinary Public Health 62 (VPH) for con- 
trolling zoonotic; diseases in developing countries it has been realised that successes 
of brucellosis control programmes in the past were variable. The development of 
improved vaccines and tests may have been over-emphasised, while on the other 
hand, epidemiology may have been ignored as a basic means of control (Robinson A, 
2003b). "More attention should be given to monitoring key indicators of disease 
status..... as well as on the collection of information to determine the effectiveness of 
specific interventions. Analysis of local surveillance data gives valuable insights into 
the epidemiology of the disease within the country" (Dr. Jackson in (Robinson A, 
2003b)). It has been recognised, that there is a gap in data collection and data analy- 
sis in VPH programmes in developing countries, and this thesis addresses it and thus 
directs future efforts of brucellosis control to achieve greater effects. 
Data collection and analysis 
Applying diverse methods of triangulation (see chapter 3) assured a high quality 
data and facilitated the qualitative and quantitative analysis. 
We were able to trace policy documents that were sufficiently close-meshed to get a 
comprehensive picture, even though some of the official policy papers could not be 
found (see chapter 5). This allowed a qualitative analysis, based on best practice, to 
identify potential policy gaps. This "best practice" has been defizied from the general 
literature on epidemiological surveillance policies, as well as from specific literature 
on brucellosis surveillance policy (see chapter 6.1). 
It showed that despite the limitations expressed for the data quality (see chapter 4), 
clear results could be generated in the quantitative analysis. The data was sound 
enough for the mathematical modelling of the birth and mortality rates in SR and the 
`2 At the Teramo (Italy) conference (1999), held on the contribution of VPH programmes to human 
health, the consensus definition of VPH was: "The contribution to the physical, mental and social 
well being of humans through an understanding and application of veterinary science". (Robinson A, 
2003b) 
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transmission rate between SR. Furthermore, the multiple regression analysis on ani- 
mal human transmission produced clear results. 
The mathematical analysis aimed to calculate the critical vaccination level for eradi- 
cation, and to compare it with the current vaccination policy. To fit the transmission 
rate between SP, the SIR-Model was applied, which has been modified in recent 
work for analysing brucellosis transmission in Mongolia (Roth F. et al, 2003) 
(Zinsstag J et al, 2005a). This thesis has therefore validated the brucellosis trans- 
mission model by applying more comprehensive data. It showed that this model 
could be applied to other contexts of brucellosis transmission. 
Contribution to the discussion on the "one health" approach 
Simultaneous epidemiological studies on public and animal health were conducted. 
This provided the opportunity to assess their epidemiological link, and to emphasise 
the importance of institutionalised interaction between public health and veterinary 
authorities. The "one health" 63 approach involves closer interaction between human 
and animal health systems which has to be addressed with the implementation of 
disease control policies in a nomadic setting. "A "one health" perspective enhances 
zoonoses detection and control by intersectoral. surveillance and communicatiore' 
(Zinsstag J et al, 2005b). 
Research partnership 
The research partnership with M. Nansalmaa and the MAS facilitated contacts with 
Mongolian institutions, and surmounting the language barrier. However, there were 
other far reaching and important benefits from this research partnership. It opened 
access to vulnerable, marginalised populations in remote areas in Khuvsgul Aimag, 
63 The term "one medicine" has been coined by Calvin Schwabe in the 1960s (Schwabe C W, 1984), 
focusing on the similar interests of human and veterinary health, and showing that the added value to 
public health of this approach could not be achieved by the disciplinary approaches alone. In the 
1980s this concept evolved to the "one health" approach, containing health to the whole ecosystem 
(Zinsstag J. et A 2005b). 
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and allowed us to understand their specific problems concerning brucellosis. De- 
tailed insights were obtained concerning limited access to diagnosis and healthcare, 
or critical neglect in the implementation of the current vaccination campaign, threat- 
ening its effectiveness. The research partnership helped to ensure the validity of the 
collected data and observations and provided therefore a strong foundation for mak- 
ing evidence based policy recommendations. 
A further benefit of this research partnership is that the Mongolian experiences, and 
scientific results obtained during brucellosis control, are now accessible to the Eng- 
lish speaking scientific world through the work described herein and through publi- 
cations (Roth F. et al, 2001) (Zinsstag J. et al, 2005a) (Roth F et al, 2006). 
3. Main findings 
Underreporting of human brucellosis 
The etiological analysis concluded that brucellosis infection in humans was mainly 
due to B. melitensis and that the animal reservoir for human infection was for the 
most part in SR (see chapter 4). The determined route of infection was animal con- 
tact, thus human infections had work related causes. The statistical analysis, how- 
ever, showed that the registered human brucellosis cases were related to infections in 
cattle and not SR. The author concludes that the registered cases are not the high risk 
population - i. e. pastoralist working with SR in nomadic settings, but the urban 
population living closer to health care facilities, mostly infected through contami- 
nated cow's milk or through contact in dairy farms (see chapter 6.2. ). 
If this is a reality, then it ensues that there could be much under-reporting of human 
brucellosis, as illustrated infigure 7.1 showing under-reporting estimates of the year 
2000. Detailed calculation leading to these figures is given in appendix 7. L. 
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Figure 7.1.: Under-reporting of human brucellosis in Mongolia (2000) 
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Derived from material collected for this thesis 
Approximately 78,000 persons were considered to suffer from active brucellosis, 
while only 992 new cases of human brucellosis have been reported (2000 64 ), leading 
to approximately 2000 registered brucellosis patients. This meant that only 2%-3% 
of all patients with active brucellosis have been serologically diagnosed and got ap- 
propriate treatment. The public health significance of human brucellosis is underes- 
timated in Mongolia. 
Missing analysis, monitoring and dissemination 
The assessment of the surveillance policy papers showed that regular data analysis 
has been mostly missing (see chapter 6.1). This has had an historically critical im- 
pact on evaluation, as conclusions could not be drawn from the evidence assembled 
" Mongolia publishcd onc of the world's highest incidence rate for human brucellosis: 41.7/100,000 
in 2000 (see chapter 2). 
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over years of control work. Unfortunately, Mongolian scientific papers did not un- 
dertake this important analysis either, only expanding on the qualitative data. 
Reviewed policy papers have indicated recommended methodologies and measures 
for surveillance. However, implementation has suffered from critical managerial and 
organisational deficits, since there was no monitoring or quality management system 
in place assuring effectiveness. More specifically, the quality of the vaccines was not 
assessed after un-cooled storage during hot seasons. The vaccination coverage was 
neither assessed through serological monitoring, nor through marking of the vacci- 
nated animals, while the entire monitoring process relied on the unverified claims of 
private veterinarians in charge of the vaccine's administration. 
Sadly, education campaigns on preventing brucellosis infection have progressively 
lost their importance over the last two decades; today, brucellosis prevention knowl- 
edge among physicians and awareness among the general population is poor. 
Insufficient animal immunisation 
The Mongolian vaccination campaign 1975 to 1985 was considered, worldwide, as 
one of the most successful large-scale immunisation programmes employing Rev. 1 
to vaccinate SR (Elberg S., 1996). The decline of the incidence rate in humans and 
the reduction of the abortion rate in SR encouraged this view. However, as docu- 
mented by the analysis briefly summarised below, prevalence rates in SR increased 
again demonstrably as soon as the vaccination campaign stopped in 1986 (seefigure 
7.2. ). 
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Figure 7.2.: Increasing brucellosis prevalence in sheep and goats after 
termination of vaccination campaign in 1986 
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ducted whole herd vaccinations during the first year of the campaign, and immu- 
nised only newborn animals during the subsequent years. The average vaccination 
rate in the first year was 76%, and 26% in the subsequent years. As illustrated in 
table 6.4. and infigure 6.6 (chapter 6.2), this vaccination coverage resulted in an 
insufficient immunisation level, as only the first year vaccination level was high 
enough to diminish brucellosis. In the subsequent years, however, the immunisation 
level remained between 15% and 35% under the critical vaccination coverage for 
eradication. This allowed a residual disease reservoir high enough to spread the dis- 
ease again as soon as the vaccination coverage was reduced. Figures showing the 
relation between the immunisation and the prevalence are put in appendix 6.4.. 
4. Discussion of the main findings 
Underreporting of human cases 
There is strong evidence confirming the finding of under-reporting of human brucel- 
losis, as shown in. figure 7.1.: (i) serological surveys conducted in the main risk 
group (herders) during the observation period concluded a constant contamination 
rate of between 16% and 30% (see chapter 4). As this risk group account for about 
25% to 30% of the whole population, the reported human cases are far below from 
what could be expected. (ii) The case definition applied (serological diagnosis) led 
to limited access to diagnosis and to published data on reported brucellosis cases that 
was not representative of the current situation (see chapter 6.2. ). (iii) Finally, the 
statistical analysis concluded that the reported human cases resulted from the disease 
reservoir in cattle but not in SR. This confirmed the assumption of limited access to 
diagnosis of the risk groups (see chapter 6.2. ). 
It is not surprising that human brucellosis is underreported in Mongolia, as human 
brucellosis is underreported worldwide, remembering the reporting rates in France 
of 20%, in Spain of 8%, in the USA of 3.5%, and in developing countries even less 
(see chapter 1). However, the situation in Mongolia is different, as the underreport- 
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ing is based on one of the highest reporting level worldwide (see chapter 2, figures 
2.1. d, andfigure 2.2). 
The applied case definition, together with the current situation of not providing sero- 
logical testing on Soura level, acts like a "filter of perception7' for the authorities. 
The author concludes, based on previous work, that the health authorities are not 
aware on the real extent of brucellosis contamination in humans, and that the public 
health significance of human brucellosis is underestimated in Mongolia. 
Considering the underreponing due to limited access to diagnosis, the recent varia- 
tions in the incidence rate 65 may mirror variations in access to diagnosis and not 
variations in the spread of disease itself. The underreporting may therefore mask 
future success or failure of disease control activities. 
Missing analysis, monitoring and dissemination 
Literature on monitoring future impact of disease burden in developing countries 
calls for situating monitoring and evaluation more strategically in a framework lead- 
ing to a pathway for evidence based decision-making (seefigure 7.3): "... there is 
often confusion in the use of terms such as data, information, monitoring, evaluation, 
and forecasting, and how these conceptually fit together in management information 
systems. " (De Savigny D. et a4 2004). 
65 Reported human brucellosis cases: 685 (2001); 652 (2002); 751 (2003); 634 (2004); 836 (2005) 
(derivedfrom matepial collectedfor this thesis) 
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Figure 7.3.: A pathway for evidence-based planning 
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Crucial in this concept is that often a short-circuit was observed going directly from 
"Information" to "Action", without considering distilling the information to evi- 
dence, packaging the information, and communicating the evidence to the stake- 
holders to transform to new knowledge or new understanding on the next steps. In 
Mongolia it was observed that there was a short-circuit between "Data" and "Ac- 
tion" (seefigure 7.3. ). The policy analysis resulted that the data were aggregated and 
tabulated, but not analysed, and not interpreted for the specific information needed 
for surveillance practice. This resulted in a weak information system. From 1980s 
onwards, the policy papers didn't include frameworks for capacity building. As a 
consequence poor knowledge was frequent among stakeholders. The decision mak- 
ers draw their plans for surveillance relying on "Data" but not on "Evidence". While 
implementing the plans, a quality management was not in place. Finally the changes 
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in indicators such as the contamination in the animal reservoir or the treatment of 
brucellosis patients have not been monitored, resulting in underreporting. Thus, the 
short-circuit went back from "Action" to "Data". 
Mathematical analysis of the vaccination campaign 
1975/1985 
Worldwide, whole herd vaccination campaigns with Rev. 1 have been - until now - 
the only accepted method to control B. melitensis among nomadic SR in developing 
countries (Blasco JM, 1997) (Banai M, 2002). As financial resources for large-scale 
compensation schemes for slaughtered animals are missing in developing countries, 
T&S programmes can only follow after significantly reducing disease prevalence. 
The success of these vaccination programmes have traditionally remained partial at 
best, because of the difficulties encountered, among others, in reaching every no- 
madic farm. In addition, the campaigns were not accompanied with bacteriological 
surveys, thus the evidence base required to assert the success or failure of the pro- 
grammes was never established (Banai M, 2002). 
The thesis addresses this gap with assessing the effectiveness of past immunisation 
campaigns. This was made possible by the new evidence base compiled in the 
course of this research work, and with providing an epidemiological model for ana- 
lysing. Hints for the critical vaccination level for eradication needed in current and 
future immunisation campaigns are given. This is important, as brucellosis is affect- 
ing the well being of societies in developing countries worldwide, and the efforts for 
research and control have to be rethought (Zinsstag J. et al, 2006). 
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5. Policy recommendations 
The development of an epidemiological surveillance cycle requires the following 
consecutives steps (see chapter 6.1) (Krdmer A. et al, 2003) (Teusch Steven M. et 
al, 2000): 
(1) Definition of the objectives 
The National Programme on "Animals' Health" (Ministry of Agriculture, 1999) de- 
clared in 1999 to eradicate brucellosis in Mongolia by 2010. For this a whole herd 
immunisation programme has been implemented in 2001, with a vaccination scheme 
providing higher vaccination coverage than in 1975/1985. The Mongolian Govern- 
ment, earmarking the funds for this vaccination campaign, seemed to be strongly 
dedicated to this aim of brucellosis eradication. 
Recommendation 
Serious deficits were observed in the implementation process (see "Findings 
above), leading to doubts if this objective could be reached. A rigorous and prompt 
quality management and vaccination monitoring would be necessary to make the 
turn around. 
(ii) Case definition 
The case definition of WHO has been applied to this point in Mongolia, without 
considering that the rural health facilities were not able to perform serological diag- 
noses of brucellosis (see chapter 6.1) They remained therefore not adequately re- 
sponsive to the needs of the population they served. This led to limited access of the 
population at risk (herders) to diagnosis and treatment (see chapter 6.2), due to the 
geographical barriers such as lack of transport facilities or not affordable transporta- 
tion costs. 
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Recommendation 
To increase access to health care for pastoral households, the Soum Hospitals must 
provide proper serological diagnosis and treatment for brucellosis. This is in line 
with the second HSDP focusing on reforming the level of referral for rural health 
services (Hill PS et al, 2006). This programme foresees improved links between 
Bag Feldshers and Sourn Hospitals to increase access of nomadic herding communi- 
ties to health care. Therefore, the Bag Feldshers have to be included in training on 
brucellosis etiology, diagnosis and treatment (see recommendation under "dissemi- 
nation" further down). The drug supply for brucellosis treatment has to be assured 
on Sourn level. 
(iii) Data collection 
A surveillance system should establish a methodology and mechanism for data col- 
lection which allows for its analysis and interpretation. WHO recommends routine 
surveillance among high risk groups, and mandatory early case-based reporting by 
health providers to upper levels of the public health sector as well as to the appropri- 
ate level of the animal sector (WHO, 1999). The intersectoral collaboration is irnpor- 
tant as surveillance data on human infection can be a sensitive indicator of infection 
in animals (and vice versa). The collaboration between the MoA and MoH was a 
well institutionalised element in the policy papers of the Mongolian Government. 
Despite this fact, interviews with partners from medical department concluded that 
the information exchange between MoA and MoH has still to be enforced (see chap- 
ter 6.1). 
Recommendation 
Collecting routine data include the sample testing in animals, and collecting reported 
human incidence. Apart from this, two problems in data collection have to be tack- 
led: (i) the underreporting in humans (see "case definition " above) and (ii) the miss- 
ing monitoring of the immunisation campaign (see "evaluation "further down). 
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"The surveillance activities of both public health and animal health sectors must be 
fully coordinated and integrated. Administrative arrangements between the two sec- 
tors must be established to facilitate immediate cross-notification of cases, as well as 
joint investigations. " (WHO, 1999). Zoonotic disease control committees should be 
established at national, provincial and local levels, and should be multidisciplinary, 
including physicians, veterinarians, epidemiologists, from MoA and MoH, as well as 
NGOs and community representation (Robinson A, 2003b). Beside information ex- 
change synergies have to be created to attempt to serve needs on human and animal 
health simultaneously for isolated populations such as nomadic people (see concept 
of "one health " above and recommendation on "implementation "further down). 
(iv) Data Analysis 
A surveillance system should determine the appropriate analytical approach to data 
analysis, ensuring the elevation of data to the status of information. A lack of ana- 
lytical approach has been observed in the Mongolian brucellosis control policy (see 
chapter 6.1). This was assessed as one of the weakest point in the surveillance pol- 
icy over most periods of time. 
Recommendation 
Analytical methods have to be introduced that allow the interpretation of the col- 
lected data (see chapter 6.2). Before analysing, data have to be cleaned, controlled, 
organised and integrated with other data. Computing with epidemiological methods, 
integrating both animal - animal transmission and animal - human transmission, is 
essential to grasp the course of disease. For this funds have to be assured. The results 
of the analysis should provide evidence for policy, the decision-making process 
leading to planning of the next steps in surveillance activities. 
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(v) Dissemination 
To ensure a proper surveillance system, decision-making authorities should be sup- 
plied with reports on health conditions, activities performed, and the actual progress 
in controlling the disease. Information should not only be addressed to the authori- 
ties at the central levels, but appropriate feedback should also be provided to inter- 
mediate authorities and to field operators. The current knowledge on brucellosis is 
poor in the population at risk and in the health sector (see chapter 6.1). The dimen- 
sion of underreporting the human cases prevented the decision makers to arrange the 
meaning of brucellosis infection according to its impact for public health. 
Recommendation 
To address this, adequate information concerning prevention and treatment of 
brucellosis should be disseminated to policy makers, physicians and the general 
population, aiming at the professional and the educational level, to increase brucel- 
losis awareness and safety education. 
To guarantee diagnosis and treatment on Sourn level (see first recommendation 
above) the knowledge on brucellosis etiology, diagnosis and treatment has to be as- 
sured with the physicians at the Sourn hospitals and with the Bag Feldshers. Besides 
instruction given when studying medicine, or during further medical course work, 
continuous training to medical staff in remote areas could be given through distance 
learning programmes. This could be done on paper-based continuing training mate- 
rial, supplemented by CDs for stand alone PC, as long as no access to the internet is 
available. 
The population at risk also has to be informed and trained on matters concerning 
prevention from brucellosis infection. Information should include eating habits, oc- 
cupational practices and management of livestock. In addition, the population at risk 
should be informed about the clinical signs of brucellosis and the urgent need to seek 
health advice at the Sourn Hospital. This could be done through radio and television. 
However, as animal health services appear to have better coverage, this knowledge 
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on human health has also to be transmitted through the channel of veterinary ser- 
vices to the nomadic population (see approach of "one health " above). 
The pupils have to be informed at school, this could be supplemented with leaflets to 
bring back home. Therefore the Ministry of Education has also to be involved, as 
school children are the group target. 
(vi) Implementation 
A surveillance system should ensure the implementation of activities guided by de- 
fined objectives. Plans for implementation should define methodology, governance, 
resources and schedule, and consider its political, legal and cultural factors. Obser- 
vations on the implementation of the current vaccination campaign lead to the con- 
clusion that the success could be seriously threaten by lack of monitoring and 
through deficits in the proper implementation (see "Findings" above and chapter 
6.1). 
Recommendation 
The keys for proper vaccination campaigns should be addressed to ensure efficient 
immunisation: (i) the vaccines should only be delivered to the veterinarians of the 
private sector shortly before administration, as long as storage with cooling system 
is not assured. (ii) The slaughter of sero-positive animals has to be implemented. (iii) 
The vaccinated animals have to be marked to ease prevention through hygienic 
methods and to facilitate monitoring. (iv) It is necessary to develop laboratory ca- 
pacities on Sourn level for both sectors, human and veterinary (human: see above 
"case definition'). (v) The vaccination campaign has to be monitored through sero- 
logical testing, allowing the evaluation of the effectiveness of the immunisation. 
Synergies in logistics between human and animal health should be sought (see con- 
cept of "one health " above). 
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(vii) Evaluation 
A surveillance system has to be regularly evaluated to ensure that defined objectives 
are met, and to ascertain its utility and relevance to public health. The assessment of 
the control policy showed that the progress of surveillance activities had been de- 
scribed, but that because the reporting system did not provide analysis, the evalua- 
tion remained weak (see chapter 6.1 ). 
Recommendation 
Therefore, to ensure successful surveillance collecting of epidemiological data and 
analysing the immunisation process remain indispensable. 
The evaluation of the vaccination campaign 1975/85 lead to the conclusion, that the 
vaccination coverage in the Mongolian context should reach at least 70% (see chap- 
ter 62. and "Findings " above) to reach the critical immunisation. level for brucello- 
sis eradication, and to avoid later flare up of the disease as soon as the immunisation 
level is reduced. However, the needed duration of this high vaccination coverage can 
hardly be predicted, as it depends on results of active surveillance data. 
6. Outlook for future control policy in Mongolia 
The literature mentions a possible switch from immunisation to T&S policy, which 
is justified on economic grounds, at a prevalence rate of 2% or less (Scientific Com- 
mitte on Animal Health and Animal Wetfare of the European Commission, 2001). 
However, such a shift is only possible on condition that: (i) the flocks are not too big 
and under strict surveillance and movement control; (ii) the animals are individually 
identified, the veterinary service for surveillance well organised, and the laboratory 
testing in place; (iii) the necessary facilities and resources for replacements or com- 
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pensation for a considerable period are available (Scientific Committe on Animal 
Health and Animal WeVare of the European Commission, 2001). 
As these requirements are not in place, such a policy shift in the Mongolian context 
of nomadic SR livestock breeding would have no chance of success. It could possi- 
bly be envisaged for control of brucellosis in cattle farms, isolated from the other 
livestock. 
This implies that brucellosis surveillance for SR in a nomadic setting in Mongolia 
has to rely on immunisation and that this immunisation has to be implemented and 
monitored according to best practice. 
Between the conception 
And the creation 
Between the emotion 
And the response 
Falls the Shadow 
Life is very long 
Extract from 
'The Hollow Men' 
by T. S. Eliot (1925) 
A good concept does not release those in control from the responsibility for the out- 
come, and it's so hard to maintain a relentless control programme all the time 
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Appendix 1.1..: Definition of list A and list B 
diseases according to O. I. E. 
"Definition of O. I. E. List A diseases: 
Transmissible diseases which have the potential for very serious and rapid 
spread, irrespective of national borders, which are of serious socio-economic or 
public health consequence and which are of major importance in the international 
trade of animals and animal products. Reports are submitted to the O. I. E. as often 
as necessary to comply with Articles 1.2.0.2. and 1.2.0.3. of the international 
Animal Health Code. 
Definition of O. I. E. List B diseases: 
Transmissible diseases which are considered to be of socio-economic and/or 
public health importance within countries and which are significant in the 
international trade of animals and animal products. Reports are normally 
submitted once a year, although more frequent reporting may in some cases be 
necessary to comply with Articles 1.2.0.2. and 1.2.0.3 of the International 
Animal Health code. " 
Cited from: (Office International des Epizooties, 2000) 
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Appendix 1.2.: Brucellosis free countries, 1994 
Countries reporting eradication of bovine brucellosis (B. abortus): 
In Europe: Bulgaria (1968), Croatia (1965), Cyprus (1932), Czech Republic 
(1964), Denmark (1962), Estonia (196 1), Finland (1960), Hungary (1985), 
Iceland (never recorded), Latvia (1963), Lithuania (1952), Luxembourg (1993), 
Netherlands (1993), Romania (1969), Slovak Republic (1964), Slovenia (1970), 
Sweden (1957), Switzerland (1963), U. K. (1993) 
In Africa: Mauritius (1986) 
Americas: Belize (1980), Canada (1989) 
Asia: Israel (1984), Japan (1992), Jordan (1992), N Korea (1959), Papua New 
Guinea (1974), Philippines (1989), U. A. E. (1992) 
Oceania: Australia (1989), French Polynesia (1984), New Zealand (1989), 
Vanuatu (1992) 
Countries reporting eradication of ovine/caprine brucellosis (B. 
melitensis): 
In Europe: Bulgaria (1968), Croatia (1965), Czech Republic (1964), Germany 
(1986), Switzerland (1963) 
In Africa: Ghana (1993), Namibia (1990) 
Americas: USA (1972), Chile (1987) 
Asia: Cyprus (1932) 
Oceania: not present 
Material out of. - (Ist International Conference on Emerging Zoonoses, 199 7) 
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Appendix 3.1.: List of interviewees 
Semi-structured interviews were conducted in autumn 2003 with key persons 
from all the authorities responsible for the control of brucellosis in animals or in 
humans at three administrative levels: central level, Aimag level and Soum level. 
Further interviews took place with scientific experts on brucellosis, patients ill 
from brucellosis and herder families. For the interviews on the level of Aimag 
and Sourn, the Aimag of Khuvsgul and the Soum. of Khutgul were chosen. 
The interviewees are listed in alphabetical order: 
Dr. ALTANTSETSEG, deputy Director of Public Health Organisation of 
Khuvsgul Aimag, interview together with Dr. NARANTSETSEG, General 
Epidemiologist, and Dr. BAIGAL, Physician, Clinic for Brucellosis; 
Dr. Batsukh BODIGEREL, interview together with Dr. Purevsuren 
BOLORTUYA, both veterinarians at the State Veterinary & Animal 
Breeding Department, MoA; 
Mrs. BYAMBA, Mongolian administrator at WHO local office (interview 
per telephone) 
Sodnom BYAMBA, Fonner leader of the Brucellosis vaccination at 
Biokombinat, now consultant at Monet Pharm Co. Lt.; 
Dr. P. CHULUUNBAATAR, former head of Brucellosis Epidemiology in 
the Central Veterinary Laboratory, MoA; is retired now; 
Dr. DARAATSEDER and Dr. OYUNTSETSEEG, both veterinarian of one 
sector of Moron, interview together with Dr. GANKHUYAG, Director of 
Aimag Veterinarian Office; 
Markus DUBACH, Swiss Consular and representing SDC, interview together 
with Ts. Enkh-AMGALAN; 
Dr. B. ENKHTUYA, Officer in charge for Communicable diseases of the 
Ministry of Health; 
J. ERDENECHIMEG, Epidemiologist at the NCCD (Infectious Diseases 
Research Centre), MoH; 
Dr. GANKHUYAG, Director of Aimag Veterinarian Office, interview 
together with Dr. ADUUCH, responsible for the serological laboratory in the 
Aimag Veterinarian Office; 
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Dr. Jalkhaa KUPUL, former director of the National Institute for Hygiene, 
Epidemiology and Microbiology; ) 
Dr. NARANTSETSEG, General Epidemiologist, interview with brucellosis 
patients at the Brucellosis Department Unit, and visiting the laboratory of 
Moron Aimag Hospital; 
L. NARANTUYA (MD, PhD, DSc), General Director of the Public Health 
Institute, MoH; 
Dr. OYLJNTSETSEEG, veterinarian of one sector of Moron: visiting milk 
and meat markets; 
Dr. Chin Y. PAK, local Program Co-ordinator Medical Mission Centre, 
Yonsei University Medical Centre Ulaanbaatar, interview together with 
GANTSETSEG, MD research student carrying out clinical research on 
Brucellosis; 
Dr. Reijo SALMELA, Medical Officer at WHO Representative Office in 
Ulaanbaatar; 
Dr. R. SODNOMDARJAA (PhD), Director of the Central Veterinary 
Laboratory, interview together with Dr. Ura BADAMSUREN, 
epidemiologist at the Central Veterinary Laboratory, MoA; 
Mrs SUKHJARGULMAA, Mongolian head of UNDP (interview per 
telephone), 
* Dr. TSERENDOLGER, Director of Sown Hospital in Khutgul;, 
9 Tsedev ULZIITOGTOKE, Vice-Director Biokombinat; 
Dr. A. YONDONDORJ (Prof Dr. Phl), Sc. D), Chief of Microbiology and 
Infectious Disease on Animals, Veterinary Research Institute, MoA; 
* Visiting herder family in the surrounding of Moron; 
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Appendix 4.1.: Spread of brucellosis in Mongolia in 
small ruminants and humans 
Brucellosis prevalence in SR and incidence in humans are shown with a 
geographical information system (GlS Mapinfo software). The dynamic infection 
and recovery processes over the whole observation period 1966 to 2002 are 
shown in short consecutive time slots (one year), in the manner of a film 
presentation. The template map of Mongolia has been downloaded from 
intemet', the data are derived from material collected for this thesis (see chapter 
3). 
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Appendix 4.2.: Brucellosis in Mongolia: human 
incidence and animal prevalence on Almag level 
For every Aimag the incidence in humans and the prevalence in cattle and small 
ruminants are plotted on the same graph, for the time period 1966 to 2002. The 
data are derived from material collected for this thesis (see chapter 3). 
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Appendix 4.3.: Infection level of brucellosis in 
cattle in Mongolia 1966 
Each infected herd poses a risk for public health, and therefore the entire herd 
has to be regarded as infected, even if few animals proved to be seropositive. 
Mongolian figures published on the prevalence in herds showed how serious the 
brucellosis contamination was. The following table shows data on a survey 
conducted in 1966 in 307 farms: the results were that cattle were infected in 
92.5% of the farms (Tserendash Choijiljav, 1972). 
Number 
Name of almag E (D E (DI cn 15 
0 55 E 44-) cn 
J-0 
1. Arkhamgal 17 17/ 58,215 4363/ 100% 7.4% 
2. Bayan-Olgil 12 10/ 24,695 1508/ 83.3% 6.1% 
3. Bayankhongor 18 141 16,433 419/ 77.7% 2.5% 
4. Bulgan 16 16/ 74,101 4869/ 100% 6.5% 
S Gobi-Altai 13 12/ 18,211 1255/ . 923% 6.7% 
6. Dundgobi 16 14/ 22,125 1141/ 87.5% 5.1% 
7 Dornod 14 14/ 59,806 1537/ . 100% 2.5% 
Zavkhan 8 23 19/ 36,762 1359/ . 1 81.3% 8.7% 
9 Tuv 25 
1 25/ 77,216 3180/ 
. 100% 4.2% 
10. Selenge 15 
1 15/ 30,262 3155/ 
100% 10.4% 
1I Uvs 17 171 44,893 1607/ . 100% 3.5% 
12 Khovd 14 10/ 24,190 1546/ . 71.4% 6.3% 
13. Khuvsgul 25 25/ 
72,929 3701/ 
100% 5.07% 1 
14 Khentee 20 20/ 10,209 9531/ . 100% 8 9.3% 
15 Sukhbaatar 14 14/ 51,377 4091/ . 100% 7.9% 
16. Uvurkhangal 19 
16/ 87,232 5371/ 
84.2% 6.1% 
17. Dornogobi 15 15/ 16,527 2145/ 100% 12.9% 
18. Umnogobl 15 
11/ 
73.3% 
7768 3441 
4.4% 
Total 307 2841 82 21 92.5% 0 6.1%_j 
(Tserendash Choyiqav, JY72) 
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Appendix 5.1.: Brucellosis incidence in humans, 
prevalence in small ruminants, and immunisation 
in small ruminants 
Brucellosis incidence in humans is shown, together with the prevalence in SR 
and the immunisation process in SR, with a geographical information system 
(GIS Mapinfo software). The template map of Mongolia has been downloaded 
from intemee. The territory covered by the immunisation process expanded 
gradually from 1975 onwards; every year additional Aimags were added to the 
programme, until 1980, when all female SR were immunised nationwide. One 
notices the success of this campaign, and while it lasted, the prevalence of 
brucellosis in SR was generally lowered nationally (see chapter 5). The data are 
derived from material collected for this thesis (see chapter 3). 
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Appendix 
Appendix 6.2.: Mathematical fit of the demographic 
parameters 
The demographic fit to the real data of the populations in small ruminants was 
done for the time period 1966 to 1990. The initial birth rate (a) was set at 
0<=ct=0.8<=2, and the initial mortality rate (g) at O<= g=0.8<=l. With this the 
most likely range was defined according to previous work (Zinsstag J et al, 
2005). The data are derived from material collected for this thesis. 
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Appendix 6.3.: Mathematical fit of the transmission 
rate 
The transmission rate ( 8) was fitted to the data of the susceptible (S) and infected 
(I) small ruminants for the time period without disease control interventions, to 
best observe the natural spread of disease. The test and slaughter campaigns 
came to an end in 1968, and the whole herd vaccination campaign started 
gradually in 1975. The most likely range was defined with O<= animal contact 
rate = 1.56e-'< = 0.1 considering the previous work (Zinsstag J et al., 2005). 
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Appendix 6.4.: Discrepancy of vaccination from 
required vaccination level in small ruminants 
The local epidemiological situation is compared with the vaccination policy and 
gives the hint on the appropriateness of the chosen vaccination policy, by 
showing the discrepancy of the vaccination level from the required vaccination 
level (see chapter 6). The data are derived from material collected for this thesis. 
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Hentiy Aimag, sheep & goats 
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Appendix 7.1.: Estimation of under-reporting in 
human brucellosis in Mongolia (2000) 
a Rural population 
b Ulaanbaatar 
c urban without UB 
d Total Mongolian population 
Calculation exposed population: 
e whole rural 
f half urban 
number % source 
1,030,500 (National Statistical 
Oftice o 'Mongolia, 760,100 
616,900 
2003) 
2,407,500 100% a+b+c, 
1,030,500 a 
688,500 (b+e)12 
Estimated total exposed population: 1,719,000 71 % -If 
rural households 
persons/ hh 
herder household 
number of herdsmen 
employees manufacturing animal 
products 
m agricultural specialists 
268,443 100% (NationalStatistical 
Qflice ofIffongolia, 
2003) 
3.84 A 
191,526 71% (National Statistical 
Of0ce qfMongolia, 
2003) 
421,392 5) (National 
Statistical Ojjic(, oj' 
Mongolia, 2003) 
6,200 (National Statistical 
Of 
. 
fice of Mongolia, 
2003) 
307 
Appendix 
Calculation infected DoDulation: 
* seropositive herders 16% (State Veterinarv & 
Animal Breeding 
Department ol tilt, 
Ministn' /m. Food & 
Agriculture et ti/, 
2001) 
* seropositive herders 25% (Garin-Bastiffi B., 
1999) 
P estim. nomadic pop. & agric. specialists 741,431 (i *j) +M 
q estimated nomadic pop. / total pop 31% p1d 
r nomadic pop / total pop 26% 5) (Ebright JR et al, 
2003) 
S a) Estimation total infected herders: 152,364 ((n + o)12) *1) 
t exposed pop. minus (herders & agric. 977,569 9-P 
Spec. ) 
U estimation seropos. exposed non agric. 1.5% 2) (Jezek Z., 19 70) 
POP 
v b) Estim. total infec. pop. without 14,664 t *11 
herders 
w Estimated total infected population 167,028 7% S+v 
Calculation population with active 
brucellosis: 
x herders with active brucel. 10% (Garin-Bastuji B., 
1999) 
y herders with active brucel. 9% (State Veterinat), & 
AnimalBreeding 
Department qf*the 
Ministryfor Food 
Agriculture et al, 
2001) 
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ndix 
z a) Estimation herders with disease 70,807 ((x +y)12 *p 
outbreak: 
aa No-herder pop with active brucellosis 0.75% u12 
ab b) Estim. No-herder pop. with active 7,332 t *aa 
brue. 
ac Estim. total pop with active 78,138 3% --+ab 
brucellosis 
Calculation of reportin 
ad reported cases (=incidence in year 992 6) 
2000) 
ae Duration of illness in statistics in years 3 after 3 y. =new case 
(Roth F. et al, 2003) 
af Estimated number of total reported 1,984 0.08% ad*2 see 3) 
cases 
Ca lculation labortory confirmation 
A estimated laboratory confirmation 3,968 0.16% af*2 see 4) 
ag reported cases of active brucellosis 2.54% aflac 
1) no data, not considered, thus conservative estimation 
2) Surveys resulted 3% seropositive among non-agriculturalpop. (1970s): here haýf of'this rate 
is taken 
3) Average duration of illness is estimated at 2 years, as many chronic cases occured 
4) af*2 (estimation: half of the laboratory confirmed are reported) 
5) Information usedfor plausibility check 
6) (Health Development Centre, Mongolia, 2002) (National Centerfor Health Development, 
2001) (The Directorate ofMedical Services, 2002) 
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Abstract 
We developed a dynamic model of Ii vestock-to- human brucellosis transmission in Mongolia. The 
compartmental model considers transmission within sheep and cattle populations and the transmis- 
sion to humans as additive components. The model was fitted to demographic and seroprevalence 
data (Rose Bengal test) from livestock and annually reported new human brucellosis cases in 
Mongolia for 1991-1999 prior to the onset of a mass livestock-vaccination campaign (S 19 Brucella 
aborrus for cattle and Rev I Brucella melitensis for sheep and goat). The vaccination effect was fitted 
to livestock- and human-brucellosis data from the first 3 years of the vaccination campaign (2000- 
2002). Parameters were optimized on the basis of the goodness-of-fit (assessed by the deviance). The 
simultaneously fitted sheep-human and cattle-human contact rates show that 90% of human 
brucellosis was small-ruminant derived. Average effective reproductive ratios for the year 1999 
were 1.2 for sheep and 1.7 for cattle. 
c 2005 Elsevier B. V. All rights reserved. 
Ke vvvords: Brucella spp.; Animal-human transmission model; Livestock vaccination; Sheep; Cattle, Public 
health, Mongolia 
*. Corresponding author. Tel.: +41 61 284 81 39; fax: +41 61 284 81 05. 
E-mail address: jakob. zinsstagC&unibas. ch (I. Zins,, tag). 
0167-5877/$ - see front matter ýC ,ý 
2005 Elsevier B. N. All fights reserved. 
doi: 10.1016/j. prevetiiied. 2005.01.017 
78 1. Zinsstag ei zil. II>rei, eiiiii, i, Vetennary Medicine 69 (2005) 77-95 
1. Introduction 
Brucellosis is one of the world's major zoonoses (Boschiroli et al., 2WI). Human 
brucellosis commonly is caused by exposure to infected livestock and livestock products 
(mostly raw milk and milk products). The clinically most-important causative bacteria in 
humans are in decreasing order of severity of illness: Brucella melitensis (small rurninants), 
Brucella abortus (cattle), Brucella suis (pigs) and Brucella canis (dogs). There is no recorded 
transmission of the infection between humans (Krauss et al., 1996) but humans can very rarely 
infect animals (Pamas et al., 1966). In humans, mortality is negligible, but the illness can last 
for several years (Madkour, 2001). In animals, brucellosis mainly affects reproduction and 
fertility, reduces survival of newborns (Sewell and Brocklesby, 1990) and reduces milk yield. 
Mortality of adult animals is insignificant (Sewell and Brocklesby, 1990). 
Control strategies available to prevent human infection are pasteurisation of milk, 
livestock vaccination and the elimination of infected animals. In Mongolia, after numerous 
surveys in the 1960s, the World Health Organization (WHO) came to the conclusion that 
livestock vaccination was the only effective way to control brucellosis. The production of 
livestock vaccines successfully was established in the early 1970s and a country-wide 
mass- vaccination program of livestock planned for II years started in 1975 under difficult 
field conditions. The vaccination of livestock successfully reduced human incidence of 
brucellosis to less than one case per 10,000 per year (Kolar, 1977). The vaccination 
program was interrupted in the early 1980s due to the end of WHO assistance and 
democratic reform followed by the shift away frorn dependence on the former Soviet 
Union in 1990; human brucellosis re-emerged. Based on a request of the Mongolian 
Government to WHO to provide assistance again in brucellosis control and to resurrect the 
vaccination program and recommendations made to the WHO and the Mongolian 
government (Garin-Bastuji, 1999), a whole-herd vaccination strategy covering 10 years 
was developed (Mikolon, 1999) to start in 2000. 
Available models of brucellosis transmission consider only transmission between single 
livestock species and no transmission to humans, although brucellosis is transmitted to 
humans from both small ruminants (sheep and goat) and cattle (Roe, 197T. Carpenter et, 11., 
1987; Dalrymple, 1993; Gonzalez-Guzman and Naulin, 1994), Our main objective was to 
develop a dynamic model of livestock-to-human brucellosis transmission to estimate 
demographic (birth rate, mortality) and transmission parameters (contact rates) between 
livestock and livestock to humans as an underlying basis for a cost-effectiveness analysis of 
a nation-wide mass-vacci nation programme for livestock, which is reported elsewhere 
(Roth et al., 2003). Minor objectives were: (1) to fit vaccination parameters to data on the 
first 3 years of the national brucellosis livestock-vaccination campaign in Mongolia and (2) 
to simulate the brucellosis epidemic with and without specified interventions. 
2. Materials and methods 
2.1. Data collection 
Livestock demographic data were provided by the Mongolian Statistical Office 
(Mongolian Statistical Yearbook, 1999). Animal brucellosis-seroprevalence survey data 
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(Rose Bengal-, RBT) were provided at the provincial level for cattle and sheep for the 
years 1990-1999 by the Ministry of Agriculture for the model fit without intervention 
(Appendix A). The RBT is a simple and inexpensive test to detect antibodies against 
Brucella spp. in serum of many species. For the diagnosis of B. melitensis in sheep its 
sensitivity and specificity were recently estimated at 95 and 100% against culture 
(Ferreira et al., 2003), However, other authors point out that sensitivity and specificity 
vary in different settings and depending on investigators (Maichomo et al., 1998., 
Ostanello et al., 1999; MacMillan, 1997). The seroprevalence in cattle and sheep varied 
between 0.5 and 3%. (S. E. < 0.045% in cattle and <0.035% in sheep). Data on the 
ongoing mass-vaccination campaign were provided from 2000 to 2002 (Appendix A). 
The quality of the available official national demographic and seroprevalence 
data presented could not be checked, but ongoing studies on brucellosis in livestock 
indicate that the reported seroprevalence is underestimated (A. Mikolon, personal 
communication). Our analysis is thus rather conservative with regard to the impor- 
tance of brucellosis and was restricted to seroprevalences provided by the RBT. 
Baseline disease data on reported cumulative incidence of human brucellosis listed by 
province (Mongolian: Aimag), for 1990-1999, were provided by the Infectious Disease 
Research Institute (IDRI) in Ulaan Baatar. The human-brucellosis data are comprised 
of annually reported human cases that were diagnosed clinically and in general 
confirmed by two of the following tests (RBT, Huddelson or Wright). These tests were 
not standardized between the different Mongolian provinces. However, Mongolian 
physicians have long-standing experience with diagnosing clinical brucellosis and we 
see no reason to suspect that accuracy of clinical diagnosis would have changed in 
the decade of data we used. Brucella cultivation from human patients rarely is 
attempted. 
2.2. Model 
2.2.1. General considerations 
We developed a deterministic model with stochastic parameter specification of animal- 
to-human brucellosis transmission in steps of I year (t) (Table I and Fig. 1), which is 
adapted to the availability of data for validation. Because only data on seropositive animals 
were available, we used (instead of "infectious" and "recovered" compartments), only 
one "seropositive" compartment. We considered transmission between sheep, between 
cattle, and from both livestock species to humans. We omitted the transmission between 
goats and from goats to humans due to the lack of data. We neither account for brucellosis 
in yaks and camels, nor for transmission between cattle and small ruminants for the same 
reason. Sheep total-population data are only available for the years 1995-1999. We 
reconstructed the total population for the years 1990-1994 by linear regression on the years 
1995-1999 in analogy to the almost-linear growth of the cattle population. A posteriori, the 
sheep-brucellosis component was refitted to data on sheep population and brucellosis 
prevalence found after extensive archive studies in Ulaan Baatar for the years 1984-1999 
(F. Roth, personal communication). Brucellosis affects mostly fertility and milk 
production. In the model, we consider a seroprevalence-dependent effect on sheep and 
cattle birth rates (Bemues et al., 1997) (see Section 2.3, Fig. 1, Table 1, Appendix B), e. g. 
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Fig. 1. Model forjoint human-animal brucellosis transmission in Mongolia modified after Roth et al. (2003), with 
permission from the Bulletin of the World Health Organization. 
for cattle 
(Iýc(eftecfive) ý Clc(basehne) (X +Y+ Z) 
(1) 
where q is the prevalence- dependent reduction of birth rates u, (including abortions) 
among the seropositive (expressed as uniform probability distribution, Table 1), X the 
number of susceptible, Y the number of seropositive and Z is the number of vaccine- 
protected cattle. The incidence (Fig. 1, infected sheep and cattle) is calculated by the 
product of y, (yj (proportion of infectious), expressed as uniform probability distribution 
(see Table 1), the P (contact rate), the number of susceptible X (or U) and the number of 
seropositive Y (or V). Thus, the incidence in cattle is 
incidencOcattle ý YAXY 
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2.3. Compartments andflows between compartments 
Compartment U (Fig. 1) is the susceptible-sheep population (national sheep population 
of Mongolia minus V). Compartment V is the brucellosis-seropositive population. The size 
of Vis obtained by multiplying the national sheep population with the prevalence estimated 
in annual surveys. Compartment W is the brucellosis- vaccinated sheep (Rev]). 
Compartment X is the susceptible-cattle population (national cattle population of 
Mongolia minus Y). Compartment Y is the brucellosis-seropositive cattle population. Its 
size is obtained by multiplying the national cattle population with the prevalence estimated 
in annual surveys. Compartment Z is the brucellosis-vaccinated cattle (S 19 vaccine). 
Compartment A represents the whole Mongolian human population, because precise 
estimates of the population atrisk are not available. In Mongolia, reported Brucellosis patients 
are officially registered for 3 years. Compartment B represents the annually newly registered 
brucellosis patients and compartment C the registered patients between years 2 and 3 of state 
registration, after which they are considered no longer as registered brucellosis patients. Thus, 
the annual rate of flow (K) from B to C (Fig. 1, registry) by definition =I and the end-of- 
registry constant = 0.5, i. e. inverse of the duration of'registration in compartment (C). In this 
way, the model takes Mongolian health policy into account. 
The descriptions of' flows (Fig. I) are as follows: flows into the susceptible-sheep 
compartment (U) are sheep birth, loss oj'inimunity and loss of vaccination immunity: sheep 
birth (unit: sheep/year) = ces(U +V+ W)(I - (ij(V1(U +V+ M)))(I - C, O)Re. O, where C1, 
is the birth rate of sheep (Table 1), multiplied by the sum of all compartments (U +V+M. 
This term is again multiplied by a seroprevalence-(U/U +V+M dependent decrease of 
sheep birth rate (I - q) (Bernues et aL, 1997). For the simulation of intervention, the whole 
term is multiplied by I minus the proportion of vaccination protected sheep (cys1)RCv0 
(Table 2), where cy, is the vaccination coverage of newborn sheep and VR, v, 
is the 
proportion of reduction of transmission of Rev] vaccine (see below). The loss of immunity 
of sheep (unit: sheep/year) is considered by the term r, V where i:, is an immunity-los, ", 
parameter (Table 1) multiplied with compartment V (seropositive sheep). Loss of 
vaccination immunity in sheep (Revi) (unit: sheep/year) = TRev[W, where TR, vl 
is a 
vaccination-immunity-loss parameter multiplied with compartment W(inimunized sheep). 
Flows out of compartment U are mortality of susceptible sheep, infected sheep and 
vaccinated young and adult sheep (Rev, ]): mortality (unit: sheep/year) of susceptible 
sheep = -(p, U + 6, U), where it, is the mortality rate of sheep and 8, is the extra mortality 
rate of sheep due to the snow-storm disasters (see below). Infected sheep (=incidence in 
sheep) (unit: sheep/year) is = -y,, ý, UVin analogy to Eq. (2) (see above). Vaccinatedyoung 
and adult sheep (Revl) (unit: sheep/year) is composed of the proportion of protected young 
sheep as fraction -Cysl)Revl of sheep birth, and adult sheep vaccination = -CasVR-03, 
where cas is the coverage of adult-sheep vaccination and VRev, is the efficacy of RevI 
vaccine. The division by three of the adult vaccination accounts for two rounds of adult 
vaccination in 6 years. Flows into compartment U appear as positive terms and flows out of 
compartment U as negative terms in the differential Eq. (AA) dUldt in Appendix B. All 
other differential equations are constructed in the same way. 
Flows going into the compartment of seropositive sheep V are infected sheep as 
described above. Flows out of compartment V are mortality of seropositive sheep loss of 
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Table 2 
Intervention-related parameters used in the model 
83 
Parameter (Symbol and description) Assumption Unit (remarks) 
Sheep 
"K,, I Vaccine efficacy of RevI 0.65 Straight propoition 
, R, \ I Inverse duration of Uniform (0.2,0.25) Year 
vaccination protection of Rev I 
Vaccination covenige adult sheep Scenario no vaccination =0 Year 
Scenario 5065 = 0.5 
Scenario 8065 = 0.9 
Scenario 80100 = 0.8 
ý, Y, Vaccination coverage young sheep Scenario [to vaccination =0 Year' 
Scenario 5065 = 0.5 
Scenario 8065 = 0.9 
Scenario 80100 = 0.8 
V11 Proportion tested and Scenarios with and Year 
slaughtered sheep without vaccination =0 
Scenario test and slaughter 40% 04 
Cattle 
"Sig Vaccine efficacy of S 19 0.65 Straight proportion 
rsig Inverse duration of Uniform (0.125,0.142) Year 
vaccination protection of S 19 
CAý Vaccination coverage adult cattle Scenario no vaccination =0 Year 
Scenario 5065 = 0.5 
Scenario 8065 = 0.8 
Scenario 80100 = 0.8 
C', Vaccination coverage young cattle Scenario no vaccination =0 Year 
Scenario 5065 = 0.5 
Scenario 8065 = 0.8 
Scenario 80 100 = 0.8 
q), Proportion tested and Scenarios with and Year 
slaughtered cattle without vaccination =0 
Scenario test and slaughter 40% 0.4 
immunity and test and slaughter of seropositive sheep. Mortality of seropositive sheep 
V= -(jt, V + SsV) is analogous to the mortality of susceptible sheep (see above) but for the 
compartment V Test and slaughter (unit: sheep/year) of seropositive sheep = -ýO, v where 
ýp, is the proportion of tested and slaughtered sheep multiplied with V The loss of immunity 
is already described above but appears as negative term -F., V in the differential equation 
(A. 2) (dVIdt) in Appendix B. Flows going into the compartment of immunized sheep Ware 
vaccinated young and adult sheep (Rev]): adult-sheep vaccination = (c.,, vR,, 1 U)/3 (see 
above) and young-sheep vaccination= (CysNey I *ýJU + V+ W)( I -(I? (VI(U+ V+ W))))). 
The latter term expresses the fraction of newborn sheep being protected from transmission 
(see above: sheep birth). Flows going out of compartment W are mortality of immunized 
sheep and loss of vaccination immunity of sheep. Mortality of immunized sheep W is 
-(tt, W + S, W) in analogy to the mortality of susceptible and seropositive sheep but 
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multiplied with W. The loss of vaccination immunity (unit: sheep/year) ofsheep = _'CRev IW 
is analogous to the description above but as a negative term. Adult- and young-sheep 
vaccination appear as positive terms in differential equation (A. 3) (dW/dt) in Appendix 13, 
whereas mortality of immunized sheep and the loss of vaccination immunity ofsheep are 
negative terms. 
Flows into the cattle compartments are analogous to those for sheep. Vaccinations of 
newborn cattle are accounted by multiplying the whole term with (I - (c)cvsj9)) where cyc 
(Table 2) is the vaccination coverage of young cattle and vý ,, 19 
is the proportion ofreduction 
of transmission resulting from the S19 vaccine (see below). 
Flows into compartment A (susceptible humans) are human birth and end of registr ' 
v. 
Human birth (unit: humans/year) = Clh(A +B+ C) where a,, is the human birth rate 
multiplied by the sum of all human compartments. Ent] of registry (unit: humans/ 
year) = XC, where ;ý is the end-of-registry (i. e. end of any one person ,s inclusion in the 
registry) constant multiplied with compartment C (registered cases in years 2-3). Flows out 
of A are infected humans and mortality of susceptible humans. Infected humans (unit: 
humans/year) (animal-to-human transmission) = -((ycPchAY) + (y., PhAVý) is described 
below. Mortality (unit: humans/year) of susceptible humans is = Ito, where /, tl, is the 
mortality rate of humans multiplied with compartment A. (Changes of compartment A are 
expressed in Eq. (A. 7) (dA/dt) in Appendix B. ) Flows into compartment B are infected 
humans = ((ycPchAY) + (y., P, hAV)), which take a positive sign for this compartment. Flows 
out of B are mortality and registry. Mortalit ' N, 
(unit: humans/year) of annually reported 
cases = jthB in analogy for compartment A. Registr 
"v 
(unit: humans/year) = -KB, with the 
registry constant K=I as outlined above. Eq. (A. 8) (dBldt) considers changes of annually 
reported cases. Finally, flows into compartment C are registry cases and flows out of C are 
end of registry and mortality of registered cases (years 2-3). Registry = KB and end of 
registry (unit: humans/year) = -ýX, where X is the end of registry parameter multiplied 
with C. Mortality of registered cases = _AhC in the same way as for compartments A and 
B. (Eq. (A. 9), (dCldt) specifies changes among the registered cases. ) 
2.4. Fitting the transmission model 
The fitting of the model to the data was done with VensiMTM systems-analysis software 
(Ventana Systems Inc., 60 Jacob Gates Road, Harvard, MA, USA; www. vensim. com) 
using the Powell nonlinear maximum-likelihood optimization algorithm (Press et al., 
1991). Parameters were optimized on the basis of the goodness-of-fit, which is called 
"payoff" in Vensim software. The payoff compares the log likelihood of the current model 
with the log likelihood of a perfect model (having as many parameters as data points). The 
best model is the one with smallest payoff. In the first step, mortality and birth rates were 
optimized for the susceptible sheep (U), cattle (K) and humans (A) (Fig. 1). Birth rates were 
expressed proportionally to the total populations; mortality parameters in livestock 
included natural mortality and off take. In the second step, the transmissions within sheep 
and within cattle were fitted by fixing the demographic parameters. To fit the transmission 
process, the proportions of infected V and Y were expressed as uniform probability 
distributions and their boundaries were varied to identify the best fit (in terms of the 
deviance) of contact rates for the transmission between sheep and between cattle and the 
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loss of immunity. The transmission to humans is expressed as additive contributions of 
transmission from sheep and cattle to humans (Fiv. 1, sheep-to-hurnan transmission; cattle- 
to-human transmission): 
(Y, heepýsh,, PAV) + (y,,,, j, 
&,, j, AY) (3) 
where A is the susceptible human population. The effective reproductive ratio and 
threshold vaccination coverage were estimated according to Scott and Smith (1994), 
using the confidence limits of the proportions of infectious animals obtained during the 
fitting process. Long-term properties were investigated by keeping the animal populations 
stable from year 1999 onwards (in keeping with the limited carrying capacity of Mongolian 
pasture). 
2.5.1"itting of the vaccination interventions 
In the year 2000, the Mongolian authorities started the mass vaccination of their 
ruminants. However, the onset of the vaccination campaign coincided with consecutive 
snow-storm disasters in the winters 1999-2002 and the loss of' >7 million animals. (A 
concurrent outbreak of foot-and-mouth disease in 2001 was not taken separately into 
account because ofthe lack of disease-specific data. ) These massive demographic changes 
had to be considered for the fitting and validation ofthe vaccination campaign. Thus, the 
demographic change of the snow-storm disasters were fitted as an extra mortality from 
1999 to 2002. The estimated mortality rates of cattle 8, and sheep 6, due to the snow-storm 
are 22 and 10% per year, respectively. The extra snow-storm mortalities were used for the 
fitting process of the vaccination campaign but not for the simulations of the different 
vaccination scenarios (see below). For the fitting of the vaccination campaign, the 
vaccination efficacy and vaccination coverage (see below) were optimized against the 
reported seroprevalence of brucellosis in sheep and cattle and the reported cases of human 
brucellosis. 
2.6. Simulation of vaccination and test-and-slaughter scenarios 
The current practice in Mongolia (since 1990) consists of low-level surveillance, with 
occasionally required testing of livestock herds followed by voluntary slaughter of 
seropositive animals without compensation. The present vaccination strategy (since 2000) 
aims to vaccinate all adult animals twice within 6 years (1/3 of the total adult population per 
year). All animals born during the 10 years of the plan will be vaccinated once (at <I year of 
age). The reported efficacy in reducing transmission was measured as the prevented fraction 
(I - R), where R is the relative risk of disease in those who received the intervention 
compared to those who do not (Smith and Morrow, 1991). The vaccines used in cattle (Strain 
B 19, B. abortus) and small ruminants (Rev 1, B. melitensis) should reduce transmission by at 
least 65% (Nicoletti, 1977). These efficacies include also potential losses due to cold-chain 
deficiency (Mikolon, personal communication). Vaccine-coverage scenarios were set to 50 
and 80% (same scenarios for sheep and cattle). The proportion of protection (PP) is computed 
as the product of the reduction of transmýission V(R,, I; S19) of the respective vaccine and the 
vaccination coverage C(ys; as; ycýae) (Eq. (4)). The proportion of protection of vaccinated young 
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and adult sheep and young and adult cattle were the product ot'vaccine-related reduction of 
transmission and vaccination coverage. 
pp - ci) (4) 
Three different vaccination scenarios were considered assuming PP of 32%) 0, = 65%, 
c= -50%); 52% (v = 65%, c= 80%) and 80% (v = 100%; c= 
80%), respectively. For Rev 1, 
we considered an annual loss of vaccination immunity as a random function (uniform (0.2, 
0.25); inverses of the duration of vaccination immunity of 4-5 years, WHO, 1998) and for 
S 19, an annual loss of vaccination immunity as a random function (uniform (0.125,0.142)ý 
inverses of duration of vaccination immunity of 7-8 years, AFSSA. 2001). The FAO (J. 
Otte) suggested including the testing and slaughtering of seropositive animals as a separate 
intervention. For the simulation, the current capacity of livestock RBT of the Mongolian 
veterinary laboratories was doubled to consider the proportion ý0, for cattle and ýps for sheep 
of 4017c of' animals being tested and the seropositive animals removed. 
2.7. Sensitivity anaývses 
Sensitivity analyses were done for the fitting of the model without interventions and for 
the intervention scenarios of 52%, PP. For this we used multivariate Monte Carlo sensitivity 
simulation (MVSS) in Vensim TM with 200 simulations over the range of parameters 
specified in Table I (first column on the right). Monte Carlo multivariate sensitivity works 
by sampling a set of numbers from within bounded domains. To perform one multivariate 
test, the distribution for each parameter specified is sampled, and the resulting values used 
in a simulation. All simulations then are surnmarized by calculating mean values and 95% 
confidence limits. 
3. ResulLs 
3.1. Parameter optimization without inten, entions 
The model fitted the susceptible livestock and human populations very well (in Figs. 2a 
and 3, the observed and fitted values for cattle and humans overlie). The fits to the 
seropositive sheep and cattle and annually reported human brucellosis cases are presented 
in Figs. 2b and 3. In Table 1, the fitted parameters with their 95% confidence limits are 
presented. For sheep and cattle, the unknown proportions infectious were estimated by 
variation of their boundaries in a uniform distribution. The boundaries with the best payoff 
were then used in the model. For sheep, best payoff was obtained for a proportion of 
infectious ranging between 0.2 and 0.8 and for cattle between 0.1 and 0.85. The 
simultaneously fitted sheep-human and cattle-human contact rates show a contribution of 
small ruminant-derived human brucellosis of >90% indicating a dominance of B. 
melitensis in human brucellosis. Average effective reproductive ratios for the year 1999 
indicated a slow-growing epidemic. The proportion of protection (Eq. (4)) needed to 
interrupt transmission was 0.46 for sheep and 0.66 for cattle. Long-term properties of the 
model (assuming stable sheep and cattle populations) predict a peak of seropositive 
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Fig. 2. (a and b) Fit of the model to livestock total population (a) and scropositive (b) data: filled squares, reported 
sheep population, empty squares, fitted sheep population (95% upper confidence limit, empty circles; and dashed 
line and 95% lower contidence limit, crosses with dashed line)ý filled diamonds, reported cattle population; empty 
diamonds, fitted cattle population (95% upper confidence limit, empty circles; and dashed line and 95% lower 
confidence limit, crosses with dashed line) 
animals between 2020 and 2030 in sheep and between 2030 and 2040 in cattle. In humans, 
the growth rate between 1991 and 1999 was maintained and human brucellosis would peak, 
in parallel to that in sheep between 2020 and 2030. 
3.2. Fit of vaccination inten, entions 
After fitting the transmission model to the period from 1990 to 1999 (Figs. 2 and 3), 
during which no vaccination intervention happened, we used the estimated parameters to fit 
the model to the starting period of the national livestock brucel losis- vaccination campaign 
from 2000 to 2002. For sheep and cattle, the fitted vaccination campaign follows the trends 
of the observed seroprevalences. In a simultaneous fit, the fitted coverages are 0.97 (95% CI 
0.57,1) for young sheep (cys), I (not estimated, 1) for adult sheep (c, 'j, 1 (95% CI 0.43,1) 
for young cattle (cy, ), 1 (0.45,1) and for adult cattle (cýc) (Table 2). The vaccine efficacies 
are 0.63 (0.45,0.84) for RevI O'Revj) and 1 (0.72,1) for S19 (vsl, )). The number of 
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Fig. 3. Fit of the model to human total population and human brucellosis patient data: filled squares. reported 
susceptible human populatiom empty squares, fitted susceptible human population (95% upper contidence limit, 
empty circles; and dashed line and 95% lower confidence limit, crosses with dashed line); filled diamonds, 
reported human brucellosis cases (compartment B). empty diamonds, fitted, human brucellosis cases (951/c upper 
confidence limit; empty circles and dashed line and 95c/, lower confidence limit, crosses with dashed line). 
predicted vaccinated animals overshoots in the first year the reported number and fits better 
in the consecutive years (data not shown). 
3.3. Simulation ofspecified inten, entions 
3.3.1. Vaccination 
A sensitivity analyses with and without the intervention scenario of 52% PP are 
presented in Figs. 4 and 5. In sheep, the reported seroprevalences for the years 2000-2002 
agree best with a trend between the scenarios of 52 and 80% protection (Fig. 6a). In cattle, 
the simulated vaccination scenarios follow the reported trend for the years 2000-2002 but 
at a higher level (Fig. 6b). 
3.4. Test and slaughter 
The simulation of the RBT of 40% of the sheep and the removal of the seropositives 
predicts a decrease comparable to that in the vaccination scenarios. The test-and-slaughter 
intervention appeared more effective to reduce brucellosis prevalence in cattle than the 
vaccination scenarios. However, neither the vaccination nor test-and- slaughter intervention 
scenarios in cattle lead to elimination by 10 years. 
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Fig. 4. Sensitivity analysis of the prediction of the brucellosis seroprevalence in sheep without intmention. Bold 
line: mcaný filled circles: upper 95% confidence limitl crosses: lower 95%, confidence limit. 
4. Discussion 
4.1. Model 
To our knowledge, this reported model is the first comprehensive dynamic assessment of' 
livestock-to-human brucellosis transmission fitted to a period of transmission with and 
without intervention. The model conception was adapted to the available data (only 
16 
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A"A 
v 
1999 21 x H) 21X I1 21 XQ 21 x0 2(X 14 21 M)5 2t 9 K, 21 N)7 2( N ýN 21 x 
Year 
Fig. 5. Sensitivity analysi. ý, of the prediction of the brucellosis seroprevalence in sheep with the scenario of 52% 
PP using Rev 1. Bold line: mean; filled circles: upper 95% confidence limit; crosses: lower 95% confidence limit. 
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seroprevalence data), the needs of economic assessment (Roth et al., 2003) and the 
consideration of the Mongolian hrucellosis patient registry policy to adapt the analysis to 
the needs and decision pathways of the Mongolian authorities (Habicht et al., 1999). A 
more general model, without considering Mongolian registration policy, would need to 
include the duration of untreated human brucellosis and the loss ofhurnan post-infection 
immunity. 
7 
I 16 1 
(14 
1999 210(1 2001 201)2 -(Hll 
2(H 2(K)', 2MO 2007 200S 20(r) 
(, a Year 
7 
1991) 21 x)() 2(xll 2(X)2 2(X 13 2(N" 2(W 2(W 
Year 
Fig. 6. (a-c) Effect of livestock brucellosis vaccination and test and slaughter of 40% of the sheep and cattle 
population (a and b) on human annual cumulative brucellos'is incidence (c) (filled squares, control scenario; filled 
circles, reported vaccination; empty tfiangles, 32% proportion of protectim crosses, 52% proportion of 
protection; empty circles, 80% proportion of protection, empty diamonds, 40% test and slaughter; prevalences 
and cumulative incidences are given as straight proportions). 
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The fit to the data seems satisfactory but the model captures only the large trends of the 
diseased compartments of livestock and humans (and not the smaller modulations). An 
estimation of the susceptible-sheep population for the missing years was done by linear 
backward extrapolation in analogy to the almost-linear growth trend of the cattle 
population (see Fig. 2a). A posteriori, the sheep-brucellosis component was refitted to a 
more complete data set and the contact rate ý, was 3% lower (1.519 e7 against 1.56 e-7) 
to the previous estimate based on the linear backward extrapolation of the susceptible 
sheep population. The proportions of infectious sheep and cattle might in fact range in 
more-narrow bands. BUrki and Sackmann (personal communication) estimate it between 
50 and 60%, but the presented range yielded the best fit and is in line with Parnas et al. 
(1966) who estimated the range of' shedders between 22 and 60%. That most human- 
brucellosis cases found in our model were small ruminant derived is in line with recent 
isolations of Brucella strains from human patients in Mongolia. All isolated strains (n = 8) 
were B. melitensis (Nansalmaa, personal communication). 
The estimated threshold coverage of the vaccination must be corrected for the efficacy of 
the vaccines. Ibe efficacy of Rev I is considered to be 0.95 (AFSSA) and for S 19 to be 0.7 
(NicoletLi, 1977-, WHO, 1998). This would need a corrected coverage of approximately 50% 
for sheep and 95% for cattle. The considerations on vaccine efficacy are also in line with 
observations by Denes (1997) in Mongolia. Our model shows higher numbers of vaccinated 
animals and a lower reduction of seroprevalence in livestock compared to the reported data. 
Nicoletti (personal communication, 2002) considers that the vaccine efficacy in mass 
vaccinations is actually much higherthan that obtained in vaccine trials, due to the herd effect. 
This could explain partially the strong reduction of sheep and cattle prevalence obtained by the 
reported number of vaccinated animals. The long-term predictions have to be considered with 
caution, especially due to the recent massive demographic changes in the livestock 
92 A Zinsstag et A lPreventive Velerina? y Medicine 69 (2005) 77-95 
populations. The population should recover certainly from the consecutive snow-storm 
disasters; however, a comprehensive assessment of the effective carrying capacity of 
Mongolian pasture should inform policy on a sustainable regulation of livestock density. 
4.2. Interventions 
In general, the model mechanism is able to fit and simulate plausibly the different 
interventions. But, the long time-step causes oscillations and a lag period of the effect on 
human disease. The model predicts a decrease of seroprevalence in livestock by the 
vaccination campaign. After 10 years, the intervention strategies should be reviewed to 
consider that brucellosis might remain only in certain areas. In cattle, a test-and-slaughter 
policy should be considered at the end of the mass-vaccination campaign, if compensation 
could be offered for slaughtered animals. The model can produce estimates of the numbers 
of animals for which compensation is needed. The vaccination campaign seems more 
effective to reduce prevalence in sheep than in cattle. This work confirms the control 
strategy already chosen in the 1970s WHO brucellosis-control project, which effectively 
reduced human brucellosis through livestock mass vaccination (Kolar, 1977) and 
contributes a quantitative framework of analysis. 
4.3. Limitations of the model 
We did not consider geographical differences of the disease prevalence, age dependence, 
nor could we include goats (which might play an important role in the transmission to 
humans). The model could become smoother by reducing time steps to half-year or quarter- 
year intervals. This probably also would reduce the overestimation of the vaccinated animals 
in our model. We should bear in mind that the quality of the demographic and seroprevalence 
data are unknown, but the overestimation of the vaccinated animals and the provided coverage 
figures would indicate that the actual animal numbers are smaller than reported. The model 
could be used to assess other zoonoses and food-bome diseases. Improvements of the model 
should include spatial effects and might be formulated using Bayesian Markov Chain Monte 
Carlo methodology (Marshall et al., 2003) 
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Appendix B. Differential equations for the fitting and simulation of vaccination 
dU 
-=, ', sv-7Revlw+ ct, (U+V+W) 
R 
dt (u +v+ IV) 
11 
X0- (ý'ystRevl)) - PsU - 6sU - YsOsUV - Casl)ReNl - (A. 1) 3 
dV 
Yspsuv ,,, V - psv - &V - V, V (A. 2) dt 
dW 
Cas I'Rev + Ols (U +V+ IV) I 
dt 3 (U i- v+ W) 
)( (t'ysl'Rev I)- 14 "' - 6sW - TRev IW (A. 
3) 
dX 
-= ec 
Y+ TSIgz + cy, (X +Y+ Z) (X+ Y+Z) dt 
(1 (q( »» 
x 
tic X- ScX - Y, ß, Xy- CacvS19 - (A. 4) 3 
dY 
Tt = YAXY - F, y- it, Y-3, Y- ý0, Y dt (A. 5) 
dZ 
= Cac VS 19 
ý+ 
ei, (X +Y+ Z) 
y)))) 
(Cyc lls 19) dt 3(1(, 7 
( 
(X+ Y +Z) 
- ticz - 8,: Z - TS19Z (A. 6) 
dA 
-= Ceh(A +B -4- Q 4- ý. C - ((y, o,,, Av) + (YcOchAY)) - PhA (A. 7) dt 
dB 
ý ((YsPshAV) + (YP, hAY)) - AhB - KB (A. 9) dt 
dC 
-ý KB - /thC -; ýC (A. 9) dt 
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Human health benefits from livestock vaccination for brucellosis: 
case study 
Felix Roth, ' Jakob Zinsstag, l Dontor Orkhon, I G. Chimed-Ochirl Guy Hutton, ' Ottorino Cosivi, I Guy Carrin, ' 
& Joachim Otte' 
Objective To estimate the economic benefit, cost-effectiveness, and distribution of benefit of improving human health in Mongolia 
through the control of brucellosis by mass vaccination of livestock. 
Methods Cost-effectiveness and economic benefit for human society and the agricultural sector of mass vaccination against 
brucellosis was modelled. The intervention consisted of a planned 10-year livestock mass vaccination campaign using Rev-1 
livestock vaccine for small ruminants and S19 livestock vaccine for cattle. Cost-effectiveness, expressed as cost per disability- 
adjusted life year (DALY) averted, was the primary outcome. 
Findings In a scenario of 52% reduction of brucellosis transmission between animals achieved by mass vaccination, a total of 
49 027 DALYs could be averted. Estimated intervention costs were US$ 8.3 million, and the overall benefit was US$ 26.6 million. 
This results in a net present value of US$ 18.3 million and an average benefit-cost ratio for society of 3.2 (2.27-4.37). If the costs 
of the intervention were shared between the sectors in proportion to the benefit to each, the public health sector would contribute 
11 %, which gives a cost-effectiveness of US$ 19.1 per DALY averted (95% confidence interval 5.3-486.8). If private economic gain 
because of improved human health was included, the health sector should contribute 42% to the intervention costs and the cost- 
effectiveness would decrease to US$ 71.4 per DALY averted. 
Conclusion If the costs of vaccination of livestock against brucellosis were allocated to all sectors in proportion to the benefits, 
the intervention might be profitable and cost effective for the agricultural and health sectors. 
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Introduction 
Brucellosis is one of the world's major zoonoses, alongside bo- 
vine tuberculosis and rabies (1). Brucella infection is endemic in 
humans and livestock in Mediterranean Countries (2,3). It is 
also present in Asia, sub-Saharan Africa, and Latin America (4-6. 
The importance of brucellosis is not known precisely, but it can 
have a considerable impact on human and animal health, as well 
as wide socioeconomic impacts, especially in countries in which 
rural income relies largely on livestock breeding and dairy products. 
Human brucellosis is caused by exposure to livestock and livestock 
products. The most important causative bacteria in decreasing 
order are: Brucella melitenjis (small ruminants), B. aborms (cattle), 
B. suis (pigs), and B. canis (dogs). Infection can result from direct 
contact with infected animals and can be transmitted to consumers 
through raw milk and milk products. Human-to-human trans- 
mission of the infection does not occur (7). 
In humans, the symptoms of disease are extreme weakness, 
joint and muscle pain, headache, undulant fever, hepatomegaly, 
splenomegaly, and night sweats (8). Mortality is reported to be 
negligible, but the illness can last for several years. In animals, 
brucellosis mainly affects reproduction and fertilityý reduces sur- 
vival of newborns, and reduces milk yield. Mortality of adult 
animals is insignificant (9). 
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Control strategies available to prevent human infection 
are pasteurization of milk, livestock vaccination, and elimina- 
tion of infected animals. In Mongolia, livestock rearing and milk 
production are important branches of the economy, employing 
approximately 50% of the population. In the 1970s, mass vac- 
cination of livestock successfully reduced the annual incidence 
in humans to less than one case per 10 000 a Kolar, personal 
communication, 1999, J Kolar, personal communication, 2000). 
After democratic reform, and the shift away from dependence 
on the former Soviet Union in 1990, human brucellosis re- 
emerged as a major, but preventable, source of illness. A large 
survey conducted during 1990-95 among herdsmen and other 
people who work with animals showed that 16% of the examined 
population were infected (10). Transmission mainly seems to be 
an occupational hazard. In contrast, in Saudi Arabia, where con- 
sumption of raw milk is important, 30% of the people reported 
as having brucellosis were aged < 15 years (8). 
The Mongolian authorities suspect that the high inci- 
dence of brucellosis causes significant economic losses. On the 
basis of recommendations made to WHO U 1), a whole-herd 
vaccination strategy covering 10 years was developed to start in 
2000 (12). Very little is known about the economic implica- 
tions of brucellosis and brucellosis control for human health in 
any country (13). The particular zoonotic nature of brucellosis 
needs a multisectoral assessment, including human health, the 
socioeconomic situation of the concerned population groups, 
and livestock production. 
The main objective of this study was to estimate the cost- 
effectiveness to human health and the potential net economic 
benefits of a nationwide mass vaccination programme for live- 
stock over a period of 10 years. In order to present cost-effective- 
ness and cost-benefit ratios from different perspectives (health 
sector, agricultural sector, households, and society), a tool was 
developed that attributed costs and benefits to these different 
perspectives. 
Material and methods 
Selection of alternatives 
From 1990, Mongolia has practised low-level surveillance, with 
occasional testing of livestock herds, followed by voluntary 
slaughter of infected animals. No state compensation is given 
for slaughtered animals. 
Our analysis of the potential benefit of livestock vaccination 
is based on the vaccination scheme proposed in the Mongolian 
budget in 2000 for whole-herd vaccination (Appendix A, web 
version only, available at: http: //www. who. int/bulletin) within 
the first six years, this scheme aims to vaccinate all adult animals 
twice (one-third of the total adult population per year). All 
animals born during the 10 years of the plan will be vaccinated 
once (at age <I year). For the selection of vaccination scenarios, 
we assumed the reported efficacy for reduction of transmission 
as the prevented fraction (I - R), where R is the relative risk of 
disease in those who receive the intervention compared to those 
who do not (14), and that the vaccines to be used in cattle 
(strain B19, Brucella abortus) and small ruminants (Rev-1, B. 
melitensis) should reduce transmission by at least 65% (15). In 
addition, a hypothetical efficacy of vaccine of 100% was also 
tested. Vaccine coverages were assumed to be 50% and 80%, 
respectively, to allow for frequent problems with cold chains. 
These assumptions produced three alternative vaccination 
scenarios, with percentages for protection from transmission of 
32% (65% efficacy x 50% coverage), 52% (65% efficacy x 80% 
coverage), and 80% 0 00% efficacy x 80% coverage). We as- 
surned that different vaccination coverages would not affect the 
budget for the intervention because the costs of personnel, trans- 
port, and vaccine costs would remain very much the same irre- 
spective of whether the farmers and their animals were present 
or absent when the mobile teams visited. 
Form of evaluation 
We performed an incremental cost-effectiveness analysis to 
compare the cost and health effects of the vaccination programme 
for the human population with the cost and health effects of cur- 
rent practice. The burden of brucellosis on the human population 
was estimated for different age groups and sexes from data on 
morbidity and mortality and on the duration of the disease (case- 
fatality and remission rates). The benefit-cost analysis focused on 
the net monetary gain associated with different vaccination strat- 
egies (current practice vs 32%, 52%, and 80% protection from 
transmission) for brucellosis prevention and control. The net 
present value is used as a key evaluation criterion. 
Data collection 
We developed a conceptual framework to consider human health 
and livelihood, and animal production and health perspectives. 
Baseline disease data on reported cumulative incidence of hu- 
man brucellosis listed by Aimag province for 1990-99 were 
provided by the Infectious Disease Research Institute in 
Ulaanbaatar, Mongolia. The Ministry of Agriculture Survey 
provided data on prevalence of animal brucellosis at the 
provincial level for cattle, sheep, and goats for 1990-99. The 
quality of data could not be checked, but ongoing studies on 
brucellosis in livestock indicate that reported prevalence is under- 
estimated. Our analysis thus is rather conservative. 
A household survey was undertaken of 240 patients clini- 
cally diagnosed with brucellosis who attended public health 
facilities between May and August 2000. To complete and com- 
pare the data, a Delphi study was organized with two panels: 
one consisted of 17 specialists in human brucellosis, the other of 
16 national experts on animal brucellosis. 
Benefit measurement and valuation 
Disability-adjusted life year (DALY) is used as a measure of health 
outcome. An estimate of the burden of disease for brucellosis is 
not readily available (16), so we therefore estimated the DALYs 
lost as a result of the disease by assuming that brucellosis is 
associated with a class 11 (0.2) disability weight, as the disease is 
perceived as very painful and affects occupational ability even 
during periods of remission (17,18). Average age at onset was 
calculated for every age group. For the duration of illness, we 
considered data by Beklemischew on the duration of clinical cure 
of 1000 patients with brucellosis in the Russian Federation (19). 
The frequency distribution of clinical disease duration fits best 
with an exponential function for an average duration of 4.5 
years. For duration of disease, we used @Risk expon function, 
with P=4.5 years. For cost effectiveness, we used the median of 
the cumulated discounted DALYs, which corresponds to a me- 
dian duration of brucellosis of 3.11 years. 
The economic evaluation included the impact on human 
health costs and income loss, coping costs, and impact on live- 
stock production. Benefits in monetary terms were computed 
for three different sectors. For the agricultural sector, we consid- 
ered the benefit of avoidance of losses in animals and animal 
products; for the public health sector, we considered the benefit 
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of avoiding costs and for private households with patients 
suffering from brucellosis, we considered the benefit resulting 
from avoidance of out-of-pocket payments for treatment, loss of 
income (opportunity costs), and costs of coping. 
The sum of all three mentioned benefits was considered a 
benefit for society as a whole and represents a monetary valua- 
tion of the health beriefit. The method avoided double counting of 
common costs between the public health sector and payments 
for treatments made by patients. For every sector, the net present 
value and benefit-cost ratio were computed. The Mongolian 
NI inistry of Agriculture, which started implementation of the 
vaccination campaign in 2000, established a budget calculation 
for the whole I 0-year campaign of about 11334 million Mongo- 
lian Tugrik (MNT) (equivalent to about US$ 10.5 million on 
the basis of an exchange rate of MNT 1080 = US$ I in October 
2000) (Appendix A). 
Costing 
A societal perspective was used to conduct the costing part of 
the analysis (20). The costing is based on the budget of the 
Mongolian Ministry of Agriculture for the I 0-year vaccination 
campaign against brucellosis (Appendix A). This budget con- 
siders the number of animals to be vaccinated; cost of vaccines 
(B, melitensis Rev- I and B. aborrus S 19); service costs of vaccina- 
tion (transportation, cold chain, and veterinary fees); costs re- 
lated to ear tagging; service costs for surveillance and diagnostic 
tests; and costs of health education, training, and advocacy for 
herders. The overhead costs of national and local government 
authorities that administered the programme were not consid- 
ered in the calculations, as the marginal cost for adding this 
brucellosis control programme were expected to be negligible. 
As all breeders' activities are shared within the family, marginal 
product lost because of their involvement in the campaign was 
very low to zero: we assumed that the time a farmer spent on the 
campaign did not make him lose money from an activity he 
could have pursued instead. Consequently, the opportunity 
cost of breeders' time was given a value of zero (21). 
Quantities and unit costs for animals and animal prod- 
ucts were obtained from the household survey, Delphi panels, 
and business publications (22). Livestock production was 
calculated from herd structures and productivity parameters 
with the Livestock develop mentplanningsystem (LDPS2) (23,24). 
Quantities and unit costs for the human health sector and oppor- 
tunity costs of human brucellosis infection were generated by 
the Delphi panel, patient-based household survey, and Mon- 
golian Ministry of Health. All model calculations were in MNT, 
with prices from the year 2000 (MNT 1080 = US$ 1). 
Sharing costs among sectors 
As the vaccination campaign improves human health through 
interventions in the veterinary sector, the allocation of costs of 
the intervention among different sectors had to be decided. 
Although the benefit side can be assigned easily to the breeders 
(benefits from livestock production), patients (reduced out-of- 
pocket expense and coping costs), and public health sector (avoid- 
ance of hospitalization and drugs), the costs cannot be assigned 
wholly to the agricultural sector or to the health sector. 
In order to attribute the cost to the different sectors, we 
applied basic elements of the technique for joint cost allocation 
in multipurpose projects, known as the "separable costs-remaining 
benefits" method (25). In the vaccination campaign against bru- 
cellosis, all expenditure was associated with animal health, while 
human health benefit was produced without separable costs. 
We therefore used an adaptation of the method, in which we 
regarded all costs as joint costs and allocated the costs proportion- 
ally to the benefit. Out of this allocation, the cost-effectiveness 
of the intervention for human hea-Ith could be derived, as could 
measures for economic benefit. 
Modelling 
To assess the reduction of the effects of brucellosis in humans 
and animals by its control through vaccination in livestock, we 
modified and extended the susceptible-infected-recovered 
models of brucellosis transmission used by Gonzalez-Guzinan 
& Naulin (26) to include animal-to-human transmission (Fig. 
I ). Poisson regression analyses of existing data on the provincial 
level showed a significant ecological relation between 
seroprevalence of brucellosis in cattle and sheep and cumulative 
incidence of reported human cases. The coefficients from such 
analyses were used as initial parameter estimates for the Fitting of 
deterministic equations (Vensim; Ventana Systems Inc., Harvard, 
Massachusetts, USA). The model was validated with human 
and livestock demographic and disease data from 1991 to 1999 
(before the start of the vaccination campaign by steps of one 
year). The validation of the vaccination intervention used data 
from the first three years of the ongoing brucellosis mass vacci- 
nation campaign in Mongolia (2000-02). The detailed model 
will be published elsewhere. 
Fig. I shows the model framework, which is composed of 
compartments for susceptible sheep and cattle (scrologically nega- 
tive by the Rose Bengal test). We omitted transmission from 
goats because of the lack of data, but the productivity of goats 
was considered in the economic analysis by using disease data 
from sheep. Susceptible sheep and cattle become infected and 
move to the compartments of seropositive sheep and cattle (Rose 
Bengal test). We did not consider a compartment of "recovered", 
because data on seroprevalence were available for validation of 
the model only. The compartment of seropositivc animals is 
composed of an unknown proportion of infected animals ca- 
pable of infecting other animals and humans. The transmission 
(infected sheep and cattle in Fig. 1) is shown in the example of 
cattle in equation (1), in which Yis the proportion of infectious 
animals, expressed as a uniform probability distribution, P is the 
contact rate, Xare susceptible cattle, and Yare seropositive cattle. 
yoxy (1) 
Seropositive animals may convert to seronegative animals (loss 
of immunity). For the fitting of between-animal transmission, 
the boundaries of the proportion of infective animals were varied 
to identify the best fit. Transmission to humans is expressed as 
the additive contributions of transmission from sheep and cattle 
to humans (sheep-to-human transmission and cattle-to-human 
transmission in Fig. 1) in equation (2), in which A is the suscep- 
tible human population. 
XA) + (y, , ý,, p 
ph,, 
p 
UA) 
Compartment A represents the whole Mongolian population, 
as precise estimates of the population at risk are not available. 
Compartment B represents the annual number of patients newly 
registered as having brucellosis. The economic analysis was based 
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Fig. 1. Model for joint human-animal brucellosis transmission in Mongolia (for an explanation of symbols, see text) 
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on this compartment and accounted for the whole treatment cost, 
including treatment of chronic cases in the same year. The an- 
nual rate of outflow (registry in Fig. 1) of compartment B=I by 
definition. Compartment C represents the patients registered as 
having brucellosis between year 2 and 3 of state registration 
(end of registry = 0.5 by definition), after which they are no 
longer considered as registered brucellosis patients. The model 
takes Mongolian health policy into account, as it is important to 
adapt assessments to local health policy decision pathways (217). 
The estimation of DALYs is also made on compartment B, but by 
using the duration of untreated brucellosis. The different 
vaccination scenarios were expressed as the proportions (32%, 
52%, and 80%) of vaccinated young and adult sheep and cattle 
protected from transmission. 
Estimates of the transmission parameters obtained by fit- 
ting this model were used to simulate various scenarios for 10 
years with and without interventions (Appendix B, web version 
only, available at: http//www. who. int/builetin). Outcomes of 
the simulations were prevalence in animals and annual cumula- 
tive incidence in humans. As inputs into the economic assess- 
ment, these were expressed as normal probability functions, 
with means and standard deviations provided from Monte Carlo 
sensitivity analysis on the fitted parameters in Vensim, and were 
linked to human health and livestock productivity (Appendix C, 
web version only, available at: http: //www. who. int/builetin). 
Links to prevalence of animal disease were expressed as prob- 
ability distributions for the decrease in fertility (annual calving 
or kidding rates) and milk production (Appendix C, ref. 13). 
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Human health parameters, such as duration of treatment 
and hospital and outpatient treatment, were derived front the 
household survey. Human age and sex distributions were ob- 
tained from the cases reported in 1999 (Appendix D, web version 
only, available at http: //www. who. int/builetin). 
Human health parameters and livestock productivity pa- 
rameters linked to outcomes of the transmission model and hu- 
man and livestock demographic population structures (28) were 
then introduced into a new human and animal health eco- 
nomic model (ECOZOO) developed for this study (Appendices 
D-G, web version only, available at: http: //www. who. int/bul- 
IcLin) (29). ECOZOO is composed of a spreadsheet backbone 
in Microsoft Excel, which is linked to @Risk stochastic simulation 
capability and LDPS2. ECOZOO simultaneously computes 
human and animal effectiveness and economic assessments of 
health interventions. 
Fig. 2. Effect of livestock brucellosis vaccination on humans. 
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Adjustment for timing of costs and benefit 
Our economic evaluation was based on the 10-yearperiodof 
the vaccination programme planned for 2000-09 (base year 
1999) by the Mongolian authorities. Limitation of the period 
of analysis was arbitrary and biased the estimated net benefit of 
the vaccination campaign downwards. The transmission model 
therefore was also run for 30 years to estimate time to eradica- 
tion ofthe disease, on the assumption that vaccination of young 
animals would continue in the same way. For consistency rea- 
sons, the monetary benefits, costs, and health benefits were dis- 
counted at the same rate. A discount rate of 5% was used (30), 
with a rate of 3% used in the sensitivity analysis. 
Allowance for uncertainty 
The uncertainty of disease frequency outputs of the determin- 
istic models, health care unit costs, health care units, livestock 
numbers, livestock product prices, and livestock production pa- 
rameters was expressed as probability distribution functions using 
@Risk. Distributions of the societal benefit--cost ratios were then 
calculated for the different sectors with a latin hypcrcube sam- 
pling type, with 500 iterations on 180 different variables specified 
as @Risk functions, The relative contribution of the different 
variables was explored in an automatic sensitivity analysis in 
@Risk. Sensitivities were expressed as dimensionless, normalized 
regression coefficients (R-square). Manual sensitivity analyses were 
done at the level of the economic model by varying selected 
input parameters (scenarios of 32%, 52%, and 80% protection 
and 3% and 5% discount rates). 
Results 
Incremental analysis to compare relevant 
alternatives 
The protection achieved depends on the efficacy of the available 
vaccines and the vaccine coverage, We assumed that different vacci- 
nation coverages do not affect the budget for the intervention 
for comparisons of annual cumulative incidence of brucellosis 
in humans between different protection scenarios. When the 
scenario of 32% protection from transmission was considered, 
the incidence dropped from six cases per 10 000 at the begin- 
ning ofthe programme to five cases at the end of the programme, 
whereas with the scenario of 52% protection from transmission 
it dropped to one case per 10 000 with the same costs involved 
(Fig. 2). The scenario of 52% protection considered the ob- 
served efflcacy of S 19 (1-5) and Rev- I vaccines and a feasible 
level of coverage (Mikolon A, personal communication, 2000). 
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Major outcomes 
Table I presents the major economic outcomes by scenario. 
When the scenario of 52% protection and 5% discount rate was 
considered, axi average number of 61070 (median 49 027) DALYs 
could be averted through use of the intervention. The same sce- 
nario showed discounted intervention costs of NINT 8957 
million (about US$ 8.3 million) and an overall discounted benefit 
of NINT 28 753 million (about US$ 26.6 million). This results in 
a net profit value of NINT 19 796 million (about US$ 18.3 mil- 
lion) and a benefit-cost ratio for society of 3.2 (range 2.27-4.37). 
Cost-sharing scenario 
We developed a cost-sharing scenario to take into consideration 
the multisectoral effects of the intervention (Table 2). This de- 
rived a realistic ratio for cost-effectiveness and profitability of the 
intervention, If costs of the intervention were shared in proportion 
to the benefit of each sector, the public health sector would con- 
tribute I I% to the intervention costs, giving a cost-effectiveness 
of US$ 19.1 (95% confidence interval 5.3-486-8) per DALY 
averted (Table 3). If private economic gain because of improved 
human health was included, the health sector would contribute 
42% to the intervention costs and the cost-effectiveness would 
decrease to US$ 71.4 (19.7-1824.1) per DALY averted. 
Sensitivity analysis of benefit-cost ratio and 
DALYs 
A sensitivity analysis of the benefit--cost ratio was done by Monte 
Carlo simulation in @Risk, with 180 variables expressed as prob- 
ability distributions 0 1). The most sensitive parameters were 
hospital cost (sensitivity 0.69), transport cost (0.36), meat price 
(0.25), human cumulative incidence (0.2), cashmere price 
(0.19), unit doctor's fee (0.14), and unit cost of hospital food 
(0.13). All other variables had sensitivities <0.1. The DALY 
estimate was highly sensitive to the duration of disease (sensitiv- 
ity = 0.96) and disease incidence (0.15). 
Discussion 
At present, the health sector has to bear the cost of human 
brucellosis at a level of nearly 60 cases per 100 000 per year 
because of the lack of an effective control programme in the 
livestock sector. As human brucellosis originates essentially from 
livestock and livestock products, the health sector is expected to 
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profit if brucellosis in livestock is controlled. Although it would 
not be cost effective for the health sector to cover the full cost of 
the programme, it could be asked to contribute a share (such as the 
share suggested by our cost allocation model) that would make 
the programme cost effective from the health sector perspective. 
Table 2 shows that with the cost-sharing scenario, the 
intervention could be profitable for the health and agricultural 
sectors. The Ministry of Agriculture could meet its share of the 
project costs, possibly with donor support. As livestock breeders 
are likely to be the most favoured beneficiaries of the vaccination 
campaign (economically), they might be willing to contribute 
to the campaign, and clearly there is some interest from the 
public sector in attaining a higher degree of cost recovery from 
this group. 
The patients are the second group of beneficiaries. As pa- 
tients would have contracted brucellosis if there had been no 
intervention, they avoid out-of-pocket expenses and income 
loss. As there is no way of identifying people who might have 
avoided infection, no mechanism would allow their contribution 
to the intervention costs to be obtained. As shown inTable 2, 
however, the campaign would still be profitable to the public 
health sector, if less than 85.6% (3240/3782) of the costs are 
attributed to this sector. The case for attribution of private costs 
that result from disease to the public health sector can be strength- 
ened through the argument of poverty reduction. When a patient 
is ill from brucellosis, this has a strong impact on the household 
economy in terms of out-of-pocket contributions to health costs 
and change in income. Brucellosis mass vaccination for livestock 
may thus contribute towards alleviating poverty in households. 
Health expenditure for Mongolia in 1998 amounted to 
US$ 33.2 million, and international clonorsupport to the Mon- 
golian health sector was US$ 4 million 0 2%) (32). Given this 
background, the intervention costs for the vaccination 
programme (US$ 10.5 million over 10 years) are very significant. 
With the cost-sharing scenario, the multisectoral character of i nter- 
vcruions to control zoonotic diseases is taken into consideration. 
When we computed the cost-effectiveness ratio frorn the Min- 
istry of Health's point of view, US$ 19.1 per DALY would be 
averted, which falls into WHO's range of highly cost-effective 
programmes (<US$ 25 per DALY averted) (33). When we in- 
cluded the incremental costs of patients in the total incremental 
costs, US$ 71.4 per DALY would be averted, which is still in 
the next band of cost effective (<US$ 150 per DALY averted). 
In our context, the cost-effectiveness result of US$ 19.1-71.4 
(costs allocated to patients plus public health sector costs) per 
avoided DALY represents 5.7-21.5% of the gross domestic 
product per capita (US$ 333 in 1999 (34)) and therefore also 
can be rated as attractive from this point of view. 
Our assessment is based on a disability weight of 0.2. 
More research is needed to establish the disability weight of 
human brucellosis. The median duration of disease (3.11 years) 
we used (on the basis of on data from Beklemischew (20)) tallies 
Table 1. Summary results of a1 0-year brucellosis vaccination campaign in Mongolia 
Variable 
80% 
Discounted rate 
Protection 
52% 
Discounted rate 
32% 
Discounted rate 
3% 5% 3% 5% 3% 5% 
Scenario 
Vaccine efficacy (%) 100 6S 65 
Vaccine coverage (%) 80 80 so 
Protected animals (%) 80 52 32.5 
Health benefits 
Discounted cumulated median DALYsa 
Disability class weight I Not done Not done Not done 24 530 Not done Not done 
Disability class weight 11 63 217 52 618 58 675 49 027 52 618 42 394 
Intervention costs (MNT million)'., 9 806.2 8 957.3 9 806.2 8 957.3 9 806,2 8 9S7.3 
Benefits in monetary terms (MNT million) 
A Agriculture sector' 21 702. S 18 850.0 19 133.8 16 611.6 13 630.5 11 816.8 
B Public health system, 4 062.7 3 513.1 3 760.9 3 240.3 3 237.7 2 779.9 
C Out of pocket contributed for health care' 6 718.6 5 809.8 6 219.6 5 358.7 5 354.3 4 597.3 
D Private incomeg 4 441.8 3 841.0 4 111.9 3 542.8 3 539.8 3 039A 
B+C1 10 781.3 9 322.9 22 894.7 8 599.0 8 592.0 7 377.2 
A+C+D' 32 862.9 28 500.8 29 465.3 25 513.1 22 524.6 19 463.5 
A+B+C+Dj 36 925.6 32 013.9 33 226.2 28 753.4 25 762.3 22 233.4 
DALY = disability-adjusted life year. 
Budget of Ministry of Agriculture. 
MNT = Mongolian Tugrik. 
Discounted net incremental profit to the breeder, 
Discounted reduction of costs in public health sector. 
Discounted reduction of heath costs to patient. 
Discounted reduction of income loss to patient. 
Discounted total benefit to overall health sector. 
Discounted total benefit to private society. 
Discounted total benefit to society. 
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Table 2. Scenario for allocation of intervention cost and benefit over the sectors with 52% animals protected and 5% discount rate 
Sector Allocation of intervention Net present valueb Benefit-cost 
(million MNT)a (million MNT) ratio' 
Costs Benefits 
Agriculture 
Breeders 5 174.9 16 611.6 11 436.7 3.2 
Public 00 0 
Total 5174.9 16611.6 11436.7 3.2 
Human health 
Public health 
Ministry of Health, central government 1 009.4 
Health insurance scheme, health insurance fund 0 
Patients 
Out of pocket contribution to health costs 1 669.3 
Change in household income 1 103.7 
Total 3782.4 
Total private sector 7 947.9 
Total society 8 957.3 
3 240.3 2 230.9 3.2 
00 
5 358.7 3 689.4 3.2 
3 542.8 2 439.1 3.2 
12141.8 8359.4 3.2 
25 513.1 17 565.2 3.2 
28 753.4 19 796.1 3.2 
M1= MNT 1080 (October 2000). 
Benefits minus costs. 
Benefits over costs (range 2,27-4.37) 
Table 3. Cost effectiveness for human health in scenario with 52% animals protected and 5% discount rate 
Discounted intervention cost per DALY saved Median, 
Disability class 11 Disability class I 
Public health sector perspective 
MNT 20 589 (5676-525 729) 41 150 (10 925-1 157 569) 
usP 19.1 (5.3-486.8) 38.1 (10.1-1071.8) 
% of gross domestic product/capitac 5.7 (1.6-146.2) 11.4 (3-321.9) 
Societal perspective' 
MINIT 77 149 (21267-1 970 000) 154 195 (40 938-4 337 615) 
us$ 71.4 (19.7-1824.1) 142.8 (37.9-4016.3) 
% of gross domestic product /capita 21.5 (5.9-547.9) 42.9 (11.4-1206.3) 
Lower confidence limit 2.5% quantile and upper confidence limit 97.5% quantile. 
US$ Iý 1080 MNT (October 2000). 
Gross domestic product/capita = MNT 359 583 (23). 
For public health sector avoided out-of-pocket health costs and change in household income 
with the Mongolian policy to register brucellosis cases over a 
period of three years. The efficacies ofthe livestock vaccines in 
the field are probably higher than the efficacies used (herd 
effect) (P Nicaletti, personal communication, 2002). 'I'his would 
make the scenario of 80% protection (benefit-cost ratio 3.57) 
very likely. 
Further benefits might well result. Farmers and their families 
should be informed about risky behaviour during the lambing 
season and the minimal hygiene requirements. Control of bru- 
cellosis could have far-reaching effects for the Mongolian 
economy by opening up new international trade opportunities 
for livestock. The true value of agricultural production might be 
higher than that calculated if higher value markets were opened 
up as a result of brucellosis control. On the other hand, the 
market prices in 2000 used in the current analysis may overstate 
the value of increased production, as increased supply might 
not be countered by increased demand and thus would lead to 
decreased prices. This could, however, lead to consumer welfare 
effects, as consumers could either purchase more livestock prod- 
ucts for the same level of expenditure or consume the same 
amount of livestock products but spend less of their disposable 
income. Overstocking, which could result in permanent deg- 
radation of the carrying capacity of the land, could lead to a situa- 
tion in which the incremental agriculture production is less than 
predicted. It is impossible, however, to predict the future size of 
herds - for example, recent snow disasters and droughts in 
2000 and 2001 caused an estimated loss of 7 million animals 
(and a loss of US$ 250 million (35)), and, in the affected areas, 
restocking is needed. Brucellosis mass vaccination for livestock 
thus also may contribute to poverty alleviation for breeders, 
Conclusion 
Mass vaccination of livestock against brucellosis in Mongolia 
would be cost effective and would result in net economic benefit 
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if interventions costs were shared between the different benefi- 
ciaries on the basis of an intersectoral economic assessment. The 
presented trans-sectoral analysis is applicable to other zoonoscs 
and environmental threats to public health and contributes to 
the perception that interventions in the livestock sector can 
control disease transmission to humans (3 n). M 
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116SUM6 
Avantages pour I'hornme de la vaccination du cheptel contre la brucellose : 6tude de cas 
Objectif Estimer l'int6r6t 6conornique et le rapport co6t/eff icacit6 net s'6tablit donc ý US $18,3 millions, avec un rapport moyen 
- r6partition comprise des avantages 6conomiques - des progrýs co6tiavantages pour [a socik6 de 3,2 (2,27-4,37). Si l'on 
sanitaires obtenus en Mongolie en prockant ý la vaccination de r6partissait les coOts de cette intervention entre les secteurs en 
masse du cheptel contre la brucellose. fonction des b6n6fices qu'ils en retirent, la saW publique devrait 
Wthodes Le rapport co6t/efficacit6 et 'intkýt 6conomique de contribuer ý hauteur de 11 % et obtiendrait un rapport co6t/ 
la vaccination de masse contre la brucellose pour la soci6t6 efficacit6 de US $19,1 par DALY 6vit6e (intervalle de confiance 
humaine et le secteur agricole ont W mod6lis6s. Cintervention 95 %: 5,3-486,8). En revanche, si l'on inclut dans le calcul les 
a consist6 6 planifier sur 10 ans la vaccination de masse du b6n6fices priv6s dus ý I'am6lioration de la sant6 humaine, le 
cheptel par ]a souche Rev-1 pour les petits ruminants et S19 secteur de la sant6 devrait alors contribuer 6 hauteur de 42 % 
pour les bovins. Le principal r6sultat obtenu aW le rapport des co6ts de l'intervention, ce qui ram6ne le rapport co6t/ 
coat/efficacit6, soit le co6t par ann6es de vie ajust6es sur efficacit6 ý US $74,1 par DALY 6vit6e. 
l'incapacit6 (DALY) 6vit6es. Conclusion Si l'on r6partit les co6ts de la vaccination du cheptel 
R6sultats Dans I'hypoth6se d'une diminution de 52 % de la contre la brucellose en fonction des b6n6fices que retire chaque 
transmission de la brucellose chez I'animal grAce 6 la vaccination, secteur de cette intervention, celle-ci pourrait s'av6rer profitable 
on peut 6viter 49 027 DALY. On estime le coGt de cette intervention et rentable pour la sant6 et I'agriculture. 
a US $8,3 millions et le gain brut a US $26,6 millions. Le b6n6fice 
Resumen 
Beneficios para la salud humana de la vacunaciön 
Objetivo Estimar ei beneficio econämico, la relaciön costo- 
eficacia y la distribuciön de los beneficios para la saiud humana 
reportados por la vacunaciön masiva del ganado contra la 
brucelosis en Mongolia. 
Mitodos Se modelizaron la reiaciön costo-eficacia y el beneficio 
econörnico para la sociedad y ei sector agricola de la vacunaciön 
masiva contra la brucelosis. La intervenciön consistiö en una 
campaha de 10 ahos de vacunaci6n masiva del ganado, basada 
en la administraciön de la vacuna Rev-1 para pequehos rumiantes 
y la vacuna S19 para ei ganado bovino. Como variable de 
del ganado contra la brucelosis- estudio de casos 
evaluaciön se utilizö la relaciön costo-eficacia, expresada como 
costo por aft de vida ajustado en funciön de la discapacidad 
(AVAD) evitado. 
Resultados En un escenario de reducci6n del 52% de la 
transmisiön de brucelosis entre los animales, gracias a la 
vacunaciön masiva, se pudo evitar un total de 49 027 AVAD. Ei 
costo estimado de la intervenciön ascendiö a US$ 8,3 millones, y 
el beneficio global a US$ 26,6 millones. Ello se traduce en un 
valor rieto de US$ 18,3 millones y una relaciön beneficio-costo 
media para la sociedad de 3,2 (2,27-4,37). Si los distintos sectores 
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compartieran los costos de la intervenciön en proporciön al 
beneficio de cada uno, el sector de sAcl püblica contribuirýa con 
un 11 %, lo que arroja una reiaciön costo-eficacia de US$ 19,1 
por AVAD evitado (intervalo de confianza del 95%: 5,3-486,8). 
Incluyendo el beneficio econömico privado resultante de la mejora 
de la salud humana, el sector de la salud deberia contribuir con 
el 42% a los costos de intervenciön, y la reýaciön costo-eficacia 
aumentaria a US$ 71,4 porAVAD evitado. 
Conciusiön Si ýos costos de la vacunaciön del ganado contra la 
brucelosis se asignaran a todos los sectores proporcionalmente 
a los beneficios, la intervenciön podria ser rentable y costoeficaz 
para los sectores agricoia y sanitario. 
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Appendix A. Budget and vaccination scheme of the Mongolian Ministry of Agriculture for a whole-herd vaccination programme 
of brucellosis in cattle and small ruminants in Mongolia, (MNT millionSb) 
Intervention cost per year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Testing 8736 
Vaccination of adult sheep 
and goats, 382.84 266.05 244ý 14 
Second vaccination of 
adult sheep and goats' 382.84 266.05 244.14 
Vaccination of cows, 119.85 72.75 48.60 
Second vaccination of cows' 119.85 72.75 48.60 
Vaccination of bulls 7.09 7.09 7.09 7,09 7.09 7.09 7.09 7.09 7.09 7.09 
Vaccination of newborn 
sheep and goats, 428.70 428.70 428.70 428.70 428.70 428.70 428,70 428.70 428,70 428.70 
Vaccination of newborn 
calves, 129.43 129.43 129.43 129.43 129.43 129.43 129.43 129.43 129.43 129.43 
Cost of testing 8.52 6.68 8.41 
Eartags 325.28 325.28 325.28 325.28 325.28 325.28 325.28 325.28 325.28 325.28 
Training 50.00 
Annual intervention costs 1 480.74 1 279.29 1 183.23 1 393.18 1 229.29 1 183.23 899.02 897.17 898.90 890.49 
Cumulative intervention 
costs 10 years 11 334.54 
Discounted cumulative 
annual intervention costs 
at end of year 
5% 1 410.23 2 570.58 3 592.70 4 738.87 5 702.05 6 S85.00 7 223.91 7 831.15 8 410.59 8 957.28 
3% 1 437.61 2 643.46 3 726.29 4 964.11 6 024.50 7 015.44 7 746.42 8 454.66 9 143.59 9 806.20 
Budget assumes stable livestock population and considers number of animals to be vaccinated; cost of vaccines (B. melitensis (Rev-1) and B. abortus 
(S19)); service costs of vaccination (transportation, cold chain, and veterinary fees); costs related to ear tagging; service costs for surveillance and 
diagnostic tests; and costs of health education, training, and advocacy for herders. 
Reference for cost is year 2000. 
Adult animals (first vaccination). 
Adult animals (second vaccination), 
Young animals (less than one year old). 
Sheep 
Susceptible (U) 15 069 770 
Seropositive (V) 121 530 
Cattle 
Susceptible (X) 3 776 780 
Seropositive (Y) 48 018 
Humans 
Susceptible (A) 2446400 
Newly reported cases annually (8) 1482 
Registered cases between years 2 and 3 of registration (C) 2066 
Parameter estimates 
Proportion of infectious seropositive cattle (V) (y, ) Random uniform (0.2,0.7) 
Immunity loss constant sheep (E, ) 0 
Sheep-human contact rate 1.1 2738e-008 
Mortality rate of sheep (g) 0.79, 
Birth rate of sheep ((x, ) 0.83 
Sheep contact rate (D) I. S6082e-007 
Decrease of fertility (TI) Random uniform (0.15,0.5) (CI) 
Proportion of infectious seropositive cattle (Y) (y, ) Random uniform (0.1,0.7) 
End of regis" constant (k) 0.5 (Def b) 
Registry change (ic) I (Def) 
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Appendix B. Compartments, filted parameters, and differential equations in 1999 to 2009 by one-year steps 
Variable Value 
Compartments size in 1999 
Sheep 
Susceptible (U) 15 069 770 
Seropositive (V) 121 530 
Cattle 
Susceptible (X) 3 776 780 
Seropositive (Y) 48 018 
Humans 
Susceptible (A) 2446400 
Newly reported cases annually (B) 1482 
Registered cases between years 2 and 3 of registration (C) 2066 
Parameter estimates 
Proportion of infectious seropositive cattle (V) (y) Random uniform (0.2,0.7) 
Immunity loss constant sheep (E) 0 
Sheep-human contact rate (51h) 1.1 2738e-008 
Mortality rate of sheep (g) 0.791 
Birth rate of sheep ((x, ) 0.83 
Sheep contact rate (P) 1.56082e-007 
Decrease of fertility (ij) Random uniform (0.15,0.5) (CI) 
Proportion of infectious seropositive cattle (Y) (y) Random uniform (0.1,0.7) 
End of registry constant (k) 0.5 (Def 1) 
Registry change (K) I(DO 
Cattle animal contact rate (0) 3.49736e-007 
Cattle animal human contact rate 2.1 1247e-009 
Cattle birth rate (cx) 0.28 
Human birth rate ((x, ) 0,018159 
Human mortality rate (lo. ) 0.00333868 
Cattle immunity loss constant (c) 0 
Cattle mortality rate (g. ) 0.23c 
Vaccine efficacy of Rev I (v ) 0.651 ,,,., Vaccine efficacy of S1 9 (v ) 0.651 519 
Inverse duration vaccination protection S 19 (, r ) Random uniform (0.125,0.142) s1q Inverse duration vaccination protection Rev-1 Random uniform (0.2,0.25) 
Vaccination coverage (adult) sheep (c. ) 
No vaccination 0 
Scenario 50651 0.5 
Scenario 80659 0.8 
Scenario 80100, 0.8 
Proportion of young sheep vaccinated (c ) , No vaccination 0 
Scenario 5065 0.5 
Scenario 8065 0.8 
Scenario 80 100 0.8 
Vaccination coverage (adult) cattle (c. ) 
No vaccination 0 
Scenario 5065 0.5 
Scenario 8065 0.8 
Scenario 80100 0.8 
Proportion of young cattle vaccinated (c,, ) 
No vaccination 0 
Scenario 5065 0.5 
Scenario 8065 0.8 
Scenario 80 100 0.8 
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(Appendix B, cont. ) 
Variable Value 
Differential equations for the fitting and simulation of vaccination 
dU 
e, V + r, ýF + 
(0ý(U +V+ WM - (17( 
V )))(I UU - rAUV - c. V,,, (0.333)U Tt ý (U +V+ W) 
dV 
= rAUV - EY -, u, v dt 
dW 
= c. V,., (0.333)U + (aý (U +V+ W) (I - (q( 
V 
))) (C'V") - 11W - -r,,, W dt (U +V+ W) 
dX 
= ecy + (Cý(X +y+ Z)(I - OX 
y )))(I -(c, v,,, ))-AX - y,, 8, XY - c. v,, 9(0.333)X + r,, Z dt (X +Y+ Z) 
dY 
= y,, 6, XY - eýY -, uX dt 
dZ 
=c-v,, 9(0.333)X+(ný(X+Y+Z)(i-(q( 
y 
dt (X+Y+Z) 
))(C, VSý, )-/J, Z-rS., z 
dA 
= a, (A +B+ C) + AC - ((A, rA Y) + (. 8, r, A V)) -, U, A dt 
dB 
t t T= 
A Y) + (, 0,, r, A V)) -, U, B- x6 
dC 
= )tB _ PC _ AC dt 
0.83 during vaccination campaign, accounts for stable sheep population assumption. 
Def = definition. 
0.28 during vaccination campaign accounts for stable cattle population assumption. 
Also accounts for loss of efficacy in field. 
Also accounts for loss of efficacy in field (U). 
5065 = scenario with 50% coverage and 65% efficacy. 
8065 = scenario with 80% coverage and 65% efficacy. 
80100 = scenario with 80% coverage and 100% efficacy. 
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Appendix C. Key functions used to link disease outcome to human health and livestock productivity 
Area Definition 
Human health 
Number of cases = (Population/proportion of age and sex class), exposure constantb 
Livestock productivity 
Fertility = Annual number of offspring per breeding female 
= Baseline fertilityc x (1 - (Beta-Pert (10%; 15%; 50 %)d X prevalence)) 
Cattle milk production = Annual milk production per lactating female, 
= Baseline milk production eX (1 - (Beta-Pert (10%; 15%; 25%)' x prevalence)) 
Cumulative incidence. 
Age- and sex-specific exposure constant, derived from the proportion of the respective age or sex group among those with disease to their respective 
proportion in the total population (01) based on the reported brucellosis cases in 1999 (Appendix B). 
Baseline proportion of annual number of offspring per breeding female in cattle, sheep, and goats. 
Beta-Pert Distribution (D2) with minimum, most likely and maximum decrease of fertility among diseased (considers abortions, sterility, and mortality 
of newborn) (Appendix Q (W). 
Baseline annual milk production per breeding female. 
Reduction of milk production among seropositive adult female animals (Appendix Q (W). 
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Appendix D. Calculation of exposure constants' 
Population Human population Proportion of Reported human Proportion of all Exposure 
of Mongolia in total population brucellosis cases brucellosis cases constant 
1999 (a) in 1999 (b) (e) 
Children 
Aged <5 years 193 900 0.08 is 0.01 0.0008 
Aged 5-15 years 604 500 0.25 152 0.10 0.0250 
Women 834 900 0.34 611 0.41 0.1394 
Men 813 100 0.33 704 0.48 0.1584 
Total 2 446 400 1482 
, Exposure constants, e= axb, calculated based on 1999 population and reported brucellosis data (23, Ministry of Health, personal communication). 
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Disease data from the transmission model, 
Prevalence (p) 
In unvaccinated animals (sheep and cattle) for years 1 to 10 Normal (mean, Standard deviation) 
In vaccinated animals (sheep and cattle) for years 1 to 10 Normal (mean, Standard deviation) 
Cumulative incidence (c) 
In humans if animals unvaccinated for years 1 to 10 Normal (mean, Standard deviation) 
In humans if animals vaccinated for years 1 to 10 Normal (mean, Standard deviation) 
Livestock prices (MNT) (E 1) 
Sheep 
Meat off farm (/kg) Normal (754; 3 11) 
Hides off farm (/hide) Normal (3617; 1322) 
Goats 
Cashmere (/kg) Normal (34583; 5485) 
Meat off farm (/kg) Normal (754; 3 11) 
Hides off farm (/hicle) Normal (7083; 4875) 
Cattle 
Meat off farm (/kg) Normal (692; 248) 
Hides off farm (/hide) Normal (14083; 2476) 
Decrease in livestock production (E2) 
Fertility (sheep, goats, cattle) (Beta-Pert (10%; 15%, 50%) 
Milk production (cattle) (Beta-Pert 0 0%; 15%; 25W) 
Human health cost (MNT) 
Hospital costs per day (for Ministry of Health) (B) Normal (8646; 5194) 
Outpatient visits (E4) Normal (4; 2) 
Unit cost (out of pocket) 
Current transport (E, ý Pert (0; 3200; 80000) 
Hospital hotel (E4) Pert (0; 2000; 2 SOOO) 
Hospital food (E4) Pert (0; 3000; 8SO00) 
Hospital drug (E4) Pert (0; 1 500; 6SO00) 
Doctor fee (E4) Pert (0; 500; 30000) 
Loss of income per case (E4) Pert (9000; 30000; SOOOOO) 
I Data used were outputs of Versim Monte Carlo sensitivity analysis. 
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Appendix F. Herd composition and productivity parameters in 1999 
Variable Value Source or basis of calculation or estimate 
Cattle 
Total population 3 824 700 (F 1) 
Female breeders in base year 1 449 800 (F 1) 
Male breeders in base year 72 490 Estimate a ratio of 1/20 for breeding male to female 
Female replacement in base year 391 446 Female calves ' survival rate 
Male replacement in base year 144 980 Estimate ratio of 1/20 for preselection of breeding male to female 
Other stock in base year 678 634 Total animals - all other categories (animals for offtake) 
Female young in base year 543 675 (Fl) 
Male young in base year 543 675 (F 1) 
Annual calving rate 0.75 (F 1) 
Survival rate of replacement 0.72 (F 1) 
Sheep 
Total population 15 191 300 (F 1) 
Female breeders in base year 6 846 500 (F 1) 
Male breeders in base year 136 930 Estimate ratio of 1/50 for breeding male to female 
Female replacement in base year 2 244 625 Female lambs 'survival rate 
Male replacement in base year 273 860 1/25 for preselection of breeding male to female 
Other stock in base year 6 790 Total animals - all other categories (animals for offtake) 
Female young in base year 2 841 298 (F 1) 
Male young in base year 2 841 298 (F 1) 
Annual lambing rate 0.83 (F 1) 
Survival rate of replacement 0.79 (F 1) 
Goats 
Total population 11 033 900 (F 1) 
Female breeders in base year 4 835 200 (F 1) 
Male breeders in base year 96 704 Estimate ratio of 1/50 for breeding male to female 
Female replacement in base year 1 585 220 Female lambs 'survival rate 
Male replacement in base year 193 408 1/25 for preselection of breeding male to female 
Other stock in base year 310 152 Total animals - all other categories (animals for offtake) 
Female young in base year 2 006 608 (F 1) 
Male young in base year 2 006 608 (F 1) 
Annual lambing rate 0.83 (F 1) 
Survival rate of replacement 0.79 (F 1) 
References 
Fl. Agriculture. In: Baji; khuu K, Tegshjargal T, Orso G, editors. Mongolian 
statistical yearbook. Ulaan Baatar: National Statistical Office; 1999. 
Bulletin of the World Health Organization 2003,81 (12) 
Human health benefits from livestock vaccination for brucellosis 
Appendix G. Human health input variables from household survey and Delphi panel 
Disease characteristic Value Source or basis of calculation or estimate 
Proportion of chronic cases 0.66 (G 1) 
Duration of illness (years) 4.5 Data on duration of clinical cure of 1000 brucellosis patients in Russia 
Proportion of inpatient in chronic cases 0.40 (G 1) 
Average age at onset (for DALYs) (years) 
Women 37.00 (0) 
Men 37.00 (0) 
Children 
Aged 5-15 IO. SO (0) 
Aged <5 3.20 (0) 
Inpatient days 
Women 21.00 (G 1) 
Men 21.00 (G 1) 
Children 
Aged 5-15 21.00 (G4) 
Aged <5 21.00 (G4) 
Proportion of hospitalization O. So (G 1) 
Rate of non-formal treatment 0.45 (G 1) 
Proportion of cases reporting loss of income 0.42 (G 1) 
Coping cost per case (MNT) 10.00 As we assume that relatives replace for the routine work of the patients 
and not extra persons have to be engaged; only a symbolic figure has 
been considered. 
Disability-adjusted live years 
Disability weight (D) 0.20 No reference was found so far. A class 0,2 has been chosen since the 
disease is perceived as very painful. Sensitivity analysis for 0,1 has been done. 
Discount rate (r) 0.05 Discount rate 5% with sensitivity analysis 3% based on the interest rate for 
savings in USD in Mongolia: 5.4% (November 2000) and real growing 
rate of the Mongolian economy: 3.3% in the last few years. 
Age weighing (C) 0.16 (G5) 
Parameter of age weighting (beta) 0.04 (G) 
Duration of disability in years (L) (median) 3.11 Data on duration of clinical cure of 1000 brucellosis patients in the Russian 
Federation (G2). a 
The frequency distribution of clinical disease duration fits best with an exponential function for an average duration of 4. S years. For duration of 
disease, we used @Risk expon function with beta = 4.5 years. For cost effectiveness, we used the median of the cumulated discounted DALYs, 
which corresponds to a median duration of brucellosis of 3.11 years 
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